UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-SB

GENERAL FORM FOR REGISTRATION OF
SECURITIES OF SMALL BUSINESS ISSUERS

UNDER SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

SUPERCONDUCTIVE COMPONENTS, INC.
(Name of Small Business Issuer in its charter)

            Ohio                                                  31-121318
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                              Identification No.)

                             1145 Chesapeake Avenue
                              Columbus, Ohio 43212
          (Address, including zip code, of principal executive offices)
                                 (614) 486-0261
                           (Issuer's telephone number)

Securities to be registered pursuant to Section 12(b) of the Act: None

Securities to be registered pursuant to Section 12(g) of the Act: common stock,
without par value


TABLE OF CONTENTS

Part I

Forward Looking Statements..................................................................................I-1
Item 1.           Description of Business...................................................................I-1
Item 2.           Management's Discussion and Analysis of Financial Condition
                   and Results of Operations ...............................................................I-16
Item 3.           Description of Property...................................................................I-20
Item 4.           Security Ownership of Beneficial Owners and Management....................................I-20
Item 5.           Directors and Executive Officers, Promoters and Control Persons...........................I-23
Item 6.           Executive Compensation....................................................................I-25
Item 7.           Certain Relationships and Related Transactions............................................I-27
Item 8.           Description of Securities.................................................................I-27

Part II

Item 1.           Market Price of and Dividends on the Registrant's Common
                    Equity and Related Shareholder Matters..................................................II-1
Item 2.           Legal Proceedings.........................................................................II-2
Item 3.           Changes in and Disagreements with Accountants.............................................II-2
Item 4.           Recent Sales of Unregistered Securities...................................................II-2
Item 5.           Indemnification of Officers and Directors.................................................II-2

Part F/S

Financial Statements........................................................................................F-1

Part III

Item 1.           Index to Exhibits.........................................................................III-1


PART I

FORWARD-LOOKING STATEMENTS

This document contains forward-looking statements that reflect the views of management with respect to future events and financial performance. These forward-looking statements are subject to certain uncertainties and other factors that could cause actual results to differ materially from such statements. These uncertainties and other factors include, but are not limited to, the words "anticipates", "believes", "estimates", "expects", "plans", "projects", "targets" and similar expressions which identify forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of the date the statements were made.

ITEM 1. DESCRIPTION OF BUSINESS

INTRODUCTION

Superconductive Components, Inc. ("SCI" or the "Company"), an Ohio Corporation, was incorporated on May 29, 1987 to develop, manufacture and market products based on or incorporating high temperature superconductor ("HTS") materials. HTS materials are complex metal oxides - ceramics - of certain stoichiometries (mixture ratios) which exhibit the superconducting phenomena under certain conditions. These complex metal oxides are identified as members of the Perskovite family of ceramic materials.

The strategy of the Company has been to find commercially viable applications for HTS materials and, subsequently, other ceramic and metal materials. The Company's objective has been to stay intellectually current with the advancing technology in HTS materials, and search out commercially viable applications by being in the market place. This objective has been widened to include other Perskovites, as well as other metals and alloys, in materials other than HTS materials.

Until 1998, the Company relied primarily on its own resources for the research and development necessary to stay current with HTS technology and also to develop products for other applications. In 1998, the Company engaged in sponsored research for Nanophase Technology Corporation, Inc. and also received several awards for research from two United States Government Agencies, NASA and the National Science Foundation. The Company intends to continue to seek such funding because this funding maintains and expands the technical understanding within the Company.

The Company believes that it is a leader in these technologies and that a foundation has been built for commercialization of these technologies in its chosen markets.

BACKGROUND OF SUPERCONDUCTIVITY AND ADVANTAGES OF HIGH TEMPERATURE SUPERCONDUCTIVITY

A superconductor is an element, inert-metallic alloy, or compound that will conduct electricity without resistance when cooled below a certain critical temperature. This phenomenon was discovered in 1911 in the metal Mercury when it was cooled with liquid Helium to -273DEG. Centigrade. This cooling enables the material to carry electrical currents without loss of energy and, due to the increased current the metals can carry, be used to generate very large magnetic fields. Scientists realized that the phenomenon of superconductivity raised the possibility of less expensive electrical generation and transmission, powerful magnets and levitation. In the past, the only way to achieve this phenomenon was to submerge the metals in liquid Helium. Because of the Helium's inherent instability in liquid form and cost issues, the wide spread use of superconductors in commercial applications was impractical. These metals, now known as Low Temperature Superconductors ("LTS"), are superconductive at temperatures from absolute 0 up to as high as +23DEG. K.

With the discovery of new ceramic compounds in 1986, superconductivity can now be accomplished at higher temperatures by using liquid Nitrogen to cooling. The boiling point of Liquid Nitrogen is 77 K or -196DEG.C. These new ceramics bring superconductivity into the realm of the practical since liquid Nitrogen is inexpensive, stable, long-lasting, and the largest component in our atmosphere and environmentally friendly. These materials are known as HTS.

I-1

HTS provide the potential for significant increases in performance of electrical systems. Every electrical application delivers electricity from its source to a user through the use of "conductors". However, conventional conductors, such as Copper, exhibit some performance disadvantages. These performance disadvantages include resistance to electric current, causing power loss, heat generation, interference and noise, each of which can significantly decrease the performance of electrical systems.

Superconductors have the ability to conduct electrical current with zero resistance, no power loss, and no generation of heat below some critical current. The performance advantages of HTS materials in electronics applications include reduced component size and weight, and increased operating speeds, and in transmission applications include lower on-line losses. HTS materials exhibit these properties when cooled to 77DEG. K, a process easily obtainable with inexpensive liquid Nitrogen. LTS require cooling to as cold as 4DEG. K or -273DEG. C, with the use of the more expensive liquid Helium.

The required use of liquid Helium has made wide spread applications of LTS superconductors impractical in many applications. The higher operating temperatures of HTS superconductors have reduced the operating costs for HTS products since the required liquid Nitrogen is inexpensive and readily available. However, the HTS material itself, as a ceramic, is more difficult to form into products than the metallic LTS materials. Therefore, it has been necessary to develop a number of new or modified processes to achieve satisfactory results with the HTS material. In its product lines, the Company believes that it has been a leader in the development of these processes.

HISTORY OF THE COMPANY

The Company was founded in 1987 by Dr. Edward R. Funk and his wife Ingeborg Funk to develop, manufacture, and market HTS materials for commercial applications of the newly-discovered superconducting ceramics. The Company's initial efforts were directed toward mastering the manufacturing process for making high temperature superconducting ceramic powders, as discussed in further detail below. During this period, the market for high temperature superconductors was very small, estimated at $1 million a year or less, consisting primarily of demonstration kits and small amounts of HTS powder for research purposes. Sales, though relatively small, covered a wide range of superconducting products, including powder, pressed "pills", and solid shapes for research applications.

Subsequently, the Company began to develop other forms of HTS materials. A broad commercial market for products using HTS superconducting materials has not yet developed, although small niche markets have emerged for some products. In the second half of 1989, the Company began to focus on the market for superconducting thin-film materials, made from the Company's sputtering targets. These HTS sputtering targets are used by customers of the Company in a vapor deposition process to make thin films of the target material. This process operates in vacuum, hence, the frequently heard term, vacuum disposition or Physical Vapor Deposition, ("PVD"). HTS thin films are then patterned, using techniques similar to those in the semiconductor industry, to manufacture sensors, circuits and other devices; which in turn can be used in medical diagnostics, geological exploration, advanced radar, wireless communication and other niche applications.

The Company's HTS products are produced and marketed by its SCI Division. A second division of the Company is marketing some of the non-superconducting products that the Company has developed. For a discussion of these products, see "The SCI Division - Non-Superconducting Products."

In 1992 the Company established the Target Materials, Inc. division ("TMI") and began to market sputtering targets of materials other than superconductors for thin film deposition. This division is located within the headquarters of the Company in Columbus, Ohio and shares facilities and staff with the SCI division.

ORIGINAL COMPANY FOCUS IN HTS PRODUCTS

The Company's original focus was to offer HTS powders in various stoichiometries and bulk solid state forms of HTS materials, including sputtering targets, Levitators, Magnetic Shields, and also various kits and support equipment and materials. These products will be described in more detail in the section entitled "Expansion of Company Product

I-2

Line" below.

The market for all HTS products, although small, has historically been represented by groups seeking to establish a fundamental understanding of the properties, principals and theory of these materials and also groups focused on applications of high temperature superconductivity. The ratio of fundamental to applications research continues to shift toward commercialization of the technology as demonstrated by the increasing number of beta prototype programs in the industry.

The Company provides the basic building blocks for many of these products, since nearly all applications of HTS start with powder, which is subsequently processed into products such as wire, sputtering targets, or large single crystals, which then can be used to manufacture transmission cables, superconductive magnets, sensors, Rf filters for wireless communications, and frictionless bearing systems for linear or rotating system applications.

The Company has a suite of proprietary processes that are utilized in the production of its products. As discussed later, the Company also has licenses of patents, and its own patent and patent applications in this field. See the section of this document entitled "Intellectual Property" for additional information.

The Company's proprietary ceramic powder and powder densification processes have been successfully adapted to other electronic ceramics that exhibit unique, non-superconductive, characteristics. Some of these materials are also in transition from fundamental to applications oriented development and may be the source of significant revenues in the Company's future. These materials can be categorized as ionic or electronic conductors and materials with unique magnetic properties such as the ceramics used in non-volatile computer memories.

EXPANSION INTO OTHER MATERIALS AND THE CREATION OF THE TARGET MATERIALS (TMI) DIVISION

By early 1990, it was clear to the Company that the market for HTS superconducting powder, targets and other HTS products was still too small (about $1 to $2 million annually) to assure survival and growth of the Company. Accordingly, the Company expanded its product line to include sputtering targets made of non-superconducting ceramics, metals and metal alloys. As the demand for these products grew it became evident that this new product line could expand more rapidly if it were managed as a focused, non-superconductive, effort. The metal, metals alloy and simple ceramic sputtering targets were then packaged into a new division named Target Materials, Inc. (TMI). TMI is not a corporation, but is used to identify Company products in the market place.

The total market for non-superconducting metal, metal alloy and simple ceramic targets for the thin film industry is estimated at $720 million globally. The Company, through its TMI Division, also embarked on a program to move selected products developed for research and development applications into production applications. The market for these more conventional materials is characterized by intense price competition. However, there are new materials being continuously investigated, and these new ceramics or metal alloys sometimes develop rapidly into significant markets. The Company believes that its position as a supplier of research and development targets has positioned, and will continue to position the Company as a supplier for these materials as they grow into production usage. In 1999, approximately 60.0% of the Company's target shipments were classified by the Company as production, and 40.0% were classified as research and development. This is a marked change from 100.0% classification as research and development shipments in 1995. The Company's objective is to achieve an 80.0% to 20.0% ratio of production to research and development shipments.

The Company has continually added production processes and testing equipment for the many product compositions that can be used as sputtering targets. The TMI Division standard products, as listed in its catalogue, now include nearly 200 items of ceramic materials and metals and alloys available in various sizes and shapes. TMI shipments were 67.0% of total Company shipments in 1999.

THE SCI DIVISION

The SCI Division primarily produces and markets the Company's various HTS products, which include both superconducting and non-superconducting products. The most significant of the Company's HTS products are discussed

I-3

below.

SUPERCONDUCTING PRODUCTS

HIGH TEMPERATURE SUPERCONDUCTIVE POWDERS. HTS powders are the building blocks for most applications of high temperature superconductivity. The Company offers a wide variety of HTS powders. Powders are manufactured using conventional solid state and wet chemistry, as well as proprietary processes developed or licensed by the Company. Superconducting powders represented approximately 4.0% of Company revenues in 1999, 3.2% in 1998, and 5.8% in 1997. The Company's HTS powder production is also used internally to make Levitators-TM-, HTS sputtering targets and other ceramic components.

Customers in the SCI Division have included several manufacturers of superconducting wire, wherein the powder is put into a tube and drawn and redrawn to very fine size. Such wire is now available from our customers and others in lengths sufficient to make superconducting magnets, motors, and power transmission lines. This market for the Company's HTS powder is expected to grow as these applications transition from research to prototype to production use. Some of these applications are now in the engineering-prototype stage, and are being evaluated with respect to their conventional counter parts.

The purpose of the engineering prototypes now in evaluation is to determine the technical and economic feasibility of the specific applications. It should be noted that, although it is unlikely that all of the initially configured prototypes now in test will be economically viable, there are a number of applications being tested, and the Company believes that some of these will certainly move into production in the next several years. The Company is particularly optimistic about cables, where the use of superconductors may reduce power transmission losses. In addition, because much higher currents can be carried in HTS cables for a given volume, there may be savings realized through the minimization of the disruption to dense cityscapes as the transmission and distribution grid is refitted to accommodate the unprecedented increase in demand for electric power.

Encouraging results are also being shown by companies other than SCI that make superconductive Rf filters for the distributed base stations which support the national wireless communication network.. Such applications of HTS promise to reduce noise level, decrease signal interference, and reduce the number of dropped calls. Additionally, some HTS equipped cellular base stations extend the range of the station.

Another promising application of HTS is fast response fuses, sometimes called fault current limiters. In this case, the very short (fraction of a cycle) response time of HTS material to voltage surges on electric transmission and distribution networks may reduce downtime and capital expenditures for utilities. HTS fault current limiters are self-resetting and, unlike conventional fuses, are not destroyed by a voltage surge. The Company currently has an alliance with Argonne National Laboratory in the development of this device. This product has not yet reached the prototype test stage.

It is well-known that the major market for LTS superconducting wire is in magnets for medical Magnetic Resonance Imaging ("MRI") systems. Recent tests show that HTS wire may have an economic and technical advantage for this application. Cost advantages may be achieved in new systems by the elimination of liquid Helium cooling. Technical advantages may be achieved through the higher fields obtainable by using HTS materials at very low temperatures.

The Company makes the raw materials that are used by the manufacturers of the above mentioned products, and actively solicits the business of those making such products.

SUPERCONDUCTING SPUTTERING TARGETS. The Company converts its powders into dense, precisely machined ceramic components which are used as sputtering targets by its customers for the manufacture of superconductive thin films. These thin films can then be etched in a patterns to produce electrical devices such as superconductive quantum interference devices ("SQUIDS") that are extremely sensitive to small electric and magnet fields, such as brain waves, a passing submarine, or certain electric and magnetic signatures of ore or oil deposits. This market was 3.2% of Company revenues in 1999, 2.1% in 1998, and 5.3% in 1997.

I-4

HTS materials, as thin and thick films both as sputtering targets and powder are currently used in Rf filters microwave applications such as in cellular base stations. At this time, there are several companies whose superconductive Rf filters are going into limited production. These companies include: Superconductor Technologies, Inc., Conductus, Inc., and Illinois Superconductor Corp. Other companies are thought to be developing such products based on HTS materials. The Company is a potential supplier to these producers for both HTS powder and sputtering targets.

The 'next generation' of HTS wires and cables is expected to be based on the deposition of the Ittrium Barium Copper Oxide ("YBCO") superconductor on textured metals. The deposition of the YBCO conductor is being pursued in the United States and Japan by use of the Company's sputtering targets. While this application is expected to take several years to develop, for now it enables the Company to participate in near term applications of HTS wire through its Bismuth, Strontium, Calcium, Copper and Oxygen ("BSCCO") materials, and future requirements through its YBCO ceramic components.

"LEVITATORS-TM-". The Company has a non-exclusive license from Argonne National Laboratories for producing seeded and melt textured YBCO large single domains which the Company has been issued the trademark "Levitators-TM-." A superconducting Levitator-TM- is a compact of the Company's superconductive powders which have been processed to form a large C-axis oriented grain that exhibits a high critical current density and considerable diamagnetism. The Company has advanced its technology well beyond the original Argonne licenses and expects to be issued a patent for its own proprietary processes to manufacture Levitators-TM- . At this time, the Company's large domain Levitators-TM- ("LDL"), made from its superconducting powders, exceed 30 Newtons of separating force when used with certain magnets. This value is high enough to make practical several applications including near frictionless bearing systems, flywheels energy storage devices (so called frictionless flywheels), and linear transportation devices (i.e. Maglev trains).

In 1996 the Company supplied approximately 1,600 Levitators-TM- to a major utility for a prototype frictionless flywheel energy storage ("FFES") device. The FFES device is a flywheel that rotates in an evacuated chamber and is supported by HTS Levitators-TM- so that there are no mechanical bearings. The friction factor is more than a 1,000,000 times less than the best mechanical bearings. Under these conditions, very little energy is lost to friction. Energy is applied to the flywheel to spin it up, and energy withdrawn at nearly 90.0% efficiency as needed.

At this time, the major utility company has placed the development of FFES units on hold pending further funding. The prototype for which the Company supplied for the Levitators-TM- is said to have demonstrated the feasibility of HTS levitated frictionless bearings for this application.

The Company has engaged in further research and development on its Levitators-TM-, with a view toward enhancing their performance capability and reducing the costs of production. The Company has focused its efforts on identifying a suitable replacement for one of the most expensive components of its basic powder mix for Levitators-TM-. If successful, levitator production costs will be substantially reduced.

The Company continues to collaborate with Argonne National Laboratory through a Creative Research and Development Agreement in order to advance the technology and broaden the range of applications for which Levitators-TM- are applicable. Improvements in performance, combined with a significant reduction in manufacturing costs, are expected to result from this multi-year, cost sharing, program.

The United States electric power industry is scheduled for deregulation in the very near future. This will force competition to occur between power providers well beyond their current regional boundaries. The public utility that purchased the Company's large domain levitators in 1996 currently supplies 5.0% of the electrical power used in the United States. Officials at the utility have advised the Company that they view the development of the FFE system as a key component of their competitive strategy. Other utilities may also use these systems in their competitive strategies. There are also programs to develop similar energy storage devices in Japan, the United Kingdom, Korea and Germany.

SUPERCONDUCTING ACCESSORIES. The Company provides certain accessory products that are needed, in addition to the Company's core HTS materials, to support its customers' research or manufacturing programs. These products include substrate materials, single and polycrystalline, such as Lanthanum Aluminate, Spinels and Garnets, and oriented

I-5

Magnesium Oxides. HTS accessories were 1.7% of Company revenues 1999, 1.3% in 1998 and 1.6% in 1997.

DEMONSTRATION KITS, INSTRUMENTATION ACCESSORIES FOR SUPERCONDUCTIVITY EDUCATION. Demonstration kits were the first products sold by the Company in significant volume. Packaged for the educational community, the Company continues to manufacture a family of laboratory demonstration kits designed to exhibit the key features of perfect conduction, diamagnetism and flux trapping that are unique to HTS materials. These kits are marketed directly by the Company and also through a network of educational product distributors which include Edmund Scientific, Arbor Scientifiy, Beckly Cardy and others. The instrumentation and accessories offered by the Company include a wide range of discs, dies, rare earth magnets, vacuum jars, box furnaces, digital volt meters, dewars and flasks, and related items. These combined categories represented approximately 0.6% of Company revenues in 1999, 0.9% in 1998 and 1.2% in 1997.

NON-SUPERCONDUCTING PRODUCTS

Beginning in 1996, the SCI Division of the Company manufactured and sold non-superconducting, as well as HTS products for commercial use which can be categorized as engineered powders, engineered parts, and engineered components. Products in these categories are described below.

ENGINEERED CERAMIC POWDERS. The Company has adapted its proprietary Ceramic Oxide powder production processes for the manufacture of fine, ultra-fine and nano-crystalline powders of non-superconductive materials to support a variety of expanding applications requiring electronic ceramics. These powders are used by customers of the Company in the development or manufacture of:

- Solid Oxide Fuel Cells ("SOFC");

- Ceramic Membranes for the separation of natural gas from its contaminants;

- Lithium ion batteries;

- Ceramic electrodes for harsh environments;

- Ceramic electrodes as a replacement for precious metals; and

- Capacitors.

Engineered ceramic powders were 0.01% of Company revenues in 1999, 0.4% in 1998, and 0.5% in 1997.

CERAMIC SPUTTERING TARGETS. The Company has adapted its proprietary ceramic powder densification processes to manufacture a variety of sputtering targets from its line of electronic ceramic powders. Many industries are working to utilize the unique properties of electronic ceramics to the enhance performance or reduce cost of their products.

Sputtering targets composed of complex Ceramic Oxides for applications such as non-volatile memory, thin film capacitors, thin film electrodes, and transparent electronic conductors are an emerging product line for the SCI Division, comprising 5.9% of the SCI Division's revenues in 1999, 5.8% in 1998 and 6.6% in 1997. The hope of the Company is that materials developed to supply customer's research requirements will grow into large scale production orders with the commercial success of the next generation of thin-film-based electronic devices. The Company has certain proprietary knowledge and trade secrets related to the manufacturing of these non-superconductive Ceramic Oxides sputtering targets.

SENSORS IN DEVELOPMENT BY SCI DIVISION

The SCI Division also has two development contracts involving its products to make sensors for gases at high temperature and temperature sensors for very low temperature applications. These two development contracts were 1.2% of Company revenues in 1999. The Company was not in this field of sensors prior to 1999.

SENSORS FOR HARSH ENVIRONMENTS- GASEOUS OXIDES OF NITROGEN. For

automobiles, public utilities, and other

I-6

generators of oxides of Nitrogen gas ("NO(x)"), currently no low cost detection system exists. The harmful effects of NO(x) are well known component of the green house gases that are damaging to the environment. The United States and other foreign governments continue to fund the development of solutions to reduce green house gasses in which sensors are a part of the detection and correction system. Once developed, these solutions may be legislated upon the market place. The low-cost NOx sensor market is global and may be expected to exceed several million dollars in the next decade.

The Company has recently completed Phase I of the design, development and manufacture of a sensor for NO(x) to be used in harsh environments, such as the exhaust stream of internal combustion engines. The goal of the program, funded through a competitive award by the National Science Foundation, is to build on the Company's strengths in ceramic fabrication and to devise a device, based on the ionic conductive properties of certain multi-component oxides, that is both low in cost, and also highly sensitive to NO(x) in the range required for future automobiles.

The development of a NO(x) sensor, suitable for use in next generation spark-ignition direct injection engines, or SIDI, has been given the highest priority by stakeholders in the industry, including major automobile and engine manufacturers. New, lean-burn engine technologies are nearing commercial reality, but they lack adequate sensors to monitor and control the quality of exhaust in order to operate within federally mandated pollution guidelines.

SENSORS FOR CRYOGENIC TEMPERATURES - YBCO BASED. Ultra high precision temperature sensing in the range of 77DEG. - 92DEG. Kelvin is a small niche market. The skill set developed to perfect this device will serve the Company in the manufacture of all of its planned sensors. While temperature sensors for the broad range of 4.2DEG. K to 300DEG. K are well understood, and available by reputable commercial enterprises, a greater accuracy over a limited temperature range may be a competitive advantage for YBCO based sensors in new and dynamic applications such as magnetic levitation ("MAGLEV") and flywheel energy storage, where very small temperature excursions may be used as the predictors of system disruptions or failure. In this effort the Company currently has an alliance with CRI, Inc. of Cambridge, Massachusetts.

STRATEGIC ALLIANCES, MAJOR CUSTOMERS AND SUPPLIERS

The Company attempts to do most development work in the SCI Division in cooperation with partners who will ultimately consume, or may serve as a channel to market, the Company's products and technology. In this way, the Company remains focused on providing value-added materials solutions for a range of commercial applications.

Most of the Company's products are manufactured from component chemicals and metals supplied by various vendors. The SCI Division is dependent upon ultra high purity Yttrium and other rare earths to manufacture its superconducting products. Several suppliers currently satisfy the Company's requirements for these rare earths. If the Company suddenly lost the services of such suppliers, there could be a disruption in its manufacturing process until the suppliers were replaced, but the Company has identified several other firms as potential back-up suppliers who would be capable of supplying rare earths to the Company as necessary. To date, the Company has not experienced an interruption of raw material supplies.

The top 5 suppliers to the SCI Division in 1999 were, in descending order: Argonne National Laboratories, Noah Technology Corp., MTI Corp., Cerac Corp., and Praxair Corp. In every case, the Company believes that suitable substitute vendors could be found. Also, as the Company's volume grows, the Company may make alliances or purchasing contracts with these or other vendors.

No customers in the SCI Division accounted for 10.0% or more of the total SCI revenue in 1999.

RESEARCH AND DEVELOPMENT

Materials produced by the SCI Division are utilized in markets which are either emerging (such as the various applications of HTS), or well established, but requiring the performance or cost advantages that may be available through the application of electronic ceramics (such as the semiconductor and functional thin film coatings industries). The Company's objective is to utilize its expertise in ceramics, metallurgy, materials science, chemistry and technology

I-7

transfer for the purpose of identifying new materials thought to have commercial potential and to develop that potential through an internal production division (as in the case of Target Materials), or by partnering with key industry players to grow with applications as they evolve from innovative ideas to commercial success.

The Company's initial focus on HTS was shifted upon the realization that the market for that technology would take several years to develop, and that the Company's talents and capital base could also be used to provide materials solutions in a wide range of other industries. While HTS is expected to develop into a multi-billion dollar industry in the first decade of this century, the Company has diversified its efforts to concurrently participate in other materials markets. The emphasis of SCI's Division's Research has been broadened to include engineered ceramic oxide materials.

The SCI Division of the Company remains focused on the development of materials, processes and devices based on its core skills in ceramic powder fabrication, powder densification, thin film technology, and most recently thick film technology. These developments are realized through partnerships with its many customer collaborators. The Company's reliance on a commercial customer collaborator optimizes its development expenditures by focusing on the projects where customers have identified markets and agree to provide future revenue streams based on the successful completion of the project.

COMPANY SPONSORED RESEARCH AND DEVELOPMENT. The Company often undertakes commitments in the ordinary course of business that require the Company to develop methods or processes that expand the Company's skill set. In general, the Company does not initiate a formal development program to accomplish these tasks, but does absorb any expenses which may exceed the revenues provided by clients, as part of its internal development costs.

SPONSORED PRODUCT DEVELOPMENT PROGRAMS WITHIN THE SCI DIVISION

The Company has a number of research programs, including two Phase II SBIR's (Small Business Innovative Research) that are sponsored by government agencies. These programs are being conducted within the SCI Division. These programs are all believed to have significant commercial potential if the respective technologies can be fully developed. SBIRs and sponsored research and development contracts accounted for 15.9% of Company revenues in 1999, 18.8% in 1998, and 0.2% in 1997.

Several public and privately funded programs currently support continued product, process and component development within the SCI Division.

Sponsored programs include:

- NASA (National Aeronautics and Space Administration), beginning on April 1, 1999, funded a Phase II SBIR for a $580,000 program over 2 years to demonstrate the feasibility of manufacturing a large, bi-layered superconductive toroid
(ring) and related levitation/rotation system for gravity modification experiment in cooperation with Argonne National Laboratories and Wright State University. The Company's share for in-house work on this project is $310,000 over 2 years. The contract may be cancelled at any time and the 24 month duration expires on May, 2001.

- THE NATIONAL SCIENCE FOUNDATION ("NSF"), beginning on September 1, 1999, funded a Phase II SBIR program over 2 years for $400,000 for advanced manufacturing of BSCCO superconductive powders for low cost, continuous HTS wire fabrication, (with partner Intermagnetics General Corporation, Advanced Superconductor Division). The Company's share of this funding is $200,000 over 2 years and the contract may be cancelled at any time. This program expires on August 31, 2001.

- NSF, beginning on July 1, 1999, funded a Phase I STTR (Small Business Technology Transfer Program) for $100,000 for the development and technology transfer of a sensor for oxides of Nitrogen gas to be used in harsh environments, i.e. an automobile exhaust stream, (with partner the Center for Industrial Sensors and Measurement at the Ohio State University). The Company's in-house share of this funding is $50,000. This program expired on June 30, 2000 although work continues on the device in preparation of a Phase II grant application which will be submitted in January 2001.

I-8

- THE CAMBRIDGE RESEARCH INSTRUMENT CORP., funded by a Phase II SBIR (Small Business Innovative Research) subcontracted with the Company for $25,000 for the development of a superconductive temperature sensor tunable for a specific 2DEG. K region around the boiling point of liquid Nitrogen (77DEG. K) for use in a unique geological instrument. This program began on September 1, 1999, and ends on September 30, 2000.

- CERAMPHYSICS, INC., which has a funded Phase II SBIR (Small Business Innovative Research) subcontracted with the Company for the development of HTS electrodes to replace Platinum in a Department of Defense application of cryogenic capacitance energy storage. This program is for $20,500 and ends on September 1, 2001. A second phase of the program has been funded outside the government for a 13 month period beginning October 1, 2000.

All of the sponsored research and development contracts can be cancelled at the sponsor's option, with accrued costs being paid. As of August 1, 2000, the Company had $456,432 of funding from government sponsored research and development programs that could be cancelled at any time. In the event of cancellation, the SCI Division revenues would drop to half the billing rate of 1999 until or unless other non-governmental revenues or other governmental programs replaced the short fall.

To date, federal funding has been directly or indirectly responsible for an estimated 80.0% of the developmental funding of the HTS industry. Such funding, plummeted in 1992 and 1993 when the Supercollider project was terminated. Federal funding has rebounded somewhat in recent years. Management of the Company anticipates that any increase in funding for superconductivity research may benefit the Company indirectly, since many of its customer's research and development efforts receive government funding. However, while the Company continues to submit proposals to federal and private funding organizations, there is no assurance that the Company will be awarded similar contracts in the future.

COMPETITION IN THE HTS INDUSTRY

The Company has a number of domestic and international competitors in the HTS field, many of whom have resources far in excess of the Company's resources. After more than a decade of intensive development work, commercial prototypes of various large scale HTS applications are now reaching prototype test stage. It is anticipated that as commercial devices based on HTS technology begin to gain wide spread acceptance, and the attractiveness of the industry improves, new competitors for powders, sputtering targets and large superconductive single crystals will emerge. A major United States competitor of the HTS Division is The Surface Science Division of Praxair Corporation. In Europe, the SCI Division competes principally with a spin-off of Herchst Chemical Company, now named Adventis, a division of Aliatec Corporation of France. In Japan, the SCI Division's principal competitor is the DOWA Chemical Company. Some of the developers of HTS based products, such as American Superconductor Corporation, have also chosen to internally manufacture the HTS powders that they require, and therefore compete with the Company in some cases, or foreclose themselves as potential customers of the Company.

MARKETING AND SALES

The SCI Division markets its products by direct sale in the United States. Most of the Division's orders are in response to requests for quotations. The SCI Division distributes a catalogue of its products, exhibits at the several relevant shows, and engages in direct mailings. The Company also has an operating website: www.superconductivecomp.com. The Company intends to intensify its marketing efforts in the future.

The SCI Division also sells its products to distributors in some foreign markets. In March 2, 2000, the Company announced that Earth Chemicals in Japan was selected as the exclusive distributor for Japan. The Company has non-exclusive distributors in Europe, Korea, Taiwan, Israel and Singapore.

The global acceptance of the Internet has greatly increased the SCI Division's ability to promote itself to the entire scientific community, and thereby facilitated direct sales, engineering and customer support from the Company's

I-9

Columbus, Ohio facility. Notwithstanding an increasing number of distributors, more than 75.0% of the SCI Division's international sales are handled directly by the Company's in-house sales staff.

In addition to distributors and representatives around the world and its Internet website, the Company maintains a modest print advertising program, which includes the magazines PHYSICS TODAY, SUPERCONDUCTOR, CRYO-ELECTRONICS and the THOMAS REGISTER OF MANUFACTURERS. The Company publishes technical articles in scientific journals and presents technical papers at technology-based conferences, workshops and symposia.

The Company has sold HTS products to 42 countries worldwide. Approximately 25.0% of the Company's sales are foreign sales. The total number of customers served by the Company was 185 in 1999, 129 in 1998, and 95 in 1997.

Customers that accounted for more than 10.0% of the SCI Division revenue in 1999 were: NASA, NSF, NJB Pacific Corp., ENEA Corp, and Oxford Instrument Corp.

PRODUCTION CAPACITY

The SCI Division has a current HTS powder production capacity of approximately 700 kilograms per year, but is expected to increase to 1,200 kilograms per year in 2000. Increasingly, the customers of the SCI Division are inquiring about the production capacity of the Company for their future production requirements. Based on this experience and occasional loss of customers to larger competitors, management views the expansion of HTS capacity in the SCI Division as a primary objective in the year 2000.

QUALITY CONTROL

The Company's quality program uses a network of trusted and qualified suppliers, backed up by the Company's internal and contracted analytical capabilities. Incoming raw materials are tested, when required, for suitability using techniques such as X-ray diffraction, Inductivity Coupled Plasma spectrometry, Particle Size Analysis, and other methods. In addition to these tests, sample lots of the Company's complex ceramics are often fabricated to determine if a new supplier and/or new lot of input materials can be used to make a product to specification.

The quality assurance processes for Company products include Critical Temperature, carbon content, or packing density. The Company certifies its products for phase purity by XRD (X-ray Diffraction), for major and trace elemental composition by ICP (Inductively Couples Plasma), and mechanical tolerances using certified calipers and micrometers.

The amount of rejected product during internal processing was 4.5% of revenues in 1999, 3.0% in 1998, and 4.3% in 1997. Customer returns of SCI Division products were 0.1% of revenues in 1999, 0.5% in 1998, and 0.7% in 1997

The Company owns its quality control equipment and also selectively contracts with a network of domestic vendors for additional analytical capabilities. The Company's in-house analytical instruments include:

- Inductively Coupled Plasma Spectrometer (ICP) manufactured by Leeman Laboratories, Inc.;

- Particle Size Analyzer (PSA) manufactured by Toshiba Corporation.;

- X-ray diffractometer (XRD) manufactured by Rigaku Corporation;

- Electronic Dispersive X-Ray Spectrometer (EDS) manufactured by EDAX;

- Differential Thermal Analyzer (DTA) manufactured by Perkin Elmer Corporation;

- Scanning Electron Microscope (SEM) manufactured by ISI Corporation;

- Various digital calipers, analog calipers, digital and analog micrometers, routinely calibrated against NIST (National Institute of Standards) traceable standards; and

- Various digital weight scales that are routinely calibrated against NIST traccable standards.

I-10

INTELLECTUAL PROPERTY

The Company has developed or acquired intellectual property in the form of patents, patent applications, and licenses on patents.

PATENTS. The Company has applied for and received from the United States Patent and Trademark Office patent # 5,863,867 dated January 26, 1999, for Fine-Particle Bi-Sr-Ca-Cu-O Having High Phase Purity made by a Chemical Precipitation and Low-Pressure Calcination method. This material is used to make HTS powder at this time.

Several other patents have been or will be filed covering all aspects of the HTS field, including the basic concepts, the powder composition, processing, and products. Industry wide, it has been reported that over 4,000 applications exist for HTS materials, processes and applications. The Company does not have a license or patents covering all products that it makes and markets in the HTS field. The issue of ownership of basic patents for HTS materials and processes is not yet determined, and is in contention. The Company anticipates that it will be several years before these patent ownership issues are settled.

The Company may not be able to obtain licenses for manufacturing from the patent holders. Furthermore, the Company may have a liability, which cannot be determined at this time, for products produced prior to the issuance of the patents. The Company may not have the resources to defend itself in the event of a patent lawsuit (although the Company knows of no such lawsuits pending at this time).

The Company's patent attorneys are Hudak and Shunk of Akron, Ohio. Ms. Laura Shunk, a partner in that firm, is the daughter of Dr. Edward R. Funk, President of the Company.

PATENT APPLICATIONS. The Company has applied to the United States Patent and Trademark Office for a patent number covering Large Weld-Connected Superconducting Monoliths and Process for Making Same. The application date is July 1, 1998. The patent is assigned to the Company. Notice of allowance for this patent application has been received and the Company expects a patent to issue in the near future.

TRADEMARKS. The Company owns a trademark on the word "Levitator-TM-", which is used to describe the SCI Division's line of large domain YBCO seeded and melt-textured monoliths.

NON-EXCLUSIVE LICENSES. The Company has the following non-exclusive licenses:

- Sandia National Laboratories - Sandia Chemical Prep Process for line YBCO superconductive powders, license #95-000131, based on U.S. patent #4,839,339, dated June 13, 1989.

- Argonne National Laboratory Low Pressure Calcination process for low Carbon HTS material. License # ANL-IN-89-030, based on U.S. patent # 5,086,034.

- Argonne National Laboratory Levitator Package. Licenses # ANL-IN-93-008, ANL-IN-93-130, ANL-IN-93-134 based on U.S. patents # 5,504,060 (Method of Harvesting Rare Earth Barium Copper Oxide Single Crystals), #5,549,748 (Method of Harvesting Single Crystals from a Peritectic Melt), and # 5776,864 (Large Domain 123 Material Produced by Seeding with Single Crystal Rare Earth Barium Copper Oxide Single Crystals).

The Company's license agreements with Argonne and Sandia National Laboratories form the core of its technology base in HTS powder and device fabrication. The Company acquired these licenses for less cost than it could have developed similar technology internally, and was able, based on the speed at which the Company was able to commercialize the resulting HTS products, to create a revenue stream within a few months of license acquisition dates. Subsequently, the Company has built on these licenses to create its own intellectual property in the form of patents, patent applications, and industrial knowledge.

I-11

LICENSED POWDER PROCESSING TECHNOLOGIES. The processes used by the Company to manufacture High Temperature Ceramic (superconductive) Powder were invented at various national research laboratories operated by the Department of Energy. The Company has licensed these processes from the Department of Energy, which gives the Company the legal right to practice the technology in exchange for a small royalty on sales. The powders are then used to make pressed shapes which can become sputtering targets or Levitators-TM- or they can be sold without further processing to customers who will combine them with other materials to make superconductive wire and cable.

TRADE SECRETS. The Company uses the following trade secrets in the manufacture of its SCI Division products:

- Powder fabrication in non-SC powders;

- Powder densification in YBCO and Non-SC material;

- Fabrication of BI-layer structure of YBCO for use in Gravity Modification; and

- Fabrication of nano-materials.

THE TMI DIVISION

The TMI Division manufactures and markets source materials, both ceramics and metals for the thin film vacuum deposition industry (PVD - Physical Vacuum Deposition Industry). The TMI Division has served over 900 customers worldwide, with approximately 30.0% of all business being foreign sales during 1999. The TMI Division has shipped to 40 foreign countries over the past five years.

While serving as critical raw materials for the fabrication of a variety of highly engineered thin film products -- from integrated circuits to window coatings -- sputtering targets are themselves high-value-added advanced materials.

THE SPUTTERING TARGETS INDUSTRY

A number of technological changes are occurring within the sputtering industry. For example, higher purity sputtering targets and new target materials are emerging to improve the performance of thin film products for certain applications. Also, sputtering target fabrication methods, and cathode designs, are being refined and optimized to improve target material utilization and process efficiency.

The CERAMIC BULLETIN, October 1999, summarizes sputtering target consumption as follows:

                      SPUTTERED FILMS AND SPUTTERING TARGETS

--------------------------------------------------------------------------------------
                                                              AAGR*
WORLD MARKET                                1999              2004             (%)
                                            EST'D             EST'D            EST'D

--------------------------------------------------------------------------------------
Total film area (million m2)                363                764             16.0
Target consumption (million kg)             2.9                3.9              6.0
Target consumption (million lb)             6.4                8.5              6.0
Approx. target units consumed (000)         374                510              6.4
Value of material consumed (MM$)            720               1100              8.8

Source: Business Communications Co. Inc., Norwalk, Connecticut
* Average Annual Growth Rate

An estimated 2.9 million kilograms (6.4 million pounds) of sputtering target material will be consumed in 1999 to sputter-deposit 363 million square meters of thin films for microelectronics, data storage, advanced display and optical coating applications. This projection shows that, worldwide, the production of sputtered films will increase at an average annual growth rate ("AAGR") of 16.0% from 1999 to 2004, reaching 764 million square meters of sputter-deposited films in 2004.

I-12

Application of sputtering targets include the following industries:
Optical Filters, Flat Panel Displays; Photovoltaic Cells; Electronic Switches; Thin Film Resistors; Decorative Coatings; Thin Film Batteries; and Tool Coating for Wear Resistance, non-glare glass and mirrors and semi-conductors.

TMI DIVISION PRODUCTS

SPUTTERING TARGETS. The Company has chosen to focus on production applications in industries other than the semi-conductor industry. Thus, the focus of the Company is on the use of sputtering targets in industrial applications. Sputtering targets are offered in an extensive line of materials, including most ceramic materials and various metals and alloys. Customers in the solar panel, tool coating, decorative coating, electronic, optical and research industries use these targets. Non-superconducting targets represented approximately 66.4% of Company revenues during 1999, 66.6% in 1998 and 77.0% in 1997.

BONDING AND BACKING PLATES. Bonding is the process of adhering a sputtering target to a backing plate to prepare the target for use in the physical vapor deposition process. The Company offers bonding on its own, or customer supplied, backing plates with metallic solder or silver epoxy. High purity copper backing plates can also be used in thicknesses ranging from .125" to 1" on sizes from 1" to 12" and rectangles to 72" long. Bonding services generated approximately 5.5% of Company revenues in 1999. In earlier years, TMI had the bonding done though an outside source.

PROCESS KNOWLEDGE

Since its inception, the TMI Division has invested heavily in practical in-house research and development. Each item of the nearly 200 items now offered in the TMI Division's catalogue has required some degree of development, including finding vendors, developing the manufacturing processes and methods of control and standardization. The process knowledge is captured in written specifications, process set cards, logs, operating procedures and other means.

COMPETITION

The market for sputtering targets is very competitive. The Company has numerous competitors, most of which are larger and have greater financial resources than the Company. Domestically, the Company views Puretech, Inc., a division of Williams Advanced Materials, itself a division of Wellman Corporation, and Cerac Corporation as their primary competitors over the entire line of manufactured products, although as many as 30 competitors exist and compete for different portions of the sputtering target market. Further, some primary metal suppliers also produce sputtering targets.

Additionally, there are a number of foreign competitors producing sputtering targets and thin-film deposition materials throughout the world. Management believes that Tosoh Corp. has the largest worldwide market share, followed by MRC Corporation (a division of Praxair Corp.), VMC Corporation, Johnson Mathey Corporation, Nippon Mining Corporation, Puretech Inc., and Cerac Inc. All enjoy vastly superior resources than those possessed by the Company. However, few of these competitors focus their marketing efforts on the research segment of the market, due to the low volumes that characterize this market niche. Management estimates that the TMI Division has achieved a 15.0-20.0% market share of the research and development market segment.

The Company believes that the principal competitive factors in this market are price, service, quality, reliability, reproductability, availability of technical information, and timely deliveries.

The Company strives to differentiate itself from its competitors by providing a full line of manufacturing capabilities, maintaining an excellent quality rating by achieving quick turnaround on manufactured orders, and by providing personalized customer service.

Although TMI's objective is to achieve an 80.0% to 20% ratio of shipments for production to research and development, at this time, the ratio is approximately 60.0% production to 40.0% research and development. Obtaining

I-13

production business requires submitting samples, meeting the customer specifications, and developing the confidence of the customer for reliability and reproductability. Management believes that the needs of its customers generally progress from research and development quantities to pilot production to full scale production. The length of time this cycle requires varies widely. The TMI Division now has the capacity to supply production quantities to customers who have moved out of the development phase to the production of any new product. Management believes that it will be able to capture a proportion of larger production type orders in the future.

MARKETING AND SALES

The Company markets and sells its products worldwide, concentrating on the Research & Development and Industrial Production markets. Domestic sales account for approximately 70.0% of the Company's sales, compared to 30.0% export sales.

In the United States, the Company markets and sells through its internal sales staff, and through independent manufacturer's representative groups located strategically around the country. Either party may terminate the Company's contracts with its representatives within 60 days. Commission rates vary according to materials and other factors. A typical commission rate is 8.0% of gross sales dollars.

In Asia, the Company markets and sells through several non-exclusive distributors. Sales in this region consist primarily of research & development accounts. TMI currently is seeking representation in the European market.

PRODUCTION CAPACITY

In the TMI Division, the production equipment now on hand will accommodate a throughput of $4.0 million or greater per year, depending on product mix. For the TMI Division, the Company intends to acquire a larger rolling mill and a machining center by 2001. With those measures taken, the production capability of the TMI Division is expected to be approximately $6.0 million per year revenue.

MAJOR SUPPLIERS AND CUSTOMERS

The TMI Division buys raw materials, components and chemicals used in the manufacture and assembly of the Company's products. If these materials are not received in a timely manner, it may seriously affect the Company's production schedule. The Company, however, has designed its products using widely-available standard items and components, and has identified alternative vendors it may use in order to avoid production delays. The Company is not experiencing difficulty in maintaining its inventory of such components, although purchase commitments are, at times, limited by cash flow.

The TMI Division purchases various types of ceramic powder as well as metal for the production of ceramic or metal sputtering targets. These materials are purchased to Company specifications. In such cases, the price per unit of weight of the material depends strongly on the amount purchased. In some cases, the materials are very costly. The quantities purchased and price per unit weight paid by the Company varies widely, based upon cash flow considerations and inventory levels.

The Company has established supplier relations with a number of companies, some of which are importers of metals from other countries, including China and Russia. Delivery schedules are often unpredictable for these supplies, requiring the Company to maintain considerable inventory levels to avoid shortages.

The Company does not manufacture gold or platinum (precious metals) sputtering targets, but buys the finished item in these and other precious metals from one of several suppliers and resells them at a markup. In 1999, approximately 7.9% of the Company's sales were precious metals. The Company maintains a letter of credit with one precious metal supplier to cover the purchases. The Company sells precious metals on a net-10 day basis, while all other sales are net-30 days.

I-14

The Company also purchases finished targets, sometimes from competitors, or from other sources, for its own sale at a markup. This "buy/re-sell" business was approximately 15.0% of the TMI Division's sales volume in 1998 and 11.2% in 1999. The Company has appropriate purchase specifications, and performs its own receiving inspection and quality control on these products prior to shipment to its customers.

The top 5 suppliers to the TMI Division in 1999 were, in descending order: Williams Advanced Materials, Inc., Standard Resources, Inc., ACI Alloys Inc., Noah, Inc. and Alta, Inc. In every case, the Company believes that suitable substitute vendors could be found. The Company buys primarily based on quality, price and delivery to its specifications factors.

No customers in the TMI Division accounted for 10.0% or more of the total TMI revenue in 1999.

RESEARCH AND DEVELOPMENT

The TMI Division has no government support, preferring to invest in and control its research and development program in a commercial market-oriented customer-driven manner.

QUALITY CONTROL

The Company strives for world class quality in its products. The Company has experienced quality control problems in the past. Consequently, the Company in recent years has invested funds in the development and implementation of a quality assurance program to insure that each process in the manufacturing, materials purchasing and order-entry functions are more tightly controlled.

The Company has also invested in quality control equipment. The Company is currently able to perform in-house testing of its ceramic products and metals and alloys via Scanning Electron Microscopy, Edax, Differential Thermal Analysis, Electrical Resistivity, and Particle Size Analysis, Inductively Coupled Plasma, Spectagraph Equipment and X-ray Diffraction.

The quality control efforts have included preparation for certification for ISO 9000, the international standard of quality performance, as well as investment in training of personnel, preparation of specifications, purchasing and installation of equipment, purchasing of software, on-going calibration and maintenance of advanced measuring and composition analysis equipment. These efforts have produced a significant improvement in the product produced by the Company, as shown by customer returns, which were under 1.7% over-all in 1999, 2.0% in 1998 and 2.3% in 1997.

EMPLOYEES

The Company currently has 21 full-time and 2 part-time employees. Three of the Company's employees have a Ph.D. in Chemistry or Materials Science. Ten employees work primarily for the TMI Division of the Company, while the remainder work primarily for the SCI Division. In the case of shared employees, the charges are assigned in accordance with the ratio of shipped dollars.

The Company has never experienced work stoppage and considers its relations with employees to be good. The employees do not have a bargaining unit.

ENVIRONMENTAL MATTERS

The Company generates small quantities of ceramic dust from grinding or machining and has approval from the Ohio EPA to cover the exhaustion of these materials, which are primarily Zinc Oxide. The Company maintains filters and dust collectors that it believes are in accordance with all EPA regulations. The Company has been inspected from time to time by local EPA authorities and the few noted deficiencies have been corrected. As of August 1, 2000, the Company was not under any EPA strictures.

The Company does not handle "hazardous materials" as defined on the Materials Safety and Data Sheets

I-15

("MSDS"). The Company supplies MSDS sheets to its customers with all shipments as a routine procedure. The TMI Division also does not offer products made from "hazardous materials" (as defined by the MSDS, Materials Safety Data Sheets, for the materials).

COLLECTIONS AND WRITE-OFFS

The Company collected its receivables in an average of 55 days in 1999. The Company has occasionally been forced to write-off a few small invoices as uncollectible. The Company considers credit management critical to its success.

SEASONAL TRENDS

The Company has not experienced and does not in the future expect to experience seasonal trends in its business operations.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

To date, the Company has received revenue predominantly from commercial sales and also government research contracts and non-government research contracts. The Company has incurred cumulative losses of $5,526,168 from inception to December 31, 1999.

SIX MONTHS ENDED JUNE 30, 2000 AND 1999

Revenue for the six months ended June 30, 2000 was $1,499,715, an increase of $305,061 or 25.5% from the year earlier period when sales totaled $1,194,654. The increase is primarily attributable to additional research contracts in 2000 versus 1999.

The gross margin on sales of products was $212,689 or 18.5% for the six months ended June 30, 2000 compared to $235,000 or 22.1% for the earlier period. Gross margins on the Company's various products vary widely and the gross margin are impacted from period to period by sales mix and utilization of production capacity. The gross margin on the contract research is generally lower than on other products. The Company expects that gross margins will improve as sales grow.

General and administrative expenses were $231,839 or 15.5% of total revenue for the six months ended June 30, 2000 and $134,345 or 11.2% of total revenue for the earlier period. The increase in these costs relates to the expansion of the Company's infrastructure, including the addition of executive management.

Sales expense of $136,061 or 9.1% in the six months ended June 30,2000 was up from the $118,612 or 9.9% for the six months ended June 30,1999. The increase includes expenditures for the development of foreign market opportunities.

The increase of interest expense from $20,616 or 1.7% in 1999 to $33,633 or 2.2% for the six months ended June 30,2000 relates to interest on both the subordinated notes payable and on the bank borrowings. The related party waived interest on the subordinated notes in 1999.

The Company's net loss for the six months ended June 30, 2000 totaled $(94,147), or $(.07) per share, compare to a loss of $(13,192), or $(.01) per share for the previous year. The 2000 period was significantly impacted by an increase in reserves for obsolete inventory.

FISCAL YEAR 1999 AS COMPARED TO FISCAL YEAR 1998

I-16

REVENUES.

Revenues in fiscal 1999 increased by 7.2% to $2,678,362 from the fiscal 1998 level of $2,498,162. Contract research revenue in fiscal 1999 was $425,153 compared to $470,552 in fiscal 1998, a decrease of 9.6%.

Commercial sales of the Company's HTS products increased to $219,769 in fiscal 1999 from $169,683 in fiscal 1998, an increase of 29.5%. These products include HTS powder, Levitators and accessories for research and development purposes, prototypes and components. The additional increase of $175,513 is primarily related to both increased business from existing customers and the continuing addition of new customers.

In 1999, total contract research revenues were $425,153 as compared to $470,552 in 1998. Government development contract revenue was $392,617, or 14.7% of total revenues in 1999 and $167,252 or 6.7% of total revenues in 1998. NASA has been, and is expected in the near term to continue to be, the Company's largest customer, accounting for 8.9% of the Company's revenues in fiscal 1999.

The Department of Defense's budget for HTS research and development is expected to decline. Significant loss of government funding would have a material adverse effect on the Company's financial condition and results of operations.

GROSS MARGIN

Total gross margin in 1999 was $477,179 or 17.8% of total revenue as compared to $438,223 or 17.5% in 1998. Total gross margin between years remains essentially stable.

Gross margin on sales revenue for product sales was 18.6% for 1999 compared to 15.1% in 1998. The increase in gross margin on product sales of 3.5% is due primarily to increased sales as the gross margin on product sales is impacted by utilization of production capacity.

Gross margin on contract research revenue was 13.9% for 1999 compared to 28.2%. The decrease in gross margin on contract research revenue of 14.3% is due primarily to a $300,000 non-government contract obtained in 1998 which resulted in higher margins.

SELLING EXPENSE

Selling expense in fiscal 1999 decreased to $265,631 from $301,618 in fiscal 1998, a decrease of $35,987, or 11.9%. This decrease is primarily a result of a reduction in the sales staff of the SCI Division at the end of fiscal 1998.

GENERAL AND ADMINISTRATIVE EXPENSE

General and Administrative expense in fiscal 1999 decreased to $332,709, from $359,751 in fiscal 1998, a decrease of $27,042, or 7.5%, primarily due to decreased legal expenses.

RESEARCH AND DEVELOPMENT EXPENSES.

Internal research and development costs are expensed as incurred. Research and development costs, including testing, for 1999 was $15,392 compared to $41,421 in 1998. Internal research and development costs decrease when government funded projects are available.

INTEREST EXPENSE.

Interest expense was $44,473, or 1.7% of Company revenues in fiscal 1999, up 54.2% from $28,847, or 1.5% in fiscal 1998.

I-17

The increase in interest expense is attributable to the increase capital lease obligations during 1998 and 1999. Subordinated notes payable to shareholders' increased by $205,125 during 1999; however, interest was waived during 1998 and 1999 by the shareholders.

LIQUIDITY AND WORKING CAPITAL

The working capital of the Company at June 30,2000 was $173,401 compared to $119,646 at June 30,1999, an increase of $53,755, or 44.9%. The increase is working capital is due to payment of the note payable to bank by increasing long-term subordinated notes payable to the shareholders. The Company provided cash from operations for the six months ended June 30, 2000 and 1999 of $32,009 and $10,875, respectively. Significant non-cash expenses including depreciation and an inventory reserve on excess and obsolete inventory approximate $214,000 and $145,000, respectively, for the six months ended June 30, 2000 and 1999. Overall, accounts receivable, inventory and prepaids increased in excess of increases in accounts payable and accrued expenses by approximately $88,000 and $121,000, respectively, as a result of timing of receipt of inventory versus required scheduled payments on this inventory.

For the year ended December 31, 1999, working capital was $57,991 compared to $13,055 at December 31, 1998. The increase in working capital of $44,936 is due mainly to accounts payable paid by a shareholder which increased long-term subordinated notes payable. The Company provided cash from operations for the years ended December 31, 1999 and 1998 of $107,633 and $42,520, respectively. Significant non-cash expenses including depreciation and inventory reserve on excess and obsolete inventory approximate $281,000 and $292,000, respectively, for the years ended December 31, 1999 and 1998. Overall, accounts receivable, inventory and prepaids increased in excess of increases in accounts payable and accrued expenses by approximately $29,000 and $9,000, respectively, or insignificant amounts.

For investing activities, the Company used cash of approximately $66,000, $207,000, $38,000 and $21,000 for the years ended December 31, 1999 and 1998 and six months ended June 30, 2000 and 1999, respectively. The amount invested in 1998 was used to purchase machinery and equipment for increased production capacity.

For financing activities for the year ended December 31, 1999, the Company used cash of approximately $46,000. Due to tight cash flow, cash was overdrawn by approximately $31,000. Cash payments to third parties for debt and capital lease obligations approximated $73,000. Proceeds from subordinated note payable were used to pay accrued cumulative dividends on Series A and B preferred stock.

For financing activities for the year ended December 31, 1998, the Company provided cash of approximately $163,000. Proceeds from the sale of common stock and common stock options totaled $61,500 which was used to fund operations. Proceeds from subordinated notes payable by a shareholder totaled $155,000 and was used to reduce accounts payable and fund operations.

For financing activities for the year ended June 30, 2000, the Company provided cash of approximately $6,000. Due to continued tight cash flow, an additional $31,000 was overdrawn. Principle repayments on a bank note payable approximating $95,000 was paid with funds obtained from subordinated notes payable by a shareholder. Additional payments on capital lease obligations approximated $43,000. Proceeds from exercise of common stock options totaled $94,800. Proceeds were used to fund operations.

If the Company has to repay some of the short term maturing debt, it will lose a substantial portion of its financial resources to pursue its current plans. Whereas there is every reason to believe that the Company can refinance its maturing debt, there is no guarantee that it will be able to do so.

The Company will continue to manage within its financial resources and attempt to balance its working capital needs with cash flow generated from operations and available current financing. The Company will continue to seek new financing if such circumstances present more attractive alternatives to the current financing arrangements. The Company cannot be certain that it will be successful in efforts to raise new funds.

I-18

INFLATION

The Company believes that there has not been a significant impact from inflation on the Company's operations during the past three fiscal years.

FUTURE OPERATING RESULTS

The Company anticipates that operations in the coming year of 2000 will result in improving cash position. An expansion to the Company's production facility is essentially complete, and the inventory expenditures can be controlled by improved purchasing practices, and also by negotiated terms of payment.

Dr. and Mrs. Funk have purchased the 99 Series A Preferred Shares outstanding from the former owners. The cash dividend requirement on the Series B Preferred Shares of about $27,000 due in November 2000 has been reduced by conversion into common stock of many of those shares. Only 27,542 Series B Preferred shares are outstanding as of August 1, 2000.

Management believes that the Company will continue in a very cash tight condition during the year 2000 and beyond. If internal sales and expense projections are achieved, capital expenditures are limited to $50,000, and inventory growth is limited to $50,000, the Company will be able to fund payoff of principal and interest of its Series A & B Preferred Shares maturing in 2000. The Company believes the measures to control these two components of the balance sheet are in place through increased management attention. Internal sources of liquidity are primarily liquidation of inventory and operating cash flow.

The Company is posting excess inventory on its web site in an effort to sell slow moving items. Better inventory control will decrease obsolesce in the future. None of the Company's inventories degenerates with storage. However, the trends of the customer buying may increase or decrease the need, and therefore the market value, for certain materials in inventory. Changes in customer buying patterns may affect the movement of inventory.

The Company must maintain sufficient inventory to be able to ship a wide variety of products on short notice. This has been one of the principal competitive advantages of the Company. Additionally, on expensive metals such as tantalum, the price per pound is dependent on the purchasing commitment: the larger volume commitment, the lower the price. Thus the Company attempts to purchase large quantities for projected requirements, but in many cases must work out extended terms of payment.

The Company anticipates that it will require additional professional, technical and manufacturing labor in the future. This personnel addition may range from replacement of any existing employees who leave the Company, to the addition of as many as ten employees per year for the years 2000 and 2001.

The Company plans to make purchase commitments on an annualized basis for raw materials which can be purchased in larger quantities at reduced prices. In general, the Company attempts to limit inventory increase by making an annual commitment, but drawing material either as required, or on a monthly or quarterly basis. Such annual commitments may reach $500,000 in 2000 and greater in 2001. The terms of payment for such commitments are worked out with the vendor on a case-by-case basis.

Bank One has expressed a willingness to extend an open line of credit to the Company provided that Dr. and Mrs. Funk guarantee the line of credit and pledge three times this value as collateral. The Company currently has a line of credit of $100,000 with Bank One, $75,000 of which has been drawn down to date.

The availability of additional cash from Dr. and Mrs. Funk could be influenced by the death of either Dr. or Mrs. Funk. The future of the business could also be severely depressed by the incapacitation of either Dr. or Mrs. Funk. Successor management is being sought at this time.

DEVELOPMENT STAGE OF THE COMPANY'S PRODUCTS AND UNCERTAINTY REGARDING DEVELOPMENT OF MARKETS

I-19

Some of the Company's products are in the early stages of commercialization and the Company believes that it will be several years before products will have significant commercial end-use applications, and that significant additional development work may be necessary to improve the commercial feasibility and acceptance of its products. There can be no assurance that the Company will be able to commercialize any of the products currently under development.

To date, there has been no widespread commercial use of HTS products.

YEAR 2000 ISSUE

The Company has studied the "Year 2000" issues affecting its operations and has implemented all required modifications to its systems. The underlying issues are not expected to have a materially adverse affect on the Company's operations or financial position. The cost of addressing the "Year 2000" issues have not been material to the Company.

ITEM 3. DESCRIPTION OF PROPERTY

The Company's office and manufacturing facilities are located at 1145 Chesapeake Avenue, Columbus, Ohio, where it occupies about 20,000 square feet. Additional space of 10,000 square feet is currently sub-leased by the Company and can be reclaimed on three months notice. The Company has a lease on the property at $3.15 per square foot until March 1, 2001, with an option to renew. Management anticipates that relocation of the SCI Division to new quarters may be required in the next few years, as the maturing of its production processes and the need for a "clean room" image for it customers dictates relocation. However, specific plans to relocate the SCI Division have not been developed.

There is adequate power running to several locations in the building and other utilities are adequate for the projected growth.

ITEM 4. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

COMMON STOCK

The following tables set forth certain information as of August 1, 2000, with respect to the beneficial ownership of the Company's common stock by the following individuals and groups:

- each of the Company's directors;

- each of the Company's executive officers;

- each person known by the Company to beneficially own five percent (5%) or more of our outstanding common stock; and

- all of the Company's directors and executive officers as a group.

Unless otherwise indicated, we believe that each person listed below has sole voting and investment power over his or her shares.

NAME AND ADDRESS                        NUMBER OF SHARES
OF BENEFICIAL OWNER                     BENEFICIALLY OWNED(1)                   PERCENTAGE OF CLASS (2)
-------------------                     ------------------                      --------------------
Edward R. Funk
1145 Chesapeake Avenue                      842,327(3)                                  46.1%
Columbus, OH 43212

Ingeborg V. Funk
1145 Chesapeake Avenue                      842,327(3)                                  46.1%
Columbus, OH 43212


                                      I-20

Curtis A. Loveland
41 South High Street                        153,198(4)                                  11.0%
Columbus, OH 43215


Edward W. Ungar
929 Harrison Avenue                           6,760(5)                                    *
Columbus, OH 43215

Robert J. Baker
1145 Chesapeake Avenue                        4,350(6)                                    *
Columbus, OH 43212

Lloyd E. Hackman
15508 Fiddlesticks Blvd., S.E.               79,507(7)                                   5.7%
Ft. Myers, FL 33912

Charles E. Washbush
1233 Langeston Dr.                            3,750                                       *
Columbus, OH 43220

Don Raifsnider
1145 Chesapeake Avenue                        8,000(8)                                    *
Columbus, OH 43212

J.R. Gaines
1145 Chesapeake Avenue                       32,722(9)                                   2.3%
Columbus, OH 43212

Robert H. Peitz
43 Little St.                                 1,000(10)                                   *
Matawan, NJ 07747

Dr. Suvankar Sengupta
5692 Hillcrest Dr.                           25,000(11)                                  1.8%
Hilliard, OH 43026

All executive officers and
directors as a group (11 persons)(12)     1,156,614                                     61.6%


* Less than 1%

(1) For purposes of the above table, a person is considered to "beneficially own" any common shares with respect to which he or she exercises sole or shared voting or investment power, or of which he or she has the right to acquire the beneficial ownership within 60 days of August 1, 2000. Unless otherwise indicated, voting power and investment power are exercised solely by the person named above, or shared with members of his or her household.

(2) "Percentage of Class" is calculated on the basis of the number of outstanding shares, plus the number of common shares a person has the right to acquire within 60 days of August 1, 2000. As of August 1, 2000, the Company had 1,397,576 shares of common stock outstanding.

I-21

(3) Edward R. Funk and Ingeborg V. Funk are husband and wife. Under the rules of the Securities and Exchange Commission, they are deemed to beneficially own the shares of the other. Consequently the number reported above for each includes 99,702 and 185,145 common shares held of record by Dr. Funk and Mrs. Funk, respectively, 31,926 held of record by Dr. and Mrs. Funk as tenants in common; options, warrants and convertible notes for 427,950 common shares, which can be acquired by Dr. Funk and Mrs. Funk, respectively, under stock options and warrants and convertible rates exercisable within 60 days of August 1, 2000. This number also includes 96,904 common shares which are owned by Funk Metallurgical Corporation, a corporation wholly owned by Dr. and Mrs. Funk (FMC).

(4) Includes 2000, 200 shares held by Mr. Loveland in a Keough account, and 152,998 common shares held of record by Mr. Loveland for various irrevocable trusts for the benefit of Dr. and Mrs. Funk's children and grandchildren.

(5) Includes 4,260 common shares, owned by Taratec Corp., a company controlled by Mr. Unger, and 2,500 common shares, which can be acquired by Mr. Ungar under stock options exercisable within 60 days of August 1, 2000.

(6) Includes 1,000 shares which can be acquired by Mr. Baker under stock options exercisable within 60 days of August 1, 2000.

(7) Includes 3,250 shares which can be acquired by Mr. Hackman under stock options exercisable within 60 days of August 1, 2000, and 76,257 shares owned by Mr. Hackman and his family.

(8) Includes 8,000 common shares which can be acquired by Mr. Raifsnider under stock options exercisable within 60 days of August 1, 2000.

(9) Includes 20,500 common shares which can be acquired by Mr. Gaines under stock options exercisable within 60 days of August 1, 2000.

(10) Includes 1,000 common shares which can be acquired by Mr. Peitz under stock options exercisable within 60 days of August 1, 2000.

(11) Includes 15,000 common shares which can be acquired by Dr. Sengupta under stock options exercisable within 60 days of August 1, 2000.

(12) Includes 479,200 vested options, warrants, subordinated debt, and Series A preferred stock which are exercisable within 60 days of August 1, 2000, for all directors and executive officers listed.

SERIES A 10% PREFERRED SHARES

The following tables set forth certain information as of August 1, 2000 with respect to the beneficial ownership of the Company's Series A 10% Preferred Shares by the following individuals and groups:

- each of the Company's directors;

- each of the Company's executive officers;

- each person known by the Company to beneficially own five percent (5%) or more of our outstanding common stock; and

- all of the Company's directors and executive officers as a group.

Unless otherwise indicated, we believe that each person listed below has sole voting and investment power over his or her shares.

I-22

NAME AND ADDRESS                        NUMBER OF SHARES
OF BENEFICIAL OWNER                     BENEFICIALLY OWNED(1)          PERCENTAGE OF CLASS (2)
-------------------                     ------------------             --------------------
Edward R. Funk
1145 Chesapeake Avenue                                99                                100%
Columbus, OH 43212


(1) For purposes of the above table, a person is considered to "beneficially own" any Series A 10% Preferred Shares with respect to which he or she exercises sole or shared voting or investment power. Unless otherwise indicated, voting power and investment power are exercised solely by the person named above, or shared with members of his or her household.

(2) "Percentage of Class" is calculated on the basis of the number of outstanding Series A 10% Preferred Shares as of June 30, 2000, which was 99 shares.

ITEM 5. DIRECTORS AND EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

DIRECTORS AND EXECUTIVE OFFICERS OF THE COMPANY

The Company has a Board of Directors that is currently comprised of eight members. Each director holds office until the next annual meeting of shareholders or until a successor is elected or appointed. The members of the Board of Directors and the executive officers of the Company and their respective age and position are as follows:

                                                                                                       Officer or
Name                                           Age              Position with the Company            Director Since
-----------------------------------------     ------       ------------------------------------
Edward R. Funk                                 75          President, Chief Executive                     1987
                                                           Officer, Treasurer and Director

Ingeborg V. Funk                               76          Vice President                                 1987

Donald D. Raifsnider                           52          Vice President and General Manager             1997
                                                           of the TMI Division

Suvankar Sengupta                              36          Chief Scientist                                1994

Curtis A. Loveland                             53          Secretary and Director                         1987

Edward W. Ungar                                63          Director                                       1990

Robert J. Baker, Jr.                           60          Director                                       1992

Lloyd E. Hackman                               70          Director                                       1993

Charles E. Washbush                            69          Director                                       1994


                                      I-23

James R. Gaines, Jr.                           44          Director                                       1997

Robert H. Peitz                                42          Director                                       1997

EDWARD R. FUNK, SC.D., is a founder of the Company and has served as President, Chief Executive Officer, Treasurer, and a Director of the Company since its inception in 1987. Dr. Funk was the founder and was Chairman of the Board of Interpore/Cross International (f.k.a. Cross Medical Products, Inc.) ("Interpore"), a Columbus, Ohio publicly held company which manufactures electromechanical orthopedic devices and related medical products. Dr. Funk resigned as Chairman in May, 1998. In 1970, Dr. Funk also founded Funk Metallurgical Corporation, a Columbus, Ohio corporation, and served as that company's President from its inception until June 1986 and as Chairman of the Board from its inception until the business was sold in September 1988. Dr. Funk also was a founder of Astro Metallurgical Corp. of Wooster, Ohio. Dr. Funk is the husband of Ingeborg V. Funk, a Vice President of the Company.

INGEBORG V. FUNK is a founder of the Company and has served as Vice President of the Company since its inception in 1987. Mrs. Funk was also a Director of the Company from its inception until December 1, 1993. In addition, Mrs. Funk co-founded Interpore. Mrs. Funk also co-founded Funk Metallurgical Corporation, and served as that company's Vice President from its inception until June 1986, and thereafter as its President until the business was sold in September 1988.

DONALD D. RAIFSNIDER, has been with the Company since 1997, and serves as Vice President and General Manager of the TMI Division of the Company. Prior to joining the Company, Mr. Raifsnider's career encompassed Production and Material Management with Anchor Swan Corporation, along with Sales and Marketing management at Mirro Corporation and his own manufacturers representative organization.

SUVANKAR SENGUPTA, PH.D.,has served as Chief Scientist of the Company since April, 1994. Prior to joining the Company, Dr. Sengupta was a Guest Graduate Student at the Argonne National Laboratory (1991-1994) and served as a Research Assistant at the Center of Materials Science and Engineering at the University of Notre Dame (1991-1994). Dr. Sengupta is the holder of three patents in the field of high temperature superconductor technology.

CURTIS A. LOVELAND serves as Secretary and as a Director of the Company since 1987. Mr. Loveland has been a practicing attorney for 27 years and has been a partner in the law firm of Porter, Wright, Morris and Arthur LLP since 1979. Mr. Loveland's practice is concentrated in the areas of corporate law and finance. Mr. Loveland also serves on the Board of Directors of several other central Ohio companies, including Applied Innovation Inc. and Rocky Shoes & Boots, Inc. The law firm of Porter, Wright, Morris & Arthur LLP serves as legal counsel for the Company.

EDWARD W. UNGAR has been a Director of the Company since 1990. Mr. Ungar is the President and founder of Taratec Corporation, a technological consulting firm in Columbus, Ohio. Prior to forming Taratec Corporation in 1986, Mr. Ungar was an executive with Battelle Memorial Institute.

ROBERT J. BAKER, JR., PH.D. has served as a Director of the Company since 1992. Dr. Baker is the founder of Venture Resources International and the co-founder of Business Owners Consulting Group, which assist companies in the development of growth strategies, including marketing position and competitive strategies. Dr. Baker is currently a visiting member of the Capital University faculty serving the MBA program.

LLOYD E. HACKMAN has been a Director of the Company since 1993. Mr. Hackman is the former President and Chairman of Ribbon Technology, Inc., a company he founded. Ribbon Technology, Inc. produces wire products directly from molten metal for use in concrete reinforcement.

CHARLES E. WASHBUSH has been a director of the Company since 1994 and is a founding partner, owner, and board member of Corporate Finance Associates Worldwide ("CFAW"), the successor company to Corporate Finance Associates, and President of Corporate Finance Associates of Columbus, Inc. CFAW is an investment banking firm, founded in 1956, with 40 offices in the United States and Canada and 10 affiliate offices in Europe.

I-24

JAMES R. GAINES, JR. has served in various capacities with the Company since 1987 and now serves as Vice President and General Manager of the SCI Division of the Company. Mr. Gaines became a Director of the Company in June 1997. Prior to joining the Company, Mr. Gaines was in management at several small companies in cryogenics and other related fields for over ten years.

ROBERT H. PEITZ became a Director of the Company in June 1997 and is Managing Director and Head of Financial Markets for BHF-Capital Corporation in New York. Mr. Peitz is on the Board of BHF Structured Finance and BHF Realty. Previously, Mr. Peitz held positions as Chief Dealer and Vice President in charge of Interest Rate Risk Management. Mr. Peitz has been with BHF since 1988. Prior to joining BHF, Mr. Peitz was in the Management Training program at Morgan Stanley in 1987 and 1988.

FAMILY RELATIONSHIPS

Dr. Funk, who is President, Chief Executive Officer, Treasurer and a director of the Company, and Mrs. Funk, who is Vice President of the Company, are husband and wife. Mr. Peitz, who is a director of the Company, is the stepson of Dr. Funk. There are no other family relationships among the directors and executive officers of the Company.

INVOLVEMENT IN CERTAIN LEGAL PROCEEDINGS

None.

ITEM 6. EXECUTIVE COMPENSATION

The following table sets forth certain information regarding compensation paid during our fiscal years ended December 31, 1997, 1998 and 1999 to our Chief Executive Officer and each of our three other highest compensated executive officers (collectively, the "Named Executive Officers").

                                              SUMMARY COMPENSATION TABLE

                                                     ANNUAL COMPENSATION         LONG-TERM COMPENSATION
                                                  --------------------------  -----------------------------
                                                                                          AWARDS
                                                                                 --------------------------
                                                                                 RESTRICTED    SECURITIES
                                                                                    STOCK      UNDERLYING      ALL OTHER
                                                       SALARY        BONUS          AWARD        OPTIONS     COMPENSATION
    NAME AND PRINCIPAL POSITION           YEAR           ($)           ($)           ($)           (#)            ($)
----------------------------------   -------------  -------------  -----------   ------------  ------------  ---------------
EDWARD R. FUNK                           1999           $5,538             $0           $0          10,000             $0
President and Chief Executive            1998           $    0             $0           $0               0             $0
Officer                                  1997           $    0             $0           $0               0             $0




JAMES R. GAINES                          1999          $75,385             $0           $0          15,000             $0
Vice President and General               1998          $76,716             $0           $0               0             $0
Manager of the SCI Division              1997          $58,701             $0           $0          28,000             $0



DON RAIFSNIDER                          1999           $56,000             $0           $0          15,000             $0
Vice President and General              1998           $54,738             $0           $0               0             $0
Manager of the TMI Division             1997                               $0           $0          20,000             $0



SUVANKAR SENGUPTA                       1999           $70,000             $0           $0          15,000             $0
Chief Scientist                         1998           $74,985             $0           $0               0             $0
                                        1997           $58,781             $0           $0          12,400             $0

I-25

OPTION/SAR GRANTS IN LAST FISCAL YEAR

The following table sets forth certain information concerning the grant of stock options to the Named Executive Officers for the fiscal year ended December 31, 1999. The Company did not grant any stock appreciation rights for the fiscal year 1999.

                                                % OF TOTAL OPTIONS
                         NUMBER OF SECURITIES       GRANTED TO
                          UNDERLYING OPTIONS       EMPLOYEES IN      EXERCISE PRICE
         NAME                GRANTED (#)          FISCAL YEAR(2)        ($/SHARE)       EXPIRATION DATE
----------------------------------------------------------------------------------------------------------

Edward R. Funk                     10,000              11.8%              $2.00             1/13/05

James R. Gaines                    15,000              17.6%              $2.00             1/13/05

Don Raifsnider                     15,000              17.6%              $2.00             1/13/05

Suvankar Sengupta                  15,000              17.6%              $2.00             1/13/05


(1) This table covers the period from January 1, 1999 to December 31, 1999.

(2) Percentage is based upon 85,000 options granted to employees in fiscal year 1999.

AGGREGATED OPTION/SAR EXERCISES IN FISCAL 1999
AND FISCAL YEAR-END OPTION/SAR VALUES

The following table provides certain information regarding the number and value of stock options held by our Named Executive Officers at December 31, 1999.

                                                           NUMBER OF SECURITIES
                                                          UNDERLYING UNEXERCISED          VALUE OF UNEXERCISED
                                                            OPTIONS AT FISCAL            IN-THE-MONEY OPTIONS AT
                                                               YEAR-END (#)              FISCAL YEAR-END ($)(2)
                                                       -----------------------------  ------------------------------
                               SHARES
                              ACQUIRED
                                 ON         VALUE
                              EXERCISE    REALIZED
           NAME                  (#)        ($)(1)     EXERCISABLE    UNEXERCISABLE   EXERCISABLE    UNEXERCISABLE
----------------------------  ----------  -----------  ------------   --------------  -------------  ---------------
Edward R. Funk                   0               $0          3,000           10,000            $0           $1,250

James R. Gaines                  0               $0         13,200           31,800            $0           $1,875

Don Raifsnider                   0               $0          8,000           27,000            $0           $1,875

Suvankar Sengupta                0               $0          9,960           22,400            $0           $1,875

I-26


(1) Value realized represents the difference between the exercise price of the option shares and the market price of the option shares on the date the option was exercised. The value realized was determined without consideration for any taxes or brokerage expenses that may have been owed.

(2) Represents the total gain which would be realized if all in-the-money options held at year end were exercised, determined by multiplying the number of shares underlying the options by the difference between the per share option exercise price and the per share fair market value at year end ($2.125 at December 31, 1999). An option is in-the-money if the fair market value of the underlying shares exceeds the exercise price of the option.

COMPENSATION OF DIRECTORS

The Company has no standard arrangement for the compensation of members of its Board of Directors. During fiscal 1999, however, each director received an non-statutory option to purchase 500 shares of the Company's common stock at an exercise price of $2.00 per share for services performed as a director of the Company. The options are exercisable one year from the grant date and expire on the sixth anniversary of the grant date.

ITEM 7. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

RIBBON TECHNOLOGY, INC.

On July 20, 1993, the Company entered into an agreement with Ribbon Technology Corporation, an Ohio corporation ("Ribtec") to sell to Ribtec 50,000 common shares for $300,000 ($6.00 per share) and a convertible subordinated debenture for $200,000 (the "Debenture"). Lloyd Hackman, a director of the Company, is the President and majority shareholder of Ribtec. In June 1995, the Company issued 119,003 unregistered common shares to Ribtec in exchange for the cancellation of the Debenture. Ribtec obtained piggyback registration rights in the event of the registration and sale of the Company's common shares under the 1933 Act on a form permitting registration of primary or secondary offerings, for the common shares received pursuant to the Debenture.

FOURTH QUARTER 1999 ISSUANCE OF SUBORDINATED NOTES AND WARRANTS

Through December 31, 1999, Dr. Funk had advanced the Company $256,125 and Mrs. Funk had advanced the Company $161,000. Effective December 31, 1999, the Company documented these loans through the issuance of Subordinated Promissory Notes to Dr. and Mrs. Funk in the amounts of $256,125 and $161,000 respectively. These notes bear interest at an annual rate of 10% and interest is payable monthly. The notes mature on December 31, 2009 and are convertible into common stock at $2.50 per share. In addition, the Company issued Dr. and Mrs. Funk each warrants for the purchase of 75,000 shares of common stock at a per share exercise price of $2.50.

LEGAL SERVICES

Curtis A. Loveland is an officer, director and shareholder of the Company. Mr. Loveland is also a partner with Porter, Wright, Morris & Arthur LLP, the Company's legal counsel.

ITEM 8. DESCRIPTION OF SECURITIES

The Company's authorized capital stock is 15,260,000, consisting of 15,000,000 shares of common stock, without par value, 125,000 shares of Voting Preferred Shares, without par value and 125,000 shares of Non-Voting Preferred Shares, without par value (collectively, the "Preferred Shares"), of which 700 shares are designated Series A Preferred Shares and 100,000 shares are designated as Series B Preferred Shares and 10,000 shares of 10% Cumulative Convertible Preferred Shares, without par value (the "10% Preferred Shares").

I-27

COMMON STOCK

Holders of the common shares have no redemption or conversion rights, participate ratably in any distribution of assets to shareholders in liquidation and have no preemptive or other subscription rights. Holders of common shares are entitled to receive such dividends as may be declared by the board of directors. Holders of common shares are entitled to one vote for each share held on all members on which shareholders are entitled to vote, and are not entitled to vote cumulatively for the election of directors. The outstanding common shares are fully paid and non-assessable. As of August 1, 2000, the Company had 1,397,576 shares of common stock outstanding.

PREFERRED STOCK

The Articles of Incorporation of the Company authorize the Board of Directors to adopt amendments to the Articles of Incorporation to provide for the issuance of one or more series of Non-Voting Preferred Stock or Voting Preferred Stock, and to establish from time to time the number of shares to be included in each such series, to fix the designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereof (the "Blank Check Preferred Stock"). The Company currently has authorized, issued an outstanding Series A and Series B Preferred Shares.

The issuance of Preferred Stock could be used, under certain circumstances, as a method of delaying or preventing a change in control of the Company and could permit the Board of Directors, without any action by holders of the Series A or Series B Preferred Shares, or the common shares, to issue Preferred Stock which could have a detrimental effect on the rights of holders of Series A or Series B Preferred Shares, or the common shares. In certain circumstances, this could have the effect of decreasing the market price for the common shares.

SERIES A PREFERRED SHARES

The Series A Preferred Shares were authorized under the Blank-Check Preferred stock provisions of the Company's Articles of Incorporation. Each Series A Preferred Share has a stated value of $1,000.00 and is entitled to receive dividends at the rate of ten (10%) percent per annum of the stated value per share thereof. Dividends are cumulative and payable annually on the anniversary of the date of issuance of the Series A Preferred Shares (the "Series A Issue Dates"). Dividends on the first three anniversaries of the Series A Issue Date were payable either in additional Series A Preferred Shares or cash, at the Company's discretion. Thereafter, dividends are payable in cash to the extent that funds are legally available therefor. If at any time, the aggregate amount of cash dividends to be paid by the Company on the Series A Preferred Shares is insufficient to permit the payment of the full amount of cash dividend, then accrued on all issued and outstanding Series A Preferred Shares, then such cash dividends, to the extent payable, will be distributed to the holders of all outstanding Series A Preferred Shares ratably in proportion to the respective amounts of cash dividends then accrued and unpaid on such Series A Preferred Shares. So long as any Series A Preferred Shares remains outstanding, no cash dividends can be declared or paid on any junior stock or parity stock until all accrued and unpaid cash dividends on the Series A Preferred Shares have been paid to the holders thereof. In the event that any of the Series A Preferred Shares is converted to common shares, prior to a dividend payment date, no payment of, or adjustment for, dividends yet due will be made on the Series A Preferred Shares converted.

In the event of any liquidation, dissolution, or winding up of the Company, the holders of the Series A Preferred Shares then outstanding will be entitled to receive out of the assets of the Company, before any distribution or payment is made to the holders of any junior stock, including the common shares, an amount equal to the stated value per share plus any accrued and unpaid cumulative dividends thereon. If upon any liquidation, dissolution, or winding up, amounts distributable to the holders of all Series A Preferred Shares and any parity stock is insufficient to permit the payment of the full liquidation amounts on all issued and outstanding Series A Preferred Shares and parity stock, then the entire assets of the Company available for distribution to the holders of Series A Preferred Shares and parity stock will be distributed to holders of all Series A Preferred Shares and parity stock ratably in proportion to the full preferential amounts to which such holders are respectively entitled.

I-28

Except as otherwise provided by Ohio law, the holders of the Series A Preferred Shares have no voting rights.

The Company may redeem all or part of the Series A Preferred Shares at any time after the third anniversary of the Series A Issue Date at a price of 103% of the Stated Value, plus accrued and unpaid dividends through the redemption date. The Company must redeem 25% of the Series A Preferred Shares on each of the fourth, fifth, sixth and seventh anniversaries of the Series A Issue Date at a price equal to the stated value, plus accrued and unpaid dividends, through the redemption date.

The Series A Preferred Shares are convertible at any time into shares of the Company's common stock, without par value, at a rate of $6.00 per share, subject to adjustment for certain events. As of August 1, 2000, all 99 of the outstanding Series A Shares were acquired for cash by Dr. Funk.

As of August 1, 2000, $109,147 in principal and accrued dividends for shares of Series A remains to be converted to equity, or retired by the Company.

SERIES B PREFERRED SHARES

The Series B Preferred Shares were authorized under the Blank-Check Preferred Stock provisions of the Company's Articles of Incorporation. Each Series B Preferred Share has a stated value of $10. Except as otherwise provided by Ohio law, the holders of the Series B Preferred Shares have no voting rights. The Series B Preferred Shares are convertible into common shares at the rate of $5.00 per each common share, subject to adjustment for stock splits, stock dividends or any other stock divisions. The Company will pay cash in lieu of fractional shares.

Holders of the Series B Preferred Shares are entitled to receive dividends at the rate of 10% of the stated value per annum per share. Dividends will be payable on each anniversary of the issue date, defined as the date on which the Series B Preferred Shares are first issued by the Company. Dividends could be paid in either shares of Series B Preferred Shares or cash, at the Company's option, for the initial three years that the Series B Preferred Shares were outstanding, and thereafter in cash to the extent funds are then legally available for the payment of such cash dividends. The right of the holders of the Series B Preferred Shares to receive such dividends is cumulative, and accrues from the date of issuance of the Series B Preferred Shares.

If at any time, the aggregate amount of cash dividends to be paid by the Company on the Series B Preferred Shares is insufficient to permit the payment of the full amount of cash dividend, then accrued on all issued and outstanding Series B Preferred Shares, then such cash dividends, to the extent payable, will be distributed to the holders of all outstanding Series B Preferred Shares ratably in proportion to the respective amounts of cash dividends then accrued and unpaid on such Series B Preferred Shares. So long as any Series B Preferred Shares will remain outstanding, no cash dividends can be declared or paid on any junior stock or parity stock until all accrued and unpaid cash dividends on the Series B Preferred Shares have been paid to the holders thereof. In the event that any of the Series B Preferred Shares were converted to common shares, prior to a dividend payment date, no payment of or adjustment for dividends yet due will be made on the Series B Preferred Shares converted.

In the event of any liquidation, dissolution, or winding up of the Company, the holders of the Series B Preferred Shares then outstanding will be entitled to receive out of the assets of the Company, before any distribution or payment is made to the holders of any junior stock, including the common shares, an amount equal to the stated value per share plus any accrued and unpaid cumulative dividends thereon. If upon any liquidation, dissolution, or winding up, amounts distributable to the holders of all Series B Preferred Shares and any parity stock is insufficient to permit the payment of the full liquidation amounts on all issued and outstanding Series B Preferred Shares and parity stock, then the entire assets of the Company available for distribution to the holders of Series B Preferred Shares and parity stock will be distributed to holders of all Series B Preferred Shares and parity stock ratably in proportion to the full preferential amounts to which such holders are respectively entitled. A consolidation merger of the Company with or into any other company or companies, or a sale or transfer of all, or substantially all, of its property shall not be deemed to be a liquidation, dissolution, or winding up of the Company.

After the third anniversary of the issue date, the Company is entitled, at its option, to redeem the Series B

I-29

Preferred Shares, in whole or in part, at a redemption price equal to 103% of the stated value, plus the amount of any accrued and unpaid cash dividends thereon, to the date of such redemption. In case of the redemption of only a part of the Series B Preferred Shares, the Series B Preferred Shares to be redeemed will be selected by whatever means the Board of Directors, in its sole discretion, determines.

The Company is not obligated to pay to any holder of the Series B Preferred Shares the redemption price for any Series B Preferred Shares to be redeemed until such holder has surrendered to the Company certificates representing such Series B Preferred Shares.

The holders of the Series B Preferred Shares have the right and option to convert all or part of the Series B Preferred Shares then owned by them, at any time, into Common Shares.

If the Series B Preferred Shares, in whole or in part, are called for redemption, the right to convert such Series B Preferred Shares into common shares shall cease at the close of business on the day prior to the Redemption Date set forth in the notice of redemption.

As of August 1, 2000, 27,542 Series B Preferred Shares remained outstanding and had not been converted to equity.

I-30

PART II

ITEM 1. MARKET FOR COMMON EQUITY AND RELATED SHAREHOLDER MATTERS

MARKET FOR COMMON STOCK

The Company's common stock traded on the OTC Bulletin Board under the symbol "SCCI" until April 2000, at which time it began to trade on the "pink sheets." The following table sets forth for the periods indicated the high and low bid quotations for the Company's common stock as reported on the OTC Bulleting Board, except for the Quarter ended June 30, 2000, which sets forth the high and low bid quotations for the Company's common stock on the "pink sheets."

                                                                       HIGH             LOW
                                                                       ----             ---
FISCAL 1998

         Quarter ended April 2, 1998                                   2 1/2            1 1/4

         Quarter ended July 3, 1998                                    5 3/4            2

         Quarter ended October 2, 1998                                 4 3/4            2

         Quarter ended December 31, 1998                               3 5/8            1 1/4

FISCAL 1999

         Quarter ended March 30, 1999                                  4 1/4              3/4

         Quarter ended June 30, 1999                                   3 1/4            1 1/2

         Quarter ended September 30, 1999                              2 1/2            1 1/4

         Quarter ended December 31, 1999                               2 3/4            1 1/2

FISCAL 2000

         Quarter Ended March 31, 2000                                  4 1/2            2 3/4

         Quarter Ended June 30, 2000                                   3                2 1/2

The quotation provided herein may reflect inter-dealer prices without retail mark-up, markdown, or commissions, and may not represent actual transactions.

HOLDERS OF RECORD

As of August 1, 2000, there were approximately 635 holders of the common stock of the Company and 1,397,576 shares outstanding, and approximately 325 holders of Series B Preferred and 1 holder of Series A Preferred stock. There is no market for the Series A and B preferred shares. As of August 1, 2000, there were 99 shares of Series A Preferred outstanding and 27,542 Series B Preferred Shares outstanding.

DIVIDENDS

The Company has never paid cash dividends on its capital stock and does not expect to pay any dividends in the foreseeable future. Furthermore, the Company's bank loan prohibits it from paying cash dividends. The Company intends to retain future earnings, if any, for use in the business.

II-1


ITEM 2. LEGAL PROCEEDINGS

There are no known legal proceedings against the Company.

ITEM 3. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

Not applicable.

ITEM 4. RECENT SALE OF UNREGISTERED SECURITIES

In March 1997, the Company issued 90,522 shares of common stock of the Company to Dr. and Mrs. Funk in exchange for certain accounts payable to Dr. and Mrs. Funk and to Funk Metallergical, Inc. The Company issued the shares in reliance on an exemption from registration under Section 4(2) of the Securities Act of 1933 (the "Act").

On January 31, 1999, the Company issued 2,450 shares of common stock to Taratec Corporation, for consulting services in lieu of making a cash payment to Taratec Corporation for services rendered. The Company issued the shares in reliance on an exemption from registration under Section 4(2) of the Act.

On February 28, 2000, directors and executive officers of the Company purchased an aggregate of 300,000 shares of common stock of the Company upon the exercise of certain vested options. The total proceeds of the sale were $750,000, which the Company used for general working capital. The Company issued the shares in reliance on an exemption from registration under Rule 504 of Regulation D under the Act. The Company filed a Registration by Description in connection with the issuance of the shares with the Ohio Division of Securities pursuant to Section 1707.06(A)(1) of the Ohio Revised Code.

ITEM 5. INDEMNIFICATION OF DIRECTORS AND OFFICERS

Article 5 of the Company's Articles of Incorporation contains extensive provisions related to indemnification of officers, directors, employees and agents. The Company is required to indemnify its directors against expenses, including attorney fees, judgments, fines and amounts paid in settlement of civil, criminal, administrative, and investigative proceedings, if the director acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the Company. When criminal proceedings are involved, indemnification is further conditional upon the director having no reasonable cause to believe that his conduct was unlawful.

Entitlement of a director to indemnification shall be made by vote of the disinterested directors of the Company. If there are an insufficient number of such directors to constitute a quorum, the determination to indemnify directors shall be made by one of the following methods: (1) a written opinion of independent legal counsel, (2) vote by the shareholders, or (3) by the Court in which the action, suit or proceeding was brought.

The Company may pay the expenses, including attorney fees of any director, as incurred, in advance of a final disposition of such action, suit or proceeding, upon receipt by the Company of an undertaking by the affected director(s) in which he (they) agree to cooperate with the Company concerning the action, suit or proceeding, and agree(s) to repay the Company in the event that a Court determines that the director(s) action, or failure to act, involved an act, or omission, undertaken with reckless disregard for the best interests of the Company.

The indemnification provisions of the Articles of Incorporation relating to officers, employees and agents of the Company are similar to those relating to directors, but are not mandatory in nature. On a case-by-case basis, the Company may elect to indemnify them, and may elect to pay their expenses, including attorney fees, in advance of a final disposition of the action, suit, or proceeding, upon the same conditions and subject to legal standards as relate to directors. These indemnification provisions are also applicable to actions brought against directors, officers, employees and agents in the right of the Company ("derivative actions"). However, no indemnification shall be made to any person adjudged to be liable for negligence or misconduct in the performance of his duty to the Company unless, and only to the extent that a Court determines, that despite the adjudication of liability, but in view of all of the circumstances of the case, such persons reasonably entitled to indemnify for such expenses as the Court shall deem proper.

II-2


The Company has applied for but currently does not carry directors and officers insurance.

II-3


PART F/S

FINANCIAL STATEMENTS

Independent Auditors' Report..............................................................................  F-2
Balance Sheets, December 31, 1999 and June 30, 2000 (unaudited)...........................................  F-3
Statements of Operations for the years ended December 31, 1998 and 1999, and for
   the six months ended June 30, 1999 and 2000 (unaudited)................................................  F-5
Statements of Shareholders' Equity for the years ended December 31, 1998 and 1999,
   and for the six months ended June 30, 2000 (unaudited).................................................  F-6
Statements of Cash Flows for the years ended December 31, 1998 and 1999, and for
   the six months ended June 30, 1999 and 2000 (unaudited)................................................  F-7
Notes to Financial Statements.............................................................................  F-9

F-1

To the Board of Directors
Superconductive Components, Inc.
Columbus, Ohio

INDEPENDENT AUDITORS' REPORT

We have audited the accompanying balance sheet of Superconductive Components, Inc. as of December 31, 1999, and the related statements of operations, shareholders' equity and cash flows for the two years ended December 31, 1999. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Superconductive Components, Inc. as of December 31, 1999, and the results of its operations and its cash flows for the two years then ended in conformity with generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 13 to the financial statements, the Company's recurring losses from operations and lack of sufficient cash flow to fund these deficits raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 13. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

                                        /s/ HAUSSER + TAYLOR LLP

Columbus, Ohio
July 26, 2000

F-2

SUPERCONDUCTIVE COMPONENTS, INC.

BALANCE SHEETS

                                                                                                       (UNAUDITED)
                                                                                      DECEMBER 31,       JUNE 30,
                                                                                         1999              2000
                                                                                      ----------        ----------
                                     ASSETS
                                     ------

CURRENT ASSETS
     Cash (Note 2)                                                                    $      --         $      --
     Accounts and notes receivable (Note 2):
          Trade, less allowance for doubtful accounts of $24,000                          321,801           385,128
          Related party receivables, less allowance for doubtful accounts
            of $0 and $23,000, respectively                                                 4,283             4,283
     Inventories (Notes 2 and 3):                                                         531,682           584,421
     Prepaid expenses                                                                      20,804            67,000
                                                                                      -----------       -----------
               Total current assets                                                       878,570         1,040,832
                                                                                      -----------       -----------



PROPERTY AND EQUIPMENT, AT COST (Notes 2, 4 and 5)
     Machinery and equipment                                                            1,868,965         1,898,250
     Furniture and fixtures                                                                10,393            11,246
     Leasehold improvements                                                               293,491           301,467
                                                                                      -----------       -----------
                                                                                        2,172,849         2,210,963
     Less accumulated depreciation                                                     (1,440,331)       (1,589,133)
                                                                                      -----------       -----------
                                                                                          732,518           621,830
                                                                                      -----------       -----------



OTHER ASSETS (Note 2)
     Deferred stock offering costs                                                         14,744            17,289
     Other                                                                                 41,151            43,321
                                                                                      -----------       -----------
                                                                                           55,895            60,610
                                                                                      -----------       -----------
                                                                                      $ 1,666,983       $ 1,723,272
                                                                                      ===========       ===========

The accompanying notes are an integral part of these financial statements.

F-3

SUPERCONDUCTIVE COMPONENTS, INC.

BALANCE SHEETS

                                                                                                        (UNAUDITED)
                                                                                      DECEMBER 31,        JUNE 30,
                                                                                          1999              2000
                                                                                      -----------       -----------
                      LIABILITIES AND SHAREHOLDERS' EQUITY
                      ------------------------------------

CURRENT LIABILITIES
     Bank overdraft                                                                   $    30,735       $    61,765
     Note payable, bank (Note 4)                                                           95,025              --
     Capital lease obligation, current portion (Note 5)                                    74,359            40,905
     Accounts payable                                                                     305,544           324,093
     Accounts payable, shareholder                                                         45,994           137,731
     Accrued expenses                                                                     268,922           302,939
                                                                                      -----------       -----------
          Total current liabilities                                                       820,579           867,433
                                                                                      -----------       -----------


CAPITAL LEASE OBLIGATION, NET OF
  CURRENT PORTION (Note 5)                                                                 79,686            69,186
                                                                                      -----------       -----------

SUBORDINATED NOTES PAYABLE (Note 6)                                                       417,125           506,533
                                                                                      -----------       -----------

REDEEMABLE CONVERTIBLE PREFERRED
STOCK (Series A)
     10% cumulative, nonvoting, no par value, $1,000 stated
       value, liquidation and mandatory redemption at
       stated value per share plus unpaid and accumulated
       dividends ($47,091 and $36,012, respectively) (Note 7)                             180,841           107,037
                                                                                      -----------       -----------

COMMITMENTS AND CONTINGENCIES (Notes 4, 5, 6, and 14)

SHAREHOLDERS' EQUITY (Notes 7, 8, and 9)
     Convertible preferred stock, Series B, 10% cumulative,
       nonvoting, no par value, $10 stated value, optional
       redemption at 103%                                                                 691,672           360,032
     Common stock, no par value, authorized 15,000,000
       shares; 1,244,859 and 1,397,576 shares issued and outstanding,
       respectively                                                                     4,854,248         5,336,038
     Additional paid-in capital                                                           149,000           149,000
     Accumulated deficit                                                               (5,526,168)       (5,671,987)
                                                                                      -----------       -----------
                                                                                          168,752           173,083
                                                                                      -----------       -----------
                                                                                      $ 1,666,983       $ 1,723,272
                                                                                      ===========       ===========

The accompanying notes are an integral part of these financial statements.

F-4

SUPERCONDUCTIVE COMPONENTS, INC.

STATEMENTS OF OPERATIONS

                                                                                          (UNAUDITED)
                                                       YEARS ENDED                      SIX MONTHS ENDED
                                              -----------------------------       -----------------------------
                                              DECEMBER 31,      DECEMBER 31,        JUNE 30,          JUNE 30,
                                                  1999              1998              2000              1999
                                              -----------       -----------       -----------       -----------
SALES REVENUE                                 $ 2,253,209       $ 2,027,610       $ 1,151,507       $ 1,062,989
CONTRACT RESEARCH REVENUE                         425,153           470,552           348,208           131,665
                                              -----------       -----------       -----------       -----------
                                                2,678,362         2,498,162         1,499,715         1,194,654
                                              -----------       -----------       -----------       -----------

COST OF SALES REVENUE                           1,835,027         1,721,986           938,818           827,989
COST OF CONTRACT RESEARCH                         366,156           337,953           259,215           108,603
                                              -----------       -----------       -----------       -----------
                                                2,201,183         2,059,939         1,198,033           936,592
                                              -----------       -----------       -----------       -----------

GROSS MARGIN                                      477,179           438,223           301,682           258,062

GENERAL AND ADMINISTRATIVE EXPENSES               332,709           359,751           231,839           134,345

SALES AND PROMOTIONAL EXPENSES                    265,631           301,618           136,061           118,672
                                              -----------       -----------       -----------       -----------


INCOME (LOSS) FROM OPERATIONS                    (121,161)         (223,146)          (66,218)            5,045
                                              -----------       -----------       -----------       -----------

OTHER INCOME (EXPENSE)
     Interest                                     (44,473)          (28,847)          (33,633)          (20,616)
     Miscellaneous, net                            19,700            10,190             5,704             2,379
                                              -----------       -----------       -----------       -----------
                                                  (24,773)          (18,657)          (27,929)          (18,237)
                                              -----------       -----------       -----------       -----------
LOSS BEFORE INCOME TAX                           (145,934)         (241,803)          (94,147)          (13,192)

INCOME TAX EXPENSE (Note 10)                         --                --                --                --
                                              -----------       -----------       -----------       -----------

NET LOSS                                      $  (145,934)      $  (241,803)      $   (94,147)      $   (13,192)
                                              ===========       ===========       ===========       ===========


EARNINGS PER SHARE - BASIC
  AND DILUTIVE (NOTE 2)

NET LOSS PER COMMON SHARE                     $     (0.12)      $     (0.20)      $     (0.07)      $     (0.01)
                                              ===========       ===========       ===========       ===========

WEIGHTED AVERAGE COMMON
  SHARES OUTSTANDING                            1,226,138         1,188,136         1,344,030         1,183,205
                                              ===========       ===========       ===========       ===========

The accompanying notes are an integral part of these financial statements.

F-5

SUPERCONDUCTIVE COMPONENTS, INC.

STATEMENTS OF SHAREHOLDERS' EQUITY

YEARS ENDED DECEMBER 31, 1998 AND 1999 AND SIX MONTHS ENDED
JUNE 30, 2000 (UNAUDITED)

                                                          CONVERTIBLE
                                                           PREFERRED                   ADDITIONAL
                                                             STOCK,        COMMON        PAID-IN     ACCUMULATED
                                                            SERIES B        STOCK        CAPITAL       DEFICIT          TOTAL
                                                          -----------    -----------   -----------   -----------    -----------
Balance - December 31, 1997                               $   799,545    $ 4,612,738   $   149,000   $(4,952,941)   $   608,342


Accretion of cumulative dividends                              76,637           --            --         (94,137)       (17,500)


Exercise of options (4600 shares @ $2.50/share)                  --           11,500          --            --           11,500


Sale of Shares (20,000 @ $2.50/share)                            --           50,000          --            --           50,000


Net loss                                                         --             --            --        (241,803)      (241,803)
                                                          -----------    -----------   -----------   -----------    -----------


Balance - December 31, 1998                                   876,182      4,674,238       149,000    (5,288,881)       410,539


Accretion of cumulative dividends                              76,637           --            --         (91,353)       (14,716)

Conversion of preferred stock to common stock
  (35,522 shares)                                            (177,610)       177,610          --            --             --

Common stock issued in exchange for services received
  (1,920 shares @ $1.25/share)                                     --            2,400          --            --            2,400


Payment of cumulative dividends                               (83,537)          --            --            --          (83,537)


Net loss                                                         --             --            --        (145,934)      (145,934)
                                                          -----------    -----------   -----------   -----------    -----------


Balance - December 31, 1999                                   691,672      4,854,248       149,000    (5,526,168)       168,752


Accretion of cumulative dividends                              47,075           --            --         (51,672)        (4,597)


Exercise of options (37,920 shares @ $2.50/share)                --           94,800          --            --           94,800


Conversion of Series A preferred (1,379 shares)                  --            8,275          --            --            8,275


Conversion of Series B preferred (113,418 shares)            (378,715)       378,715          --            --             --


Net loss (unaudited)                                             --             --            --         (94,147)       (94,147)
                                                          -----------    -----------   -----------   -----------    -----------


Balance - June 30, 2000 (unaudited)                       $   360,032    $ 5,336,038   $   149,000   $(5,671,987)   $   173,083
                                                          ===========    ===========   ===========   ===========    ===========

The accompanying notes are an integral part of these financial statements.

F-6

SUPERCONDUCTIVE COMPONENTS, INC.

STATEMENTS OF CASH FLOWS

                                                                                                               (UNAUDITED)
                                                                                    YEARS ENDED             SIX MONTHS ENDED
                                                                              ------------------------   ----------------------
                                                                              DECEMBER 31, DECEMBER 31,   JUNE 30,     JUNE 30,
                                                                                  1999         1998        2000          1999
                                                                               ---------    ---------    ---------    ---------
CASH FLOWS FROM OPERATING ACTIVITIES
     Net loss                                                                  $(145,934)   $(241,803)   $ (94,147)   $ (13,192)
                                                                               ---------    ---------    ---------    ---------
     Adjustments to reconcile net loss to net cash provided by
       operating activities:
          Depreciation                                                           255,180      246,727      148,802      126,818
          Amortization                                                            10,119       10,116        6,599        6,599
          Inventory reserve                                                        9,220       28,605       40,074       12,253
          Provision for doubtful accounts                                          6,643        6,653       19,947         (608)
          Changes in operating assets and liabilities:
            (Increase) decrease in assets:
               Accounts receivable                                               (75,054)      81,216      (83,274)    (125,774)
               Inventories                                                       (61,674)     (12,105)     (92,813)     (85,243)
               Prepaid expenses                                                    8,861       (9,413)     (46,196)       7,792
               Other assets                                                        1,302       (7,501)         667          472
          Increase (decrease) in liabilities:
               Accounts payable                                                  (34,615)     (19,066)     101,775       19,478
               Accrued expenses                                                  133,585      (37,445)      30,575       62,280
               Deferred revenue                                                     --         (3,464)        --           --
                                                                               ---------    ---------    ---------    ---------
                    Total adjustments                                            253,567      284,323      126,156       24,067
                                                                               ---------    ---------    ---------    ---------
                         Net cash provided by operating activities               107,633       42,520       32,009       10,875
                                                                               ---------    ---------    ---------    ---------

CASH FLOWS FROM INVESTING ACTIVITIES
     Purchases of property and equipment                                         (66,322)    (207,444)     (38,144)     (21,101)
                                                                               ---------    ---------    ---------    ---------
                         Net cash used in investing activities                   (66,322)    (207,444)     (38,144)     (21,101)
                                                                               ---------    ---------    ---------    ---------

CASH FLOWS FROM FINANCING ACTIVITIES
     Bank overdraft                                                               30,735         --         31,030       25,657
     Principal repayments on notes payable, bank                                  (3,330)        --        (95,025)      (1,665)
     Principal repayments on long-term debt                                      (12,677)     (11,057)        --         (7,106)
     Proceeds from subordinated notes payable                                     80,000      155,000       89,408         --
     Principal payments on capital lease obligation                              (57,083)     (42,758)     (43,953)     (11,240)
     Proceeds from exercise of common stock options                                 --         11,500       94,800
     Proceeds from the sale of common stock                                         --         50,000         --
     Payment of cummulative dividends                                            (83,536)        --           --
     Redemption of Series A preferred stock                                                                (70,125)
                                                                               ---------    ---------    ---------    ---------
                         Net cash provided by (used in) financing activities     (45,891)     162,685        6,135        5,646
                                                                               ---------    ---------    ---------    ---------

NET DECREASE IN CASH                                                              (4,580)      (2,239)        --         (4,580)

CASH - Beginning of year                                                           4,580        6,819         --          4,580
                                                                               ---------    ---------    ---------    ---------

CASH - End of year                                                             $    --      $   4,580    $    --      $    --
                                                                               =========    =========    =========    =========

The accompanying notes are an integral part of these financial statements.

F-7

SUPERCONDUCTIVE COMPONENTS, INC.

STATEMENTS OF CASH FLOWS (CONTINUED)

                                                                                                           (UNAUDITED)
                                                                                  YEARS ENDED            SIX MONTHS ENDED
                                                                          --------------------------  ----------------------
                                                                          DECEMBER 31,  DECEMBER 31,  JUNE 30,      JUNE 30,
                                                                              1999         1998         2000         1999
                                                                              ----         ----         ----         ----
SUPPLEMENTAL DISCLOSURES OF CASH
  FLOW INFORMATION
     Cash paid during the years for:
          Interest                                                          $44,473      $28,847      $33,633      $20,616
          Income taxes                                                      $  --        $  --        $  --        $  --

SUPPLEMENTAL DISCLOSURES OF NONCASH
  INVESTING AND FINANCING ACTIVITIES

     Property and equipment was purchased by capital lease                  $63,344      $86,076         --           --

     Subordinated debt was issued to a shareholder as reimbursement
       for the shareholder paying accounts payable of the Company            55,000         --           --           --

     Common stock was issued as partial payment for accounts payable          2,400         --           --           --

     Preferred stock, Series A was redeemed by issuing additional
       subordinated notes payable                                            70,125         --           --        $70,125

The accompanying notes are an integral part of these financial statements.

F-8

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 1. BUSINESS ORGANIZATION AND PURPOSE

Superconductive Components, Inc. (the Company) is an Ohio corporation that was incorporated in May 1987. The Company was formed to develop, manufacture and sell materials using superconductive principles. Operations have since been expanded to include the manufacture and sale of non-superconductive materials. The Company's domestic and international customer base is primarily in the research, education, electronics and computer industries.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A. Interim Financial Data (Unaudited) - The unaudited financial information as of June 30, 2000 and for the six months ended June 30, 2000 and 1999 has been prepared on the same basis as the audited financial statements and, in the opinion of the Company's management, reflects all adjustments necessary for a fair presentation of the financial position and the results of operations for such interim periods in accordance with generally accepted accounting principles.

B. Inventories - Inventories are stated at the lower of cost or market on an acquired or internally produced lot basis, and consist of raw materials, work-in-process and finished goods. Cost includes material, labor and applied overhead.

C. Property and Equipment - Property and equipment are carried at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the assets for financial reporting purposes and allowable accelerated methods for tax purposes. Useful lives range from ten years on certain furniture and fixtures to three years on leasehold improvements and computer software. Expenditures for renewals and betterments are capitalized and expenditures for repairs and maintenance are charged to operations as incurred.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the fair value is less than the carrying amount of the asset, a loss is recognized for the difference. There have been no such impairment adjustments.

D. Research and Development - Internal research and development costs are expensed as incurred. Research and development expenses, including testing, for the years ended December 31, 1999 and 1998 and six months ended June 30, 2000 and 1999 were $15,392, $41,421, $11,024 and $29,414, respectively.

Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Research revenue and expenses associated to third parties are separately identified in the Statements of Operations.

F-9

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

E. Licenses - The Company has secured licenses to produce various Superconductive materials for periods up to the expiration of the applicable patents. The license fees, included in "Other Assets" on the balance sheet, are being amortized over the expected life of the agreement or applicable patent which is seventeen years. Cost and accumulated amortization of licenses at December 31, 1999 and June 30, 2000 are $24,500 and $8,661; $24,500 and $9,361, respectively.

F. Patent - The Company has secured a patent for a manufacturing process used in its operations. Costs incurred to secure the patent have been capitalized, included in "Other Assets" on the balance sheet, and are being amortized over the life of the patent. Cost and accumulated amortization of the patent at December 31, 1999 and June 30, 2000 are $26,318 and $1,206; $28,535 and $1,866, respectively.

G. Income Taxes - Income taxes are provided for by utilizing the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities using presently enacted tax rates. Deferred tax assets are recognized for net operating loss carryforwards, reduced by a valuation allowance which is established when "it is more likely than not" that some portion or all of the deferred tax assets will not be recognized.

H. Stock Based Compensation -The Company utilizes the provisions of Accounting Principles Board ("APB") No. 25, "Accounting for Stock Issued to Employees" which utilized a fair value based method. The Financial Accounting Standards Board ("FASB") Statement No. 123, "Accounting for Stock-Based Compensation", utilized a fair value based method. The FASB requires disclosure for new employee stock options of the impact to the financial statements of utilizing the intrinsic value versus the fair value based method (see Note 8).

I. Loss Per Common Share - Loss per common share amounts are based on the weighted average number of shares outstanding. The assumed conversion of preferred stock and exercise of stock options and warrants are anti-dilutive and have not been considered in the calculation of per share amounts.

J. Statements of Cash Flows - For purposes of the statements of cash flows, the Company considers all highly liquid investments purchased with a maturity of three months or less to be cash. No such investments were purchased.

K. Concentrations of Credit Risk - The Company's cash balances, which are at times in excess of federally insured levels, are maintained at a large regional bank, and are continually monitored to minimize the risk of loss. The Company grants credit to its customers, who are varied in terms of size, geographic location and financial strength. Customer balances are continually monitored to minimize the risk of loss.

F-10

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

L. Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

M. Fair Value - The estimated fair value of amounts reported in the financial statements have been determined using available market information and valuation methodologies, as applicable (see Note 12).

N. Revenue Recognition - Revenue from product sales is recognized upon shipment to customers. Provisions for discounts, returns and others adjustments are provided for in the same period as the related sales are recorded.

Revenue from contract research provided for third parties is recognized when the contracted work has been performed or as milestone results have been achieved.

O. Effects of Recent Accounting Pronouncements - In December 1999, the Securities and Exchange Commission issued Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition in Financial Statements." The guidance in SAB 101 must be adopted during the fourth quarter of fiscal 2000 and the effects, if any, are required to be recorded through a retroactive, cumulative-effect adjustment as of the beginning of the fiscal year, with a restatement of all prior interim quarters in the year. Management has not completed its evaluation of the effects, if any, that SAB 101 will have on its income statement presentation, operating results, or financial position.

NOTE 3. INVENTORIES

Inventories consist of the following:

                                                        (UNAUDITED)
                                        DECEMBER 31,      JUNE 30,
                                           1999            2000
                                         ---------       ---------
Raw materials                            $ 365,688       $ 422,556
Work-in-process                             90,841         121,511
Finished goods                             223,797         229,072
                                         ---------       ---------
                                           680,326         773,139
Less reserve for obsolete inventory       (148,644)       (188,718)
                                         ---------       ---------

                                         $ 531,682       $ 584,421
                                         =========       =========

F-11

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 4. NOTES PAYABLE - BANK

The Company has a note payable to a bank in the amount of $95,025 at December 31, 1999, due June 30, 2000 interest only payable monthly at prime (8.5% at December 31, 1999) plus .75% until maturity. In addition, the Company is contingently liable under a standby letter of credit issued in favor of a vendor at $20,000 until June 30, 2000. No collateral, other than the personal guarantee by an officer and major shareholder of the Company, collateralizes the note or letter of credit. On February 28, 2000, an officer and major shareholder of the Company paid the bank note payable totaling $89,408 in full. The Company increased the subordinated note payable to Dr. Funk as reimbursement for payment on the bank note payable.

On June 30, 2000, the Company obtained a bank line of credit in the amount of $100,000, interest at prime, maturing June 30, 2001. As of July 26, 2000, no amounts have been drawn on this line of credit. No collateral, other than the personal guarantee by an officer and major shareholder of the Company, collateralizes the bank line of credit.

NOTE 5. LEASE OBLIGATIONS

OPERATING

The Company leases certain office equipment and a building under agreements classified as operating leases. Minimum future rental payments under these non-cancellable operating leases having remaining terms in excess of one year at December 31, 1999 are as follows:

YEAR                     AMOUNT
----                     ------
2000                    $69,438
2001                     17,360
                        -------
                        $86,798
                        =======

Rent expense which includes various monthly rentals for the years ended December 31, 1999 and 1998 and June 30, 2000 and 1999 were $56,022 and $64,253, $27,928 and $22,047, respectively.

F-12

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 5. LEASE OBLIGATIONS (CONTINUED)

CAPITAL

The Company also leases certain equipment under capital leases. The future minimum lease payments by year with the present value of such payments, as of December 31, 1999 is as follows:

2000                                               $ 85,058
2001                                                 28,660
2002                                                 28,660
2003                                                 24,459
2004                                                 12,042
                                                   --------
Total minimum lease payments                        178,879
Less amount representing interest                    24,834
                                                   --------
Present value of minimum lease payments             154,045
Less current portion                                 74,359
                                                   --------
Long-term capital lease obligations                $ 79,686
                                                   ========

The equipment under capital lease at December 31, 1999 is included in the accompanying balance sheet under the following captions:

Machinery and equipment                            $288,154
Less accumulated depreciation                        77,657
                                                   --------
Net book value                                     $210,497
                                                   ========

These assets are amortized over seven years using the straight-line method and amortization is included in depreciation expense.

NOTE 6. SUBORDINATED NOTES PAYABLE

Subordinated notes payable consists of the following:

                                                                (UNAUDITED)
                                                   DECEMBER       JUNE 30,
                                                     1999          2000
                                                   --------      --------
Dr. Edward Funk                                    $256,125      $345,533
Ingeborg Funk                                       161,000       161,000
                                                   --------      --------
                                                   $417,125      $506,533
                                                   ========      ========

F-13

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 6. SUBORDINATED NOTES PAYABLE (CONTINUED)

1993 SUBORDINATED DEBENTURE AGREEMENT

Dr. Edward and Ingeborg Funk have loaned funds net of conversion to equity of $256,125 and $161,000 to the Company, respectively, from September 30, 1991 through December 31, 1999. The long term subordinated debenture agreements dated March 1, 1993 (the 1993 agreements) provides for conversion to shares of common stock at $2.50 per share. These subordinated notes payable are due on December 31, 2009. The debentures bear interest at 10% per annum. Dr. Edward and Ingeborg Funk have waived accrual of interest on outstanding amounts during 1999 and 1998. The debentures are subordinate to other senior indebtedness, as defined in the agreements. Dr. Edward Funk is the founder, Chief Executive Officer, and majority shareholder of the Company.

The Company has issued common stock purchase warrants at $2.50 per common share for 150,000 shares of common stock related to the subordinated notes payable to Dr. Edward and Ingeborg Funk. The warrants are 100% vested and expire in ten years from the date of grant of January 7, 2000.

NOTE 7. COMMON AND PREFERRED STOCK

COMMON STOCK ISSUES

During 1998, 4,600 shares of common stock were issued in exchange for options at $2.50 per share. Additionally, 20,000 shares were issued for cash at $2.50 per share.

During 1999, 960 shares of common stock were issued in exchange as partial payment for consulting services at $2.50 per share.

PREFERRED STOCK

                                    SHARES        SHARES
                                  AUTHORIZED    OUTSTANDING
                                  ----------    -----------
10% Convertible/voting               10,000         --

Nonvoting                           125,000       83,537

Voting                              125,000         --
                                  ----------    -----------
                                    260,000       83,537
                                  ==========    ===========

F-14

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 7. COMMON AND PREFERRED STOCK (CONTINUED)

In June 1995, the Company completed an offering of 215 shares of $1,000 stated value 1995 Series A 10% non-voting convertible preferred stock. In January 1996, the Company completed an offering of 70,000 shares of $10 stated value 1995 Series B 10% non-voting convertible preferred stock. For the first three years, the dividends on both issues were payable by issuing additional Series A or B preferred shares or in cash. The Series A shares are convertible to common shares at the rate of $6.00 per share and Series B shares at the rate of $5.00 per share. At the Company's option, Series A and Series B shares are redeemable at 103% after the respective third anniversary dates.

Series A has a mandatory redemption at 25% annually of the issued Series A shares at their stated value plus accrued and unpaid dividends commencing on the fourth anniversary date. As security for cash dividends, or mandatory redemption payments due on the Series A preferred shares, and to collateralize the preference upon a liquidation, dissolution or winding up of the affairs of the Company, Dr. and Mrs. Funk pledged an aggregate of 60,000 shares of common stock, $.01 par value of Interpore/Cross International (Cross) (formerly known as Cross Medical Products, Inc.). The unamortized issue costs of $14,744 (included on the balance sheet as "Other Assets") on Series A are being amortized over the remaining five year life of the issue due to the mandatory redemption of the shares.

As security for cash dividends on the Series B preferred shares, Dr. and Mrs. Funk pledged an aggregate 131,000 shares of $.01 par value common stock of Cross. Issue costs of approximately $116,110 on Series B were netted against the proceeds of that issue.

Cumulative dividends in arrears on Series A preferred stock are $47,091 ($352.00 per share) at December 31, 1999.

During 1999, Series B cash dividends totaling $83,537 were paid. Additionally, preferred stock was converted to 35,522 shares of common stock.

During 1999, the Company redeemed $41,250 of Series A preferred stock which represented an early redemption of the mandatory redemption requirement for certain shareholders. Series A accrued dividends totaling $28,875 were paid in connection with the Series A redemption.

On July 20, 2000, the Company redeemed approximately $102,000 of the outstanding Series A preferred stock. Additionally, Edward Funk purchased the remaining outstanding shares of Series A preferred stock.

Subsequent to year-end, Series B preferred shareholders converted 55,862 shares of Series B preferred shares at $5.00 per share. The Company issued 111,724 shares of common stock for the conversion of Series B and 1,694 shares common stock for cumulative dividends accrued at 10% per annum.

F-15

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 8. INCENTIVE STOCK OPTION PLANS

In November 1987, the Company adopted the 1987 Incentive Stock Option Plan (the Incentive Plan) for key employees under which options to purchase up to 40,000 shares of the Company's common stock may be granted to qualified employees, subject to the execution of stock option agreements. Options may be exercised for periods up to 10 years from the date of grant at prices not less than 100% of fair market value on the date of grant.

In February 1991, the Company adopted the 1991 Non-Statutory Stock Option Plan (the Non-Statutory Plan) under which options to purchase up to 20,000 shares of the Company's common stock may be granted to key employees, directors, consultants, advisors and sales representatives, subject to the execution of stock option agreements. Options may be exercised for periods up to 10 years from the date of grant at prices to be determined by the Board of Directors. The Company has reserved 2,000 of the shares subject to the Non-Statutory Plan for options to be granted to sales representatives.

On September 29, 1995, the Company adopted the 1995 Stock Option Plan (the 1995 Plan) as incentive to key employees, directors and consultants under which options to purchase up to 600,000 shares of the Company's common stock may be granted, subject to the execution of stock option agreements. Incentive stock options may be granted to key associates of the Company and Non-Statutory options may be granted to directors who are not employees and to consultants and advisors who render services to the Company. Options may be exercised for periods up to 10 years from the date of grant at prices not less than 100% of fair market value on the date of grant.

F-16

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 8. INCENTIVE STOCK OPTION PLANS (CONTINUED)

The cumulative status at December 31, 1999 and 1998 of options granted and outstanding, as well as options which became exercisable in connection with the Incentive Plan is summarized as follows:

EMPLOYEE STOCK OPTION PLANS

                                                         1987        1991         1995
                                                         PLAN        PLAN         PLAN
                                                         ----        ----         ----
Options outstanding -12/31/97                            9,100       4,800       14,830

Options issued or exercisable                             --          --         24,680

Options exercised                                         --        (1,600)        (500)

Options cancelled/expired                                 --          (600)      (1,500)
                                                       -------     -------      -------

Options outstanding - 12/31/98                           9,100       2,600       37,510

Options issued or exercisable                             --          --         24,680

Options exercised                                         --          --           --

Options cancelled/expired                                 --          --           (400)
                                                       -------     -------      -------

Options outstanding - 12/31/99                           9,100       2,600       61,790
                                                       =======     =======      =======

Weighted average option price                          $  2.50     $  2.50      $  2.50
                                                       =======     =======      =======

Exercise price range of options outstanding            $  2.50     $  2.50      $  2.50
                                                       =======     =======      =======

F-17

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 8. INCENTIVE STOCK OPTION PLANS (CONTINUED)

NON-EMPLOYEE DIRECTOR OPTION PLANS

                                                        1991        1995
                                                        PLAN        PLAN
                                                       ------      ------
Options outstanding - 12/31/97                          8,750       1,000

Options issued or exercisable                            --         3,000

Options exercised                                      (2,500)       (500)

Options cancelled/expired                                --          --
                                                       ------      ------

Options outstanding - 12/31/98                          6,250       3,500

Options issued or exercisable                            --         3,500

Options exercised                                        --          --

Options cancelled/expired                                --          --

                                                       ------      ------
Options outstanding - 12/31/99                          6,250       7,000
                                                       ======      ======

Weighted average option price                          $ 2.50      $ 2.50
                                                       ======      ======

Exercise price range of options outstanding            $ 2.50      $ 2.50
                                                       ======      ======

The Company utilizes the intrinsic value method under APB no. 25 to account for employee stock options. The Company has utilized the Black Scholes option pricing model for proforma footnote purposes with the following assumptions used for grants in all years. Dividend yield rate of 0%, risk-free interest rate of 6%, and expected option life in years of 4.6 years. Expected volatility was 108.7%. If the Company had utilized the fair value based method under FASB No. 123, the impact would not be significant to the financial statements.

Subsequent to year-end, the Board of Directors and shareholders approved the granting of 113,500 employee stock options and 7,000 non-employee director options. These options vest 100% one year from the date of grant and have an exercise price of $2.125.

F-18

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS

NOTE 9. WARRANTS ISSUED

Warrants unexercised at December 31, 1999, issued to related parties and others are as follows:

 # of                                                               Issue                 Exercise
Shares               Issued To           Consideration              Date    Expiration     Price
------               ---------           -------------              ----    ----------     -----

Common
Shares
------
 7,000             Edward Funk       Loan Guarantee                  8-90      8-00         $11.00
15,000             Edward Funk       Value Received                 12-94     12-01           6.00
10,000             Edward Funk       Lease Guarantee                 3-96      3-03           5.00
75,000             Edward Funk       Subordinated notes payable      1-00      1-10           2.50
75,000             Ingeborg Funk     Subordinated notes payable      1-00      1-10           2.50

NOTE 10. INCOME TAXES

Deferred tax assets and liabilities result from temporary differences in the recognition of income and expense for tax and financial reporting purposes. Significant components of the Company's deferred tax assets and liabilities are as follows at December 31:

                                                1999
                                             -----------
Deferred tax assets
     NOL Carryforward                        $ 1,578,000
     UNICAP                                       25,300
     Allowance for doubtful accounts              23,400
     Reserve for obsolete inventory               50,500
                                             -----------
                                               1,677,200

Deferred tax liability
     Property and equipment                      (13,600)
                                             -----------
          Net deferred tax asset               1,663,600

Valuation allowance                           (1,663,600)
                                             -----------

Net                                          $      --
                                             ===========

F-19

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS.

NOTE 10. INCOME TAXES (CONTINUED)

A valuation allowance has been recorded against the realizability of the net deferred tax asset, such that no value is recorded for the asset in the accompanying financial statements. The valuation allowance totaled $1,663,200 and $1,614,000 at December 31, 1999 and 1998, respectively .

The Company has net operating loss carryovers available for federal and state tax purposes of approximately $4,640,000, which expire in varying amounts from 2003 through 2014.

For the years ended December 31, 1999 and 1998, a reconciliation of the statutory rate and effective rate for the provisions for income taxes consists of the following:

                                            PERCENTAGE
                                         ----------------
                                           1999      1998
                                           ----      ----
Federal statutory rate                   (34.0)    (34.0)
Valuation allowance                       34.0      34.0
                                          ----      ----
Effective rate                             -- %      -- %
                                          ====      ====

The expense (benefit) for income taxes consists of the following:

     Current expense                     $ --      $ --
     Deferred expense                      --        --
                                          ----      ----

Total                                    $ --      $ --
                                          ====      ====

NOTE 11. RELATED PARTY TRANSACTIONS

The Company has trade and other receivables from an affiliated entity of $44,607, which has been written off as bad debt expense, related to sales of inventory, rent and reimbursement of expenses. Sales to this related party amounted to $16,962 and $22,926 in 1999 and 1998, respectively.

The Company has a note receivable from an officer of the Company in the amount of $4,283.

The Company has trade payables, shareholder of $45,994 pertaining to reimbursement for purchase of goods and services obtained for Company purposes.

For additional information regarding related party transactions, see Notes 4, 6 and 9.

F-20

SUPERCONDUCTIVE COMPONENTS, INC.

NOTES TO FINANCIAL STATEMENTS.

NOTE 12. FAIR VALUE OF FINANCIAL INSTRUMENTS

The fair value of financial instruments represents the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. Significant differences can arise between the fair value and carrying amount of financial instruments that are recognized at historical cost amounts.

The following methods and assumptions were used by the Company in estimating fair value disclosures for financial instruments:

- Cash and cash equivalents, short-term debt and current maturities of long-term debt: Amounts reported in the balance sheet approximate fair market value due to the short maturity of these instruments.

- Long-term capital lease obligations: Amounts reported in the balance sheet approximate fair value as the interest rates on these obligations approximate current rates available based on the relative stability of prime.

- Subordinated notes payable: Amounts reported in the balance sheet represent convertible debt to officers and major shareholders. Conversion rates approximate current trade prices. The stated interest is typically waived by the shareholders. Additionally, these shareholders have historically converted previous balances of subordinated convertible debt to equity. Due to the limited trading of the Company's common stock and the non-payment of interest on the subordinated debt to equity, fair market value approximates the amounts reported in the balance sheet.

- Redeemable convertible preferred stock: Amounts reported in the balance sheet approximate fair value as approximately $102,000 of the outstanding preferred stock was redeemed on July 20, 2000 at book value.

NOTE 13. CONTINUED EXISTENCE

The Company has suffered recurring losses since inception, approximating $5,526,000 at December 31, 1999, has been unable to fund payments of subordinated debt interest and dividends, and has been highly dependent upon major shareholders for working capital support funded through subordinated debentures (see Note 6) or pledge of security to raise new capital. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans to alleviate these conditions include additional marketing efforts to increase sales, searching for a merger or investment partner(s) and other actions such as research grants. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

F-21

PART III

ITEM 1. INDEX TO EXHIBITS

EXHIBIT                                 EXHIBIT
NUMBER                                 DESCRIPTION
------                                 -----------

   3(a)              Amended and Restated Articles of Incorporation of
                     Superconductive Components, Inc.

   3(b)              Restated Code of Regulations of Superconductive
                     Components, Inc.

   10(a)             Lease Agreement between Superconductive Components,
                     Inc. and University Area Rentals dated as of February
                     7, 1997.

   10(b)             Subcontract Agreement between Superconductive
                     Components, Inc. and The Ohio State University
                     effective as of April 1, 2000.

   10(c)             1987 Incentive Stock Option Plan.

   10(d)             1991 Non-Statutory Stock Option Plan.

   10(e)             1995 Stock Option Plan.

   23                Consent of Independent Accountants.

   24                Power of Attorney.

   27                Financial Data Schedules.

III-1


SIGNATURES

In accordance with Section 12 of the Securities Exchange Act of 1934, the Registrant has caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

SUPERCONDUCTIVE COMPONENTS, INC.

Date:   September 28, 2000                  By: /s/ Edward R. Funk
                                               ---------------------------------
                                               Edward R. Funk, President and
                                               Chief Executive Officer

III-2


EXHIBIT 3(a)

SECOND AMENDED AND RESTATED

ARTICLES OF INCORPORATION
OF
SUPERCONDUCTIVE COMPONENTS, INC.
(adopted SEPTEMBER 12, 1995)

Edward R. Funk, President and Curtis A. Loveland, Secretary, of Superconductive Components, Inc. (the "Corporation"), with its principal offices located at Columbus, Franklin County, Ohio, do hereby certify that in an action by unanimous written consent of the directors pursuant to Section 1701.54 of the Ohio Revised Code, the Articles of Incorporation have been amended and restated pursuant to Section 1701.72 of the Ohio Revised Code, as follows:

FIRST: The name of said Corporation shall be Superconductive Components, Inc.

SECOND: The place in Ohio where its principal office is to be located is the City of Columbus, Franklin County, Ohio.

THIRD: The purposes for which it is formed are to engage in any business or activity for which corporations are formed under Sections 1701.01 to 1701.98, inclusive, of the Revised Code of Ohio.

FOURTH:

A. AUTHORIZED SHARES.

The total number of shares of all classes of stock which the Corporation shall have the authority to issue is Fifteen Million Two Hundred Sixty Thousand (15,260,000) consisting of:

1. Fifteen Million (15,000,000) shares of Common Stock, without par value (the "Common Stock");

2. Ten Thousand (10,000) cumulative preferred shares, without par value (the "Cumulative Preferred Stock");

3. One Hundred Twenty-Five Thousand (125,000) shares of Voting Preferred Stock, without par value (the "Voting Preferred Stock"); and

4. One Hundred Twenty-Five Thousand (125,000) shares of Non-Voting Preferred Stock, without par value (the "Non-Voting Preferred Stock").


B. COMMON STOCK

The holders of the Common Stock are entitled at all times to one vote for each share and to such dividends as the Board of Directors may in its discretion from time to time legally declare, subject, however, to the voting and dividend rights, if any, of the holders of the Voting Preferred Stock and the Non-Voting Preferred Stock. In the event of any liquidation, dissolution or winding up of the Corporation, the remaining assets of the Corporation after the payment of all debts and necessary expenses shall be distributed among the holders of the Common Stock pro rata in accordance with their respective holdings, subject, however, to the rights of the holders of the Voting Preferred Stock and the Non-Voting Preferred Stock then outstanding. The Common Stock is subject to all of the terms and provisions of the Voting Preferred Stock and the Non-Voting Preferred Stock as fixed by the Board of Directors as hereinafter provided.

C. CUMULATIVE PREFERRED STOCK

Each share of the Cumulative Preferred Stock shall have a stated value of Three Hundred Dollars ($300.00) and be entitled to receive dividends at the rate of ten (10%) per annum of the stated value per share thereof, paid, at the election of the Corporation, in either (i) cash or (ii) Common Stock at the then per share market value of the Common Stock. Such dividends shall be cumulative from the date of issuance and shall be payable in arrears, when and as declared by the Board of Directors. Each share of the Cumulative Preferred Stock shall be equal to every other share of Cumulative Preferred Stock except that shares issued at different times may differ as to the dates from which dividends thereon shall be cumulative. Except as otherwise provided in this Article Fourth, each share of Cumulative Preferred Stock shall be equal to each share of Common Stock in all respects, including, without limitation, voting rights and rights upon liquidation.

Subject to an upon compliance with the provisions above, the holder of any shares of Cumulative Preferred Stock may at his option convert any such shares of Cumulative Preferred Stock into such number of fully paid and nonassessable shares of Common Stock as are issuable pursuant to the formula set forth below; provided, however, that there must be sufficient Common Stock duly and validly authorized and unissued to accommodate any such conversion.

The basic conversion rate shall be five hundred (500) shares of Common Stock for each share of Cumulative Preferred Stock surrendered for conversion.

In case at any time or from time to time the Corporation shall:

(i) take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend payable in, or other distribution of, Common Stock, or

(ii) subdivide its outstanding shares of Common Stock into a larger number of shares of Common Stock, or

(iii) combine its outstanding shares of Common Stock into a smaller number of shares of Common Stock,

then the conversion rate in effect immediately after the happening of any such event shall be proportionately increased, in case of the happening of events described in subparagraphs (i) or (ii) above, or proportionately decreased in case of the happening of events described in subparagraph
(iii) above.

To convert shares of Cumulative Preferred Stock, the holder shall give the Corporation thirty (30) days advance written notice which notice shall contain (i) the number of shares of Cumulative

-2-

Preferred Stock to be exchanged and (ii) stock certificates representing the shares of Cumulative Preferred Stock to be exchanged. The Board of Directors of the Corporation is expressly authorized to take appropriate action, without any further action by the shareholders of this Corporation, to ensure that any such conversion may be accomplished within thirty (30) days, including, without limitation thereto, the adoption of an amendment to the Articles of Incorporation to increase the number of authorized Common Stock in order to accommodate the conversion.

So long as any shares of Cumulative Preferred Stock are outstanding, the Corporation shall not, without the consent (given in writing without a meeting or by vote in person or by proxy at a meeting called for the purpose) of the holders of at least a majority of the aggregate number of shares of Cumulative Preferred Stock entitled to vote thereon, amend, change or repeal any of the express terms of the Cumulative Preferred Stock in any manner adverse to the holders thereof.

D. VOTING PREFERRED STOCK

The Board of Directors is hereby expressly authorized to adopt amendments to the Articles of Incorporation to provide for the issuance of one or more series of Voting Preferred Stock, to establish from time to time the number of shares to be included in each such series, to fix the designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereof, including without limitation the following, and the shares of each series may vary from the shares of any other series in the following respects:

(a) the division of such shares into series and the designation and authorized number of shares of each series;

(b) the annual dividend rate on the shares;

(c) the dates of payment of dividends, whether the dividends shall be cumulative and, if cumulative, the date from which dividends shall accumulate;

(d) the redemption price or prices for the particular series, if redeemable, and the terms and conditions of such redemption;

(e) sinking fund requirements, if any;

(f) the preference, if any, of the shares of such series in the event of any voluntary or involuntary liquidation, dissolution, or winding up of affairs of the Corporation;

(g) the right, if any, of the shares of such series to be converted into shares of any other series or class and the terms and conditions of such conversion; and

(h) any other relative rights, preferences, and limitations of that series.

The holders of Voting Preferred Stock shall be entitled at all times to one vote for each share, voting as a class.

-3-

E. NON-VOTING PREFERRED STOCK

The Board of Directors is hereby expressly authorized to adopt amendments to the Articles of Incorporation to provide for the issuance of one or more series of Non-Voting Preferred Stock, and to establish from time to time the number of shares to be included in each such series, to fix the designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereof, including without limitation the following, and the shares of each series may vary from the shares of any other series in the following respects:

(a) the division of such shares into series and the designation and authorized number of shares of each series;

(b) the annual dividend rate on the shares;

(c) the dates of payment of dividends, whether the dividends shall be cumulative and, if cumulative, the date from which dividends shall accumulate;

(d) the redemption price or prices for the particular series, if redeemable, and the terms and conditions of such redemption;

(e) sinking fund requirements, if any;

(f) the preference, if any, of the shares of such series in the event of any voluntary or involuntary liquidation, dissolution, or winding up of affairs of the Corporation;

(g) the right, if any, of the shares of such series to be converted into shares of any other series or class and the terms and conditions of such conversion; and

(h) any other relative rights, preferences, and limitations of that series.

Except as otherwise required by law, no holders of Non-Voting Preferred Stock shall be entitled to vote on any matter submitted to the shareholders of the Corporation.

F. SERIES A 10% NON-VOTING CONVERTIBLE PREFERRED STOCK.

There shall be created out of the authorized number of the Non-Voting Preferred Stock of the Corporation a series designated as "Series A 10% Non-Voting Convertible Preferred Stock" (the "Series A Non-Voting Preferred Stock"), to consist of 700 shares, with a stated value of $1,000 per share, of which the preferences, rights, qualifications, limitations and restrictions thereof, shall be as follows:

(1) CERTAIN DEFINITIONS. Unless the context otherwise requires, the terms defined in this paragraph shall have, for the purposes of this paragraph and paragraphs 2 through 9 below, the meanings herein specified.

COMMON STOCK. The term "Common Stock" shall mean all shares now or hereafter authorized of any class of Common Stock of the Corporation and any other shares of the Corporation, howsoever designated, authorized after the Issue Date, which have the right (subject always to prior rights of any class or series of Voting and Non-Voting Preferred Stock) to participate in the distribution of the assets and earnings of the Corporation without limit as to per share amount.

CUMULATIVE PREFERRED STOCK. The term "Cumulative Preferred Stock" shall mean all shares now or hereafter authorized of any class of Cumulative Preferred Stock of the

-4-

Corporation which are entitled to receive dividends at the rate of ten percent (10%) per annum of the stated value per share thereof and which are convertible into shares of Common Stock.

ISSUE DATE. The term "Issue Date" shall mean the date that shares of Series A Non-Voting Preferred Stock are first issued by the Corporation.

JUNIOR STOCK. The term "Junior Stock" shall mean the Common Stock and the Cumulative Preferred Stock and any class or series of shares of the Corporation issued after the Issue Date not entitled to receive any assets upon the liquidation, dissolution or winding up of the affairs of the Corporation until the shares of Series A Non-Voting Preferred Stock shall have received the Stated Value of all outstanding shares of Series A Non-Voting Preferred Stock as of the date of such liquidation, dissolution or winding up, plus any accrued and unpaid dividends to such date.

PARITY STOCK. The term "Parity Stock" shall mean, for purposes of paragraph 3 below, any class or series of shares of the Corporation issued after the Issue Date entitled to receive assets upon the liquidation, dissolution or winding up of the affairs of the Corporation on a parity with the Series A Non-Voting Preferred Stock.

SENIOR STOCK. The term "Senior Stock" shall mean any class or series of shares of the Corporation issued after the Issue Date ranking senior to the Series A Non-Voting Preferred Stock in respect of the right to receive dividends, as discussed in paragraph 2 below, or assets upon the liquidation, dissolution or winding up of the affairs of the Corporation, as discussed in paragraph 3 below.

STATED VALUE. The term "Stated Value" when used in reference to the Series A Non-Voting Preferred Stock shall mean $1,000 per share of Series A Non-Voting Preferred Stock.

(2) DIVIDENDS. Subject to the limitations set forth below, the holders of the Series A Non-Voting Preferred Stock shall be entitled to receive dividends at the rate of 10% of the Stated Value per annum per share. Dividends shall be payable on each anniversary of the Issue Date. Dividends shall be payable either in shares of Series A Non-Voting Preferred Stock or cash, in the sole option of the Corporation, for the initial three years that the Series A Non-Voting Preferred Stock is outstanding, and thereafter in cash to the extent funds are then legally available for the payment of such cash dividends. The right of the holders of the Series A Non-Voting Preferred Stock to receive such dividends shall be cumulative and shall accrue from the date of issuance of the Series A Non-Voting Preferred Stock. If at any time, the aggregate amount of cash dividends to be paid by the Corporation on the Series A Non-Voting Preferred Stock is insufficient to permit the payment of the full amount of cash dividends then accrued on all issued and outstanding Series A Non-Voting Preferred Stock, then such cash dividends, to the extent payable, shall be distributed to the holders of all outstanding Series A Non-Voting Preferred Stock ratably in proportion to the respective amounts of cash dividends then accrued and unpaid on such Series A Non-Voting Preferred Stock. So long as any Series A Non-Voting Preferred Stock shall remain outstanding, no cash dividends shall be declared or paid on any Junior Stock until all accrued and unpaid cash dividends on the Series A Non-Voting Preferred Stock have been paid to the holders thereof.

In the event that any of the Series A Non-Voting Preferred Stock is converted, as provided herein, prior to a dividend payment date, no payment of or adjustment for dividends yet due shall be made on the Series A Non-Voting Preferred Stock converted.

(3) LIQUIDATION RIGHTS. In the event of any liquidation, dissolution, or winding up of the Corporation, the holders of the Series A Non-Voting Preferred Stock then outstanding shall be

-5-

entitled to receive out of the assets of the Corporation, before any distribution or payment shall be made to the holders of any Junior Stock, an amount equal to the Stated Value per share plus any accrued and unpaid cumulative dividends thereon. If upon any liquidation, dissolution, or winding up, amounts distributable to the holders of all Series A Non-Voting Preferred Stock and any Parity Stock shall be insufficient to permit the payment of the full liquidation amounts on all issued and outstanding Series A Non-Voting Preferred Stock and Parity Stock, then the entire assets of the Corporation available for distribution to the holders of Series A Non-Voting Preferred Stock and Parity Stock shall be distributed to holders of all Series A Non-Voting Preferred Stock and Parity Stock ratably in proportion to the full preferential amounts to which such holders are respectively entitled. A consolidation or merger of the Corporation with or into any other corporation or corporations, or a sale or transfer of all, or substantially all, of its property shall not be deemed to be a liquidation, dissolution, or winding up of the Corporation.

(4) OPTIONAL REDEMPTION. After the third anniversary of the Issue Date, the Corporation may, at its option, redeem the Series A Non-Voting Preferred Stock, in whole or in part, at a redemption price equal to 103% of the Stated Value plus the amount of any accrued and unpaid cash dividends thereon to the date of such redemption. In case of the redemption of only a part of the Series A Non-Voting Preferred Stock, the Series A Non-Voting Preferred Stock to be redeemed shall be selected by whatever means the Board of Directors may, in its sole discretion, determine.

(5) MANDATORY REDEMPTION. Twenty-five percent (25%) of the Series A Non-Voting Preferred Stock issued and outstanding as of the fourth anniversary of the Issue Date shall be redeemed by the Corporation on the fourth, fifth, sixth and seventh anniversary dates of the Issue Date at a redemption price equal to the Stated Value per share plus the amount of any accrued and unpaid cash dividends thereon to the date of such redemption. The Series A Non-Voting Preferred Stock to be redeemed shall be selected by whatever means the Board of Directors may, in its sole discretion, determine.

(6) NOTICE OF REDEMPTION Notice of any redemption shall be given by the Corporation to the holders of record of the Series A Non-Voting Preferred Stock to be redeemed at their respective addresses then appearing upon the books of the Corporation not less than 30 nor more than 60 days prior to the date fixed for such redemption (the "Redemption Date"), which notice shall specify the Redemption Date, the number of shares to be redeemed, and the place where certificates representing such Series A Non-Voting Preferred Stock are to be surrendered. On the Redemption Date, all Series A Non-Voting Preferred Stock as to which such notice shall have been given shall, whether or not certificates therefor shall have been surrendered for cancellation, be deemed to be no longer outstanding for any purpose, and all rights with respect to such Series A Non-Voting Preferred Stock shall thereupon terminate, except only the right of the holders of the certificates for such Series A Non-Voting Preferred Stock to receive the amount payable upon the redemption thereof, without further dividends.

Notwithstanding any provisions of paragraphs 4 and 5 above to the contrary, the Corporation shall not be obligated to pay to any holder of the Series A Non-Voting Preferred Stock the redemption price for any Series A Non-Voting Preferred Stock to be redeemed until such holder shall have surrendered to the Corporation certificates representing such Series A Non-Voting Preferred Stock.

(7) CONVERSION RIGHTS. The holders of the Series A Non-Voting Preferred Stock shall have the right and option to convert all or part of the Series A Non-Voting Preferred Stock then owned by them, at any time, into Common Stock; provided, however, that, except for the conversion of all of the Series A Non-Voting Preferred Stock then owned by a holder, no fractional share of Series A Non-Voting Preferred Stock may be converted at any time.

-6-

The Common Stock issuable to each holder of Series A Non-Voting Preferred Stock upon conversion of any Series A Non-Voting Preferred Stock shall be, subject to adjustments as described in paragraph 8 below, based upon a conversion price of $.60 per share of Common Stock so that the number of shares of Common Stock issuable for each share of Series A Non-Voting Preferred Stock converted shall be calculated by dividing the Stated Value of each share of Series A Non-Voting Preferred Stock by $.60. Furthermore, and notwithstanding the foregoing sentences of this paragraph, the Corporation shall not be obligated to issue any fractional shares of Common Stock upon conversion of any shares of Series A Non-Voting Preferred Stock. In lieu of any fractional shares of Common Stock to which a holder of shares of Series A Non-Voting Preferred Stock would otherwise be entitled, the Corporation shall pay to such holder cash in an amount equal to the market price of the Common Stock as of the effective date of the conversion, as such price shall be allocable to such fractional shares of Common Stock. For purposes of this paragraph, the market price per share of the Common Stock on any date shall be equal to the average of the quoted prices of such shares for 30 consecutive trading days commencing 45 trading days before the date in question. In the absence of one or more such quotations, or in the absence of any trading market for such shares, the Corporation shall determine the market price of the Common Stock on the basis of such quotations, bid and asked prices, or other information as it considers appropriate and reasonable in light of the circumstances.

If the Series A Non-Voting Preferred Stock, in whole or in part, is called for redemption, the right to convert such Series A Non-Voting Preferred Stock into Common Stock ceases at the close of business on the day prior to the Redemption Date set in the notice of redemption.

(8) CONVERSION PROCEDURES. In order for the holders of the Series A Non-Voting Preferred Stock to exercise their conversion right and option, a holder of the Series A Non-Voting Preferred Stock shall give written notice to the Corporation stating that such holder thereby exercises its conversion right and option and specifying the number of shares of Series A Non-Voting Preferred Stock such holder desires to convert at that time. Such notice shall be accompanied by stock certificates representing the Series A Non-Voting Preferred Stock then being converted, duly endorsed for transfer to the Corporation. Each such conversion shall be deemed effective on the date the Corporation receives such notice and such stock certificates. Any notice given by any holder of Series A Non-Voting Preferred Stock under this paragraph shall be irrevocable, and all rights with respect to Series A Non-Voting Preferred Stock converted into Common Stock shall terminate as of the effective date of such conversion, except the right to receive certificates representing the Common Stock issuable upon such conversion.

(9) ADJUSTMENTS TO CONVERSION PRICE. If the Corporation (a) pays a dividend or makes a distribution on its Common Stock in Common Stock; (b) subdivides its outstanding Common Stock into a greater number of shares; (c) combines its outstanding Common Stock into a smaller number of shares; (d) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or (e) issues by reclassification of its Common Stock any shares of its capital stock, then the conversion privilege and the conversion price in effect immediately before such action shall be adjusted so that the holders of the Series A Non-Voting Preferred Stock may thereafter receive the number of shares of Common Stock which such holders would have owned immediately following such action if they had converted the Series A Non-Voting Preferred Stock immediately before such action.

If the Corporation merges or consolidates with another corporation or sells or transfers all or substantially all of its assets to another person and the holders of the Common Stock are entitled to receive stock, securities, or property in respect of or in exchange for Common Stock, then as a condition of such merger, consolidation, sale or transfer, the Corporation and any such successor, purchaser, or transferee shall amend the Series A Non-Voting Preferred Stock to provide that they may thereafter by converted in to the kind and amount of stock, securities, or property receivable upon such merger, consolidation, sale, or transfer by a holder of the number of Common Stock

-7-

into which the Series A Non-Voting Preferred Stock might have been converted immediately before such merger, consolidation, sale or transfer.

G. SERIES B 10% NON-VOTING CONVERTIBLE PREFERRED STOCK.

There shall be created out of the authorized number of the Non-Voting Preferred Stock of the Corporation a series designated as "Series B 10% Non-Voting Convertible Preferred Stock" (the "Series B Non-Voting Preferred Stock"), to consist of 100,000 shares, with a stated value of $10 per share, of which the preferences, rights, qualifications, limitations and restrictions thereof, shall be as follows:

(1) CERTAIN DEFINITIONS. Unless the context otherwise requires, the terms defined in this paragraph shall have, for the purposes of this paragraph and paragraphs 2 through 9 below, the meanings herein specified.

COMMON STOCK. The term "Common Stock" shall mean all shares now or hereafter authorized of any class of Common Stock of the Corporation and any other shares of the Corporation, howsoever designated, authorized after the Issue Date, which have the right (subject always to prior rights of any class or series of Voting and Non-Voting Preferred Stock) to participate in the distribution of the assets and earnings of the Corporation without limit as to per share amount.

CUMULATIVE PREFERRED STOCK. The term "Cumulative Preferred Stock" shall mean all shares now or hereafter authorized of any class of Cumulative Preferred Stock of the Corporation which are entitled to receive dividends at the rate of ten percent (10%) per annum of the stated value per share thereof and which are convertible into shares of Common Stock.

ISSUE DATE. The term "Issue Date" shall mean the date that shares of Series B Non-Voting Preferred Stock are first issued by the Corporation.

JUNIOR STOCK. The term "Junior Stock" shall mean the Common Stock and the Cumulative Preferred Stock and any class or series of shares of the Corporation issued after the Issue Date not entitled to receive any assets upon the liquidation, dissolution or winding up of the affairs of the Corporation until the shares of Series B Non-Voting Preferred Stock shall have received the Stated Value of all outstanding shares of Series B Non-Voting Preferred Stock as of the date of such liquidation, dissolution or winding up, plus any accrued and unpaid dividends to such date.

PARITY STOCK. The term "Parity Stock" shall mean, for purposes of paragraphs 2 and 3 below, the Series A Non-Voting Preferred Stock, as defined, and any class or series of shares of the Corporation issued after the Issue Date entitled to receive assets upon the liquidation, dissolution or winding up of the affairs of the Corporation on a parity with the Series B Non-Voting Preferred Stock.

SERIES A NON-VOTING PREFERRED STOCK. The term "Series A Non-Voting Preferred Stock" shall mean those shares described in paragraph (F) above.

SENIOR STOCK. The term "Senior Stock" shall mean any class or series of shares of the Corporation issued after the Issue Date ranking senior to the Series B Non-Voting Preferred Stock in respect of the right to receive dividends, as discussed in paragraph 2 below, or assets upon the liquidation, dissolution or winding up of the affairs of the Corporation, as discussed in paragraph 3 below.

-8-

STATED VALUE. The term "Stated Value" when used in reference to the Series B Non-Voting Preferred Stock shall mean $10 per share of Series B Non-Voting Preferred Stock.

(2) DIVIDENDS. Subject to the limitations set forth below, the holders of the Series B Non-Voting Preferred Stock shall be entitled to receive dividends at the rate of 10% of the Stated Value per annum per share. Dividends shall be payable on each anniversary of the Issue Date. Dividends shall be payable either in shares of Series B Non-Voting Preferred Stock or cash, in the sole option of the Corporation, for the initial three years that the Series B Non-Voting Preferred Stock is outstanding, and thereafter in cash to the extent funds are then legally available for the payment of such cash dividends. The right of the holders of the Series B Non-Voting Preferred Stock to receive such dividends shall be cumulative and shall accrue from the date of issuance of the Series B Non-Voting Preferred Stock. If at any time, the aggregate amount of cash dividends to be paid by the Corporation on the Series B Non-Voting Preferred Stock and Parity Stock is insufficient to permit the payment of the full amount of cash dividends then accrued on all issued and outstanding Series B Non-Voting Preferred Stock and Parity Stock, then such cash dividends, to the extent payable, shall be distributed to the holders of all outstanding Series B Non-Voting Preferred Stock and Parity Stock ratably in proportion to the respective amounts of cash dividends then accrued and unpaid on such Series B Non-Voting Preferred Stock and Parity Stock. So long as any Series B Non-Voting Preferred Stock shall remain outstanding, no cash dividends shall be declared or paid on any Junior Stock until all accrued and unpaid cash dividends on the Series B Non-Voting Preferred Stock have been paid to the holders thereof.

In the event that any of the Series B Non-Voting Preferred Stock is converted, as provided herein, prior to a dividend payment date, no payment of or adjustment for dividends yet due shall be made on the Series B Non-Voting Preferred Stock converted.

(3) LIQUIDATION RIGHTS. In the event of any liquidation, dissolution, or winding up of the Corporation, the holders of the Series B Non-Voting Preferred Stock and Parity Stock then outstanding shall be entitled to receive out of the assets of the Corporation, before any distribution or payment shall be made to the holders of any Junior Stock, an amount equal to the Stated Value per share plus any accrued and unpaid cumulative dividends thereon. If upon any liquidation, dissolution, or winding up, amounts distributable to the holders of all Series B Non-Voting Preferred Stock and any Parity Stock shall be insufficient to permit the payment of the full liquidation amounts on all issued and outstanding Series B Non-Voting Preferred Stock and Parity Stock, then the entire assets of the Corporation available for distribution to the holders of Series B Non-Voting Preferred Stock and Parity Stock shall be distributed to holders of all Series B Non-Voting Preferred Stock and Parity Stock ratably in proportion to the full preferential amounts to which such holders are respectively entitled. A consolidation or merger of the Corporation with or into any other corporation or corporations, or a sale or transfer of all, or substantially all, of its property shall not be deemed to be a liquidation, dissolution, or winding up of the Corporation.

(4) OPTIONAL REDEMPTION. After the third anniversary of the Issue Date, the Corporation may, at its option, redeem the Series B Non-Voting Preferred Stock, in whole or in part, at a redemption price equal to 103% of the Stated Value plus the amount of any accrued and unpaid cash dividends thereon to the date of such redemption. In case of the redemption of only a part of the Series B Non-Voting Preferred Stock, the Series B Non-Voting Preferred Stock to be redeemed shall be selected by whatever means the Board of Directors may, in its sole discretion, determine.

(5) NOTICE OF REDEMPTION Notice of any redemption shall be given by the Corporation to the holders of record of the Series B Non-Voting Preferred Stock to be redeemed at their respective addresses then appearing upon the books of the Corporation not less than 30 nor more than 60 days prior to the date fixed for such redemption (the "Redemption Date"), which notice shall specify the Redemption Date, the number of shares to be redeemed, and the place where certificates representing such Series B Non-Voting Preferred Stock are to be surrendered. On the

-9-

Redemption Date, all Series B Non-Voting Preferred Stock as to which such notice shall have been given shall, whether or not certificates therefor shall have been surrendered for cancellation, be deemed to be no longer outstanding for any purpose, and all rights with respect to such Series B Non-Voting Preferred Stock shall thereupon terminate, except only the right of the holders of the certificates for such Series B Non-Voting Preferred Stock to receive the amount payable upon the redemption thereof, without further dividends.

Notwithstanding any provisions of paragraph 4 above to the contrary, the Corporation shall not be obligated to pay to any holder of the Series B Non-Voting Preferred Stock the redemption price for any Series B Non-Voting Preferred Stock to be redeemed until such holder shall have surrendered to the Corporation certificates representing such Series B Non-Voting Preferred Stock.

(6) CONVERSION RIGHTS. The holders of the Series B Non-Voting Preferred Stock shall have the right and option to convert all or part of the Series B Non-Voting Preferred Stock then owned by them, at any time, into Common Stock; provided, however, that, except for the conversion of all of the Series B Non-Voting Preferred Stock then owned by a holder, no fractional share of Series B Non-Voting Preferred Stock may be converted at any time.

The Common Stock issuable to each holder of Series B Non-Voting Preferred Stock upon conversion of any Series B Non-Voting Preferred Stock shall be, subject to adjustments as described in paragraph 8 below, based upon a conversion price of $.50 per share of Common Stock so that the number of shares of Common Stock issuable for each share of Series B Non-Voting Preferred Stock converted shall be calculated by dividing the Stated Value of each share of Series B Non-Voting Preferred Stock by $.50. Furthermore, and notwithstanding the foregoing sentences of this paragraph, the Corporation shall not be obligated to issue any fractional shares of Common Stock upon conversion of any shares of Series B Non-Voting Preferred Stock. In lieu of any fractional shares of Common Stock to which a holder of shares of Series B Non-Voting Preferred Stock would otherwise be entitled, the Corporation shall pay to such holder cash in an amount equal to the market price of the Common Stock as of the effective date of the conversion, as such price shall be allocable to such fractional shares of Common Stock. For purposes of this paragraph, the market price per share of the Common Stock on any date shall be equal to the average of the quoted prices of such shares for 30 consecutive trading days commencing 45 trading days before the date in question. In the absence of one or more such quotations, or in the absence of any trading market for such shares, the Corporation shall determine the market price of the Common Stock on the basis of such quotations, bid and asked prices, or other information as it considers appropriate and reasonable in light of the circumstances.

If the Series B Non-Voting Preferred Stock, in whole or in part, is called for redemption, the right to convert such Series B Non-Voting Preferred Stock into Common Stock ceases at the close of business on the day prior to the Redemption Date set in the notice of redemption.

(7) CONVERSION PROCEDURES. In order for the holders of the Series B Non-Voting Preferred Stock to exercise their conversion right and option, a holder of the Series B Non-Voting Preferred Stock shall give written notice to the Corporation stating that such holder thereby exercises its conversion right and option and specifying the number of shares of Series B Non-Voting Preferred Stock such holder desires to convert at that time. Such notice shall be accompanied by stock certificates representing the Series B Non-Voting Preferred Stock then being converted, duly endorsed for transfer to the Corporation. Each such conversion shall be deemed effective on the date the Corporation receives such notice and such stock certificates. Any notice given by any holder of Series B Non-Voting Preferred Stock under this paragraph shall be irrevocable, and all rights with respect to Series B Non-Voting Preferred Stock converted into Common Stock shall terminate as of the effective date of such conversion, except the right to receive certificates representing the Common Stock issuable upon such conversion.

-10-

(8) ADJUSTMENTS TO CONVERSION PRICE. If the Corporation (a) pays a dividend or makes a distribution on its Common Stock in Common Stock; (b) subdivides its outstanding Common Stock into a greater number of shares; (c) combines its outstanding Common Stock into a smaller number of shares; (d) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or (e) issues by reclassification of its Common Stock any shares of its capital stock, then the conversion privilege and the conversion price in effect immediately before such action shall be adjusted so that the holders of the Series B Non-Voting Preferred Stock may thereafter receive the number of shares of Common Stock which such holders would have owned immediately following such action if they had converted the Series B Non-Voting Preferred Stock immediately before such action.

If the Corporation merges or consolidates with another corporation or sells or transfers all or substantially all of its assets to another person and the holders of the Common Stock are entitled to receive stock, securities, or property in respect of or in exchange for Common Stock, then as a condition of such merger, consolidation, sale or transfer, the Corporation and any such successor, purchaser, or transferee shall amend the Series B Non-Voting Preferred Stock to provide that they may thereafter by converted in to the kind and amount of stock, securities, or property receivable upon such merger, consolidation, sale, or transfer by a holder of the number of Common Stock into which the Series B Non-Voting Preferred Stock might have been converted immediately before such merger, consolidation, sale or transfer.

H. COMBINATION OF COMMON STOCK.

Effective as of the close of business on the fifth business day after the date a certificate of amendment adding this
Section H to the Corporation's Second Amended and Restated Articles of Incorporation is filed with the Secretary of State of the State of Ohio (the "Effective Time"), each ten shares of Common Stock outstanding immediately before the Effective Time ("Old Common Stock") shall be changed into one share of new Common Stock ("New Common Stock"). The changing of shares of Old Common Stock into shares of New Common Stock shall be referred to as the "Share Combination." The number of shares of Common Stock authorized to be issued by the Corporation and the par value thereof shall not be affected by the Share Combination. No fractional shares of New Common Stock and no certificate representing a fractional share of New Common Stock shall be issued as a result of the Share Combination and, in lieu of any such fractional share of New Common Stock, each holder of a share of Old Common Stock who otherwise would be entitled to receive a fractional share of New Common Stock will be entitled to receive cash in an amount equal to the market value of each share of Old Common Stock that would have been converted into a fraction of a share of New Common Stock but for this sentence, upon surrender of the certificate for such Old Common Stock. For this purpose, the market value of the shares of Old Common Stock shall be the unweighted arithmetic mean of the bid prices of the Common Stock on the over the counter market for the Common Stock for the five trading day period ending at the Effective Time. Promptly after the Effective Time, notice shall be given to the holders of record of Common Stock at the Effective Time to surrender their certificates for Common Stock for cancellation and either issuance of new certificates or the payment of cash in lieu of fractional shares, as the case may be, pursuant to the Share Combination. The appropriate officers of the Corporation are hereby empowered to adopt rules and regulations concerning the surrender and payment for fractional shares resulting from the Share Combination.

FIFTH: The Corporation, through its Board of Directors, shall have the right and power to repurchase any of its outstanding shares at such times, for such considerations and upon such terms and conditions as may be agreed upon between the Corporation and the selling shareholder or shareholders.

-11-

SIXTH: No holders of shares of the Corporation shall have any pre-emptive right to subscribe for or to purchase any shares of the Corporation of any class, whether now or hereafter authorized.

SEVENTH: Notwithstanding any provision of the Revised Code of Ohio, now or hereafter in force, requiring for any purpose, the vote or consent of the holders of shares entitling them to exercise two-thirds, or any other proportion, of the voting power of the Corporation or of any class or classes of shares thereof, such action, unless otherwise expressly required, may be taken by the vote or consent of the holders of shares entitling them to exercise a majority of the voting power of the Corporation, or of such class or classes of shares thereof.

EIGHTH: No shareholder shall have the right to vote cumulatively in the election of directors pursuant to, and in accordance with ss.1707.69(B)(10) of the Ohio Revised Code.

NINTH: These First Amended and Restated Articles of Incorporation take the place and supersede the existing Articles of Incorporation.

-12-

EXHIBIT 3(b)

RESTATED CODE
OF
REGULATIONS
OF
SUPERCONDUCTIVE COMPONENTS, INC.
(ADOPTED JUNE 15, 1988)

ARTICLE ONE

MEETING OF SHAREHOLDERS

Section 1.01. ANNUAL MEETINGS. The annual meeting of the Shareholders for the election of Directors, for the consideration of reports to be laid before such meeting and for the transaction of such other business as may properly come before such meeting, shall be held on such day and at such hour as may be fixed from time to time by the Directors.

Section 1.02. SPECIAL MEETINGS. Special meetings of the Shareholders may be held on any date. Calls for Special Meetings shall specify the time, place and object or objects thereof, and no business other than that specified in the call therefor shall be considered at any such meetings.

Section 1.03. CALLING OF MEETINGS. Meetings of the Shareholders may be called only by the Chairman of the Board, the President or, in case of the President's absence, death or disability, the Vice President authorized to exercise the authority of the President, the Secretary, the Directors by action at a meeting, or a majority of the Directors acting without a meeting, or the holders of fifty percent (50%) of all shares outstanding and entitled to vote thereat.

Section 1.04. PLACE OF MEETINGS. All meetings of Shareholders shall be held at the principal office of the Corporation, unless otherwise provided by action of the Directors. Meetings of Shareholders may be held at any place within or without the State of Ohio.

Section 1.05. NOTICE OF MEETINGS.

(A) Written notice stating the time, place and purpose of a meeting of the Shareholders shall be given by or at the direction of the President or Secretary, either by personal delivery or by mail not less than seven nor more than sixty days before the date of the meeting, to each Shareholder of record entitled to notice of the meeting. If mailed, such notice shall be addressed to the Shareholder at his address as it appears on the records of the Corporation. Notice of adjournment of a meeting need not be given if the time and place to which it is adjourned are fixed and announced at such meeting. In the event of a transfer of shares after the record date for determining the Shareholders who are entitled to receive notice of a meeting of Shareholders, it shall not be necessary to give notice to the transferee. Nothing herein contained shall prevent the setting of a record date in the manner provided by law, the Articles or the Regulations for the determination of Shareholders who are entitled to receive notice of or to vote at any meeting of Shareholders or for any purpose required or permitted by law.

(B) Following receipt by the President or the Secretary of a request in writing, specifying the purpose or purposes for which the persons properly making such request have called a meeting of the Shareholders, delivered either in person or by registered mail to such Officer by any persons entitled to call a meeting of Shareholders, such Officer shall cause to be given to the Shareholders entitled thereto notice of a meeting to be held on a date not less than seven nor more than sixty days after the receipt of such request, as such Officer may fix. If such notice is not given within twenty-one days after the receipt of such request by the President or the Secretary, then, and only then, the persons properly calling the meeting may fix the time of meeting and give notice thereof in accordance with the provisions of the Regulations.


Section 1.06. WAIVER OF NOTICE. Notice of the time, place and purpose or purposes of any meeting of Shareholders may be waived in writing, either before or after the holding of such meeting, by any Shareholder, which writing shall be filed with or entered upon the records of such meeting. The attendance of any Shareholder, in person or by proxy, at any such meeting without protesting the lack of proper notice prior to or at the commencement of the meeting shall be deemed to be a waiver by such Shareholder of notice of such meeting.

Section 1.07. QUORUM. At any meeting of Shareholders, the holders of a majority in amount of the voting shares of the Corporation then outstanding and entitled to vote thereat, present in person or by proxy, shall constitute a quorum for such meeting. The holders of a majority of the voting shares represented at a meeting, whether or not a quorum is present, or the Chairman of the Board, the President or the officer of the Corporation acting as Chairman of the meeting, may adjourn such meeting from time to time and, if a quorum is present at such adjourned meeting, any business may be transacted as if the meeting had been held as originally called.

Section 1.08. VOTES REQUIRED. At all elections of Directors, the candidates receiving the greatest number of votes shall be elected. Any other matter submitted to the Shareholders for their vote shall be decided by the vote of a majority in voting power of the shares present in person or by proxy entitled to vote upon such matter or 'such other proportion of the shares, or of any class of shares, or of each class, as is required by law, the Articles or the Regulations.

Section 1.09. ORDER OF BUSINESS. The order of business at any meeting of Shareholders shall be determined by the officer of the Corporation acting as Chairman of such meeting unless otherwise determined by a vote of the holders of a majority of the voting shares of the Corporation present in person or by proxy and entitled to vote at such meeting.

Section 1.10. VOTING BY SHAREHOLDERS. At any meeting of the Shareholders, each Shareholder of the Corporation shall, except as otherwise provided by law or by the express terms of such shares, be entitled to one vote either in person or by proxy, for each share of the Corporation registered in his name on the books of the Corporation (1) on the date fixed by the Board of, Directors as the record date for the determination of Shareholders entitled to vote at such meeting, notwithstanding the prior or subsequent sale or other disposition of such share or shares or transfer of the same on the books of the Corporation after the date so fixed, or (2) if no such record date shall have been fixed, then as of the day next preceding the date of the meeting.

Section 1.11. RECORD DATE. The Directors may fix a record date for any lawful purpose, including without limitation, the determination of Shareholders entitled to (1) receive notice of or to vote at any meeting, (2) receive payment of any dividend or distribution, (3) receive or exercise rights of purchase of or subscription for, or exchange or conversion of, shares or other securities, subject to any contract right with respect thereto, or (4) participate in the execution of written consents, waivers or releases. Said record date shall not be a date earlier than the date on which it is fixed, and shall not be more than sixty days preceding the date of such meeting, the date fixed for payment of any dividend or distribution, or the date fixed for the receipt or exercise of rights, as the case may be.

Section 1.12. PROXIES. At meetings of the Shareholders, any Shareholder of record entitled to vote thereat or to execute consents, waivers and releases may be represented at such meeting or vote thereat, and may execute consents, waivers and releases and exercise any of his other rights by proxy or proxies appointed by an instrument in writing signed by such Shareholder, but such instrument shall be filed with the Secretary of the meeting before the person holding such proxy shall be allowed to vote thereunder.

Section 1.13. INSPECTORS OF ELECTION. In advance of any meeting of Shareholders, the Directors may appoint inspectors of election to act at such meeting or any adjournment thereof; if inspectors are not so appointed, the Officer of the Corporation acting as Chairman of any such meeting may make such appointment. In case any person appointed as inspector fails to appear or act, the vacancy may be filled only by appointment made by the Directors in advance of such meeting or, if not so filled, at the meeting by the Officer of the Corporation acting as Chairman of such meeting. No other person or persons may appoint or require the appointment of inspectors of election.

-2-

ARTICLE TWO

DIRECTORS

Section 2.01. AUTHORITY AND QUALIFICATIONS. Except where the law, the Articles or the Regulations otherwise provide, all authority of the Corporation shall be exercised by or under the direction of a Board of Directors. Directors need not be Shareholders of the Corporation.

Section 2.02. NUMBER OF DIRECTORS. The number of Directors may be determined from time to time by the Directors, but the number of Directors shall not be reduced so as to abolish the office of a Director during his term. The number of Directors may also be determined at any meeting of the Shareholders called for the purpose of electing Directors, at which a quorum is present, by the affirmative vote of a majority of the shares that are represented at the meeting and entitled to vote on the proposal. The number of Directors shall be not less than three nor more than fifteen unless all of the shares of the Corporation are owned of record by one or two shareholders, in which event the number of directors may be less than three, but not less than the number of Shareholders. In the event the Directors fail to fix the number of directors, there shall be three. By a vote of a majority of those Directors in office, the Directors may fill any Director's office that is created by an increase in the number of Directors.

Section 2.03. TERM OF OFFICE. Except as hereinafter provided, Directors shall be elected to hold office until the next annual meeting of Shareholders and until their successors are elected and qualified.

Section 2.04. ELECTION. At each annual meeting of Shareholders for the election of Directors, the successors to the Directors shall be elected, but if the annual meeting is not held or if one or more of such Directors is not elected thereat, they may be elected at a special meeting called for that purpose.

Section 2.05. REMOVAL.

(A) The Directors may remove any Director if, by order of court, he has been found to be of unsound mind or if he is adjudicated a bankrupt.

(B) All the Directors or any individual Director may be removed from office, without assigning any cause, by the vote of the holders of three-fourths (3/4) of the voting power entitling them to elect Directors in place of those to be removed, provided that unless all the Directors are removed, no individual Director shall be removed in case the votes of a sufficient number of shares are cast against his removal which, if cumulatively voted at an election of all the Directors, would be sufficient to elect at least one Director. In case of any such removal, a new Director may be elected at the same meeting for the unexpired term of each Director removed.

Section 2.06. VACANCIES. A vacancy in the Board of Directors shall exist in the event (1) a Director dies or resigns, (2) a Director is removed by the Board of Directors, (3) a Director is removed by the Shareholders and the Shareholders fail to elect a new Director to fill the unexpired term or (4) the Shareholders fail at any time to elect the whole authorized number of Directors. The remaining Directors, though less than a majority of the whole authorized number of Directors, may, by a vote of the majority of their number, fill any vacancy in the Board of Directors for the unexpired term.

Section 2.07. MEETINGS. The Directors shall hold such meetings as may from time to time be called by the Chairman of the Board, the President or any two Directors. Meetings of Directors shall be held at the principal office of the Corporation or at such other place within or without the State of Ohio as the Directors may from time to time determine. Meetings of the Directors may be held through any communications equipment if all persons participating can hear each other and participation in a meeting pursuant to this provision shall constitute presence at such meeting.

Section 2.08. NOTICE OF MEETINGS. Notice of the time and place of each meeting of Directors for which such notice is required by law, the Articles, the Regulations or the Bylaws shall be given to each of the Directors by any of the following methods:

-3-

(1) In a writing mailed not less than three days before such meeting and addressed to the residence or usual place of business of a Director, as such address appears on the records of the Corporation; or

(2) By telegraph, cable, radio, wireless or a writing sent or delivered to the residence or usual place of business of a Director as the same appears on the records of the Corporation, not later than two days before the date on which such meeting is to be held; or

(3) Personally or by telephone not later than the day before the date on which such meeting is to be held.

Notice given to a Director by any one of the methods specified in the Regulations shall be sufficient, and the method of giving notice to all Directors need not be uniform. Notice of any meeting of Directors may be given only by the Chairman of the Board, the President or the Secretary or an Assistant Secretary of the Corporation. No such notice need specify the purpose or purposes of the meeting. Notice of adjournment of a meeting of Directors need not be given if the time and place to which it is adjourned are fixed and announced at such meeting.

Section 2.09. WAIVER OF NOTICE. Notice of any meeting of Directors may be waived in writing, either before or after the holding of such meeting, by any Director, which writing shall be filed with or entered upon the records of the meeting. The attendance of any Director at any meeting of Directors without protesting, prior to or at the commencement of the meeting, the lack of proper notice, shall be deemed to be a waiver by him of notice of such meeting.

Section 2.10. QUORUM. A majority of the whole authorized number of Directors shall be necessary to constitute a quorum for a meeting of Directors, except that a majority of the Directors in office shall constitute a quorum for filling a vacancy in the Board. The act of a majority of the Directors present at a meeting at which a quorum is present is the act of the Board, except as otherwise provided by law, the Articles or the Regulations.

Section 2.11. EXECUTIVE COMMITTEE. The Directors may create an Executive Committee or any other committee of Directors, to consist of not less than three Directors, and may authorize the delegation to such Executive Committee or other committees of any of the authority of the Directors, however conferred, other than that of filling vacancies among the Directors or in the Executive Committee or in any other committee of the Directors. The Executive Committee or any other committee of Directors shall serve at the pleasure of the Directors, shall act only in the intervals between meetings of the Directors and shall be subject to the control and direction of the Directors. The Executive Committee or other committee of Directors may act by a majority of its members at a meeting or by a writing or writings signed by all of its members. The Executive Committee and any other committee shall keep records of its proceedings. Any act or authorization of an act by the Executive Committee or any other committee within the authority delegated to it shall be as effective for all purposes as the act or authorization of the Directors. No notice of a meeting of the Executive Committee or of any other committee of Directors shall be required. A meeting of the Executive Committee or of any other committee of Directors may be called only by the President or by a member of such Executive or other committee of Directors, and may be held through any communications equipment if all persons participating can hear each other. Participation in a meeting by communications equipment shall constitute presence at such a meeting. An Executive Committee or other committee, once created and appointed, shall continue in office until expressly dissolved, terminated, reorganized or replaced.

Section 2.12. COMPENSATION. The Directors, by the affirmative vote of a majority in office and irrespective of any personal interest of any of them, shall have authority to establish reasonable compensation for any Director or Officer, for services rendered or to be rendered to the Corporation, including, but not limited to the following types of programs: short-term incentives, stock-related long-term incentives, performance-related long-term incentives, deferred compensation plans, disability benefits, death benefits, insurance and other fringe benefits.

Section 2.13. BYLAWS. The Directors may adopt, and amend from time to time, Bylaws for their own government, which Bylaws shall not be inconsistent with the law, the Articles or the Regulations.

-4-

ARTICLE THREE

OFFICERS

Section 3.01. OFFICERS. The Officers of the Corporation to be elected by the Directors shall be a President, a Secretary, a Treasurer and such other Officers and assistant Officers as the Directors may from time to time elect. A Chairman of the Board, if elected, must be a Director. Officers of the Corporation may be paid such compensation as the Board of Directors may determine. Any two or more offices may be held by the same person, but no Officer shall execute, acknowledge or verify any instrument in more than one capacity if such instrument is required by law, the Articles, the Regulations or the Bylaws to be executed, acknowledged or verified by two or more Officers.

Section 3.02. TENURE OF OFFICE. The Officers of the Corporation shall hold office at the pleasure of the Directors. Any Officer of the Corporation may be removed, either with or without cause, at any time, by the affirmative vote of a majority of all the Directors then in office; such removal, however, shall be without prejudice to the contract rights, if any, of the person so removed.

Section 3.03. DUTIES. Officers shall have such authority and shall perform such duties as are determined by the Directors.

ARTICLE FOUR

SHARES

Section 4.01. CERTIFICATES. Certificates evidencing ownership of shares of the Corporation shall be issued to those entitled to them. Each certificate evidencing shares of the Corporation shall bear a distinguishing number, the signatures of the Chairman of the Board, the President or a vice President, and of the Secretary or an Assistant Secretary (except that when any such certificate is countersigned by an incorporated transfer agent or registrar, such signatures may be facsimile, engraved, stamped or printed), and such recitals as may be required by law.

Section 4.02. TRANSFERS. Where a certificate evidencing a share or shares of the Corporation is presented to the Corporation or its proper agents with a request to register transfer, the transfer shall be registered as requested if:

(1) An appropriate person signs on each certificate so presented or signs on a separate document an assignment or transfer of shares evidenced by each such certificate, or signs a power to assign or transfer such shares, or when the signature of an appropriate person is written without more on the back of each such certificate; and

(2) Reasonable assurance is given that the endorsement of each appropriate person is genuine and effective; the Corporation or its agents may refuse to register a transfer of shares unless the signature of each appropriate person is guaranteed by a commercial bank or trust company; and

(3) All applicable laws relating to the collection of transfer or other taxes have been complied with; and

(4) The Corporation or its agents are not otherwise required or permitted to refuse to register such transfer.

Section 4.03. TRANSFER AGENTS AND REGISTRARS. The Directors may appoint one or more agents to transfer or to register shares of the Corporation, or both.

Section 4.04. LOST, WRONGFULLY TAKEN OR DESTROYED CERTIFICATES. Except as otherwise provided by law, where the owner of a certificate evidencing shares of the Corporation claims that such certificate has been lost, destroyed or wrongfully taken, the Officers must cause the Corporation to issue a new certificate in place of the original certificate if the owner:

-5-

(1) So requests before the Corporation has notice that such original certificate has been acquired by a bona fide purchaser; and

(2) Files with the Corporation or its agents any indemnity bond requested by the Corporation, with surety or sureties satisfactory to the Corporation, in such sum as the Officers may, in their discretion, deem reasonably sufficient as indemnity against any loss or liability that the Corporation may incur by reason of the issuance of each such new certificate; and

(3) Satisfies any other reasonable requirements which may be imposed by the Officers or Directors, in their discretion.

ARTICLE FIVE

INDEMNIFICATION AND INSURANCE

Section 5.01. GENERAL INDEMNIFICATION. The Corporation (1) shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he is or was a Director of the Corporation, or while a Director of the Corporation is or was serving at the request of the Corporation as a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent of another corporation, domestic or foreign, nonprofit or for profit, partnership, joint venture, trust, employee benefit plan or other enterprise, and (2) may indemnify or agree to indemnify any person who is or was a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he is or was an Officer, employee or agent of the Corporation, or while an Officer, employee or agent of the Corporation is or was serving at the request of the Corporation as a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent of another corporation, domestic or foreign, nonprofit or for profit, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including attorney's fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Corporation, and with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Corporation, and with respect to any criminal action or proceeding, he had reasonable cause to believe that his conduct was unlawful.

Section 5.02. SUITS BY THE CORPORATION. The Corporation may indemnify or agree to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the f act that he is or was a Director, Officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, trustee, fiduciary, officer, employee, partner, joint venturer, or agent of another corporation, domestic or foreign, nonprofit or for profit, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including attorney's fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Corporation. No such indemnification shall be made in respect of (1) any claim, issue or matter as to which such person is adjudged to be liable for negligence or misconduct in the performance of his duty to the Corporation unless and only to the extent that the court of common pleas or the court in which such action or suit was brought determines upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court of common pleas or such other court shall deem proper; or
(2) any action or suit in which the only liability asserted against a Director is pursuant to Section 1701.95 of the Ohio Revised Code.

-6-

Section 5.03. INDEMNIFICATION FOR EXPENSES. To the extent that a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Sections 5.01 and 5.02, including any action or suit brought against a Director pursuant to Section 1701.95 of the Ohio Revised Code, or in defense of any claim, issue or matter therein, he shall be indemnified against expenses (including attorney's fees) actually and reasonably incurred by him in connection with the action, suit or proceeding.

Section 5.04. DETERMINATION REQUIRED. Any indemnification under Sections 5.01 and 5.02 (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that the indemnification of the director, trustee, fiduciary, officer, employee, partner, joint venturer or agent is proper in the circumstances because he has met the applicable standard of conduct set forth in Sections 5.01 and 5.02. Such determination shall be made (1) by the Board of Directors by a majority vote of a quorum consisting of Directors who were not and are not parties to, or threatened with, such action, suit or proceeding; (2) if such a quorum is not obtainable or if a majority of a quorum of disinterested Directors so directs, in a written opinion by independent legal counsel other than an attorney, or a firm having associated with it an attorney, who has been retained by or who has performed services for the Corporation or any person to be indemnified within the past five years; (3) by the Shareholders; or (4) by the court of common pleas or the court in which the action, suit or proceeding was brought. Any determination made by the disinterested Directors or by independent legal counsel under this Section 5.04 shall be promptly communicated to the person who threatened or brought the action or suit by or in the right of the Corporation under Section 5.02, and such person shall have the right, within ten days after receipt of such notification, to petition the court of common pleas or the court in which action or suit was brought to review the reasonableness of such determination.

Section 5.05. ADVANCES FOR EXPENSES.

(A) Expenses (including attorney's fees) incurred by a Director in defending any civil or criminal action, suit or proceeding referred to in Sections 5.01 and 5.02 of this Article Five, except where the only liability asserted against a Director is pursuant to Section 1701.95 of the Ohio Revised Code, shall be paid by the Corporation as they are incurred, in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of the Director in which he agrees to (1) repay such amount if it is proved by clear and convincing evidence in a court of competent jurisdiction that his action or failure to act involved an act or omission undertaken with deliberate intent to cause injury to the Corporation or undertaken with reckless disregard for the best interests of the Corporation; and (2) reasonably cooperate with the Corporation concerning the action suit, or proceeding.

(B) Expenses (including attorney's fees) incurred by a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent in defending any action, suit, or proceeding referred to in Sections 5.01 and 5.02 of this Article Five, including any action or suit brought against a Director pursuant to Section 1701.95 of the Revised Code, may be paid by the Corporation as they are incurred in advance of the final disposition of the action, suit or proceeding as authorized by the Directors in the specific case upon receipt of an undertaking by or on behalf of the director, trustee, fiduciary, officer, employee, partner, joint venturer or agent to repay such amount, if it is ultimately determined that he is not entitled to be indemnified by the Corporation.

Section 5.06. ARTICLE FIVE NOT EXCLUSIVE. The indemnification authorized by this Article Five shall not be deemed exclusive of, and shall be in addition to, any other rights granted to those seeking indemnification under the Articles, common law, the General Corporation Law of the State of Ohio, the Regulations or any agreement, vote of Shareholders or disinterested Directors, or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

Section 5.07. INSURANCE. The Corporation may purchase and maintain insurance or furnish similar protection, including but not limited to trust funds, letters of credit or self-insurance, on behalf of or for any person who is or was a Director, Officer, employee, or agent of the Corporation, or is or was serving at the request of the Corporation as a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent of another corporation, domestic or foreign, nonprofit or for profit, partnership, joint venture, trust, employee benefit plan or

-7-

other enterprise, against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under the provisions of this Article Five. Insurance may be purchased from or maintained with a person in which the Corporation has a financial interest.

Section 5.08. SECTIONS 5.01 AND 5.02 NOT EXCLUSIVE. The authority of the Corporation to indemnify persons pursuant to Sections 5.01 and 5.02 of this Article Five does not limit the payment of expenses as they are incurred, indemnification, insurance or other protection that may be provided pursuant to any other Section of this Article Five. Sections 5.01 and 5.02 of this Article Five do not create any obligation to repay or return payments made by the Corporation under any other Section of this Article Five.

Section 5.09. DEFINITION OF "THE CORPORATION". As used in this Article Five, references to "the Corporation" include all constituent corporations in a consolidation or merger and the new or surviving corporation, so that any person who is or was a director, officer, employee, or agent of such a constituent corporation, or is or was serving at the request of such constituent corporation as a director, trustee, fiduciary, officer, employee, partner, joint venturer or agent of another corporation, domestic or foreign, nonprofit or for profit, partnership, joint venture, trust, employee benefit plan or other enterprise, shall stand in the same position under the provisions of this Article Five with respect to the new or surviving corporation as he would if he had served the new or surviving corporation in the same capacity.

ARTICLE SIX

SEAL

Section 6.01. SEAL NOT REQUIRED. The Corporation shall not be required to have a seal. Provided, however, the Officers may provide a suitable seal. A duplicate seal or seals may be kept and used by any Officers of the Corporation or by any transfer agent of the Corporation's shares.

ARTICLE SEVEN

ACTION WITHOUT A MEETING

Section 7.01. ACTION BY SHAREHOLDERS OR DIRECTORS WITHOUT A MEETING. Anything contained in the Regulations to the contrary notwithstanding, any action which may be authorized or taken at a meeting of the Shareholders or of the Directors or of a committee of the Directors, as the case may be, may be authorized or taken without a meeting with the affirmative vote or approval of, and in a writing or writings signed by, all the Shareholders who would be entitled to notice of a meeting of the Shareholders held for such purpose, or all the Directors, or all the members of such committee of the Directors, respectively, which writings shall be filed with or entered upon the records of the Corporation.

ARTICLE EIGHT

AMENDMENTS TO REGULATIONS

Section 8.01. AMENDMENTS AT A MEETING. The Regulations may be amended, or new Regulations may be adopted, at a meeting of Shareholders held for such purpose, by the affirmative vote of holders of shares entitling them to exercise a majority of the voting power of the Corporation on such proposal, or the affirmative vote of the holders of a majority of the voting power of each class or classes of shares of the Corporation entitled to vote on such proposal as a class, provided that such amendment or adoption is recommended for approval by at least three-fourths (3/4) of the Directors of the Corporation. Unless at least three-fourths (3/4) of the Directors of the Corporation recommend the approval of such amendment or adoption, the affirmative vote of holders of shares entitling them to exercise at least three-fourths (3/4) of the voting power of the Corporation on such proposal or of

-8-

three-fourths (3/4) of the voting power of each class or classes of shares of the Corporation entitled to vote on such proposal as a class shall be required.

Section 8.2. AMENDMENTS WITHOUT A MEETING. The Regulations may be amended or new Regulations may be adopted without a meeting by the written consent of holders of shares entitling them to exercise three-fourths (3/4) of the voting power of the Corporation on such proposal or by the written consent of the holders of three-fourths (3/4) of the voting power of each class or classes of the Corporation entitled to vote on such proposal as a class.

-9-

EXHIBIT 10(a)

SUBCONTRACT AGREEMENT BETWEEN SUPERCONDUCTIVE COMPONENTS, INC.
AND
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION

The following describes the terms and conditions under which The Ohio State University Research Foundation whose address is 1960 Kenny Road, Columbus, Ohio 43210-1063; hereinafter referred to as "SUBCONTRACTOR", acting on behalf of the College of Engineering, agrees to conduct studies as described below under subcontract to Superconductive Components, Inc., whose address is 1145 Chesapeake Ave., Columbus, Ohio 43212, hereinafter referred to as COMPANY.

1. WORKSCOPE SUBCONTRACTOR agrees to conduct research and development services. The scope of work described in the SUBCONTACTOR's proposal 66443-55-00 and attached hereto as Attachment A, shall be completed. The work will be conducted to partly satisfy COMPANY's, Small Business Technology Transfer contract with the National Science Foundation, entitled "NOx Sensor for Internal Combustion Engines", Dr. Prabir Dutta will act as the SUBCONTRACTOR's Principal Investigator and direct the technical activity of the subcontracted work.

2. PERIOD OF PERFORMANCE This agreement is effective on April 1, 2000 and end March 31, 2001 unless extended.

3. PRICE SUBCONTRACTOR agrees to perform the workscope on a Firm-Fixed Price basis, in the amount of $20,000. Any additional charges for services not provided for in the workscope must be approved in writing in advance.

4. REPORTING SUBCONTRACTOR will provide a technical progress report on or about November 15, 2000 and a final technical report on or before April 30, 2001.

6. BILLING AND PAYMENT COMPANY will pay according to the following payment schedule:

April 2000        $4,000           June 2000         $4,000
May 2000          $4,000           July 2000         $4,000
August 2000       $4,000

SUBCONTRACTOR will provide invoices in accordance with the above payment schedule Payments will be made by COMPANY within thirty (30) days of invoices, SUBCONTRACTOR hereby acknowledges receipt of $12,000, representing the first three (3) payments under this Agreement.

6. STANDARD OF PERFORMANCE SUBCONTRACTOR will perform the workscope in accordance with generally accepted professional practices. HOWEVER, AND BECAUSE OF THE NATURE OF SUCH EFFORT, SUBCONTRACTOR MAKES NO WARRANTY OR GUARANTEE WHATSOEVER IN CONNECTION WITH THE FURNISHING OF THE SERVICES OR THE USE OR IMPLEMENTATION OS SUCH SERVICES BY PURCHASER.

7. MATERIALS, APPLIANCES, EMPLOYEES Unless otherwise stipulated, the SUBCONTRACTOR shall provide and pay for all materials, labor, tools, equipment, transportation and other facilities necessary for the execution and completion of the work.


8. TERMINATION Performance under this agreement may be terminated by either party upon thirty (30) days written notice. Upon termination, SUBCONTRACTOR will be reimbursed for all costs and non-cancelable commitments incurred in the performance of the work, but not to exceed the fixed price specified in PRICE. Non-cancelable commitments include scheduled stipends to graduate students.

9. RIGHT TO PUBLISH SUBCONTRACTOR reserves the right to publish the results of this investigation. Before publishing, however, SUBCONTRACTOR shall notify COMPANY of its intention to publish, and shall submit the manuscript to COMPANY for review and comment. COMPANY shall have thirty (30) days from receipt of the manuscript to present any comments, which shall be in writing, to SUBCONTRACTOR. COMPANY'S comments shall be given due consideration by SUBCONTRACTOR. Furthermore, SUBCONTRACTOR agrees to not publish COMPANY'S Proprietary or Confidential Information without the prior written consent of COMPANY. The publication of the results may be delayed for a period not to exceed six (6) months if it contains a disclosure of an invention(s) on which either party desires to file a United States or foreign patent. It is understood that in no case can this provision for delay of publication pending patent filing cause a delay in the normal academic progress of a SUBCONTRACTOR graduate student with respect to preparation and submission of a graduate thesis or dissertation. SUBCONTRACTOR agrees to not incorporate COMPANY'S Confidential or Proprietary Information in any thesis or dissertation.

10. CONFIDENTIAL INFORMATION
A. During the course of performing the workscope described, SUBCONTRACTOR may be exposed to Proprietary Information of COMPANY. The Proprietary Information may include, for example, documents, data, know-how, formulae, processes, designs, customer lists, specifications, samples, reports, findings, inventions or ideas, but not limited to these forms. Regardless of the form in which the Proprietary Information was disclosed to SUBCONTRACTOR, such Information must be identified in writing as being proprietary and confidential information of the COMPANY.

B. SUBCONTRACTOR shall not use Proprietary Information disclosed by COMPANY under this subcontract for any purpose except for the purpose of performing the workscope described.

C. SUBCONTRACTOR agrees to maintain COMPANY'S Proprietary Information in confidence, and not to disclose it to any Third parties except COMPANY further agrees that the obligation of confidence undertaken above does not prevent the disclosing of any information pursuant to the subpoena power of any court of any civil investigation demand issued by a governmental agency or as otherwise may be required by law.

D. Nothing contained herein shall deprive the SUBCONTRACTOR of the right to disclose or use any information that is:

(i) generally known or which becomes generally known as evidenced by printed publications through no fault of the SUBCONTRACTOR; or

(ii) which is possessed by SUBCONTRACTOR as evidenced by dated, written records kept in the ordinary course of business, before receipt from COMPANY; or

(iii) which is disclosed to SUBCONTRACTOR by a third party who has an independent right to such information.

E. The obligation of confidentiality undertaken by the SUBCONTRACTOR shall survive any termination of this Agreement.

-2-

11. INTELLECTUAL PROPERTY Intellectual Property shall be governed by the Cooperative Agreement dated December 11, 1998 and attached hereto, as Attachment B.

12. ASSIGNMENT Neither party to the Contract shall assign or sublet it as a whole without the written consent of the other, nor shall the SUBCONTRACTOR assign any money due or to become due to him hereunder, without the previous written consent of COMPANY.

13. APPLICABLE LAW This agreement shall be governed and construed in accordance with the laws of the State of Ohio.

14. EQUAL OPPORTUNITY During the performance of the Contract and to the extent that Executive Order Number 11246 may be applicable to this contract, SUBCONTRACTOR agrees as follows:

A. SUBCONTRACTOR will not discriminate against any employee or applicant for employment because of race, color, religion, sex, national origin, ancestry, physical handicap, mental condition, marital status, age, or veteran status. SUBCONTRACTOR agrees to post in conspicuous places, available to employees and applicants for employment, any notices provided to the SUBCONTRACTOR, which set forth the provisions of this nondiscrimination clause.

B. SUBCONTRACTOR will, in all solicitations or advertisements for employees placed by or on behalf of SUBCONTRACTOR, state that all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, ancestry, physical handicap, mental condition, marital status, age, or veteran status.

15. CERTIFICATION OF NONSEGREGATED FACILITIES
A. "Segregated facilities", as used in this provision, means any waiting rooms, work areas, rest rooms and washrooms, restaurants and other eating areas, time clocks, locker rooms and other storage or dressing areas, parking lots, drinking fountains, recreation or entertainment areas, transportation, and housing facilities provided for employees, that are segregated by explicit directive or are in fact segregated on the basis of race, color, religion, or national origin because of habit, local custom, or otherwise.

B. SUBCONTRACTOR certifies that it does not and will not maintain or provide for its employee any segregated facilities at any of its establishments, and that it does not and will not permit its employees to perform their services at any location under its control where segregated facilities are maintained. SUBCONTRACTOR agrees that a breach of this certification is a violation of the Equal Opportunity clause in this contract.

16. CLEAN AIR AND WATER CERTIFICATION SUBCONTRACTOR certifies that any facility to be used in performance of this contract is not X listed on the Environmental Protection Agency List of Violating Facilities.

SUBCONTRACTOR agrees to notify COMPANY immediately, in writing, of the receipt of any communication from the Administrator, or a designee, of the Environmental Protection Agency, indicating that any facility intended or being used in performance of this contract is under consideration to be listed on the EPA List of Violating Facilities.

17. SURVIVABILITY The provisions of Sections 9, 10 and 11 shall survive any termination or expiration of this Agreement

-3-

Agreed to and Accepted:

The Ohio State University                   COMPANY
Research Foundation                         Superconductive Components, Inc.



By                                          By:
  -------------------------------------       ----------------------------------
Signed:                                     Signed:
       --------------------------------            -----------------------------
Title:                                      Title:
      ---------------------------------           ------------------------------
Date:                                       Date:
    -----------------------------------          -------------------------------

-4-

ATTACHMENT A

STATEMENT OF WORK

TITLE: NOx SENSOR FOR INTERNAL COMBUSTION ENGINES

1) Synthesis and the characterization of the auxiliary phases

Responsibilities:

CISM:

- Formulation of the compound
- Microstructural studies

SCI:

- Synthesis of the powder
- Characterization of the powder

ACTIVITIES

1. Formulation of the compound
2. Synthesis of the powder
3. Calcination of the powder
4. Phase analysis by XRD
5. Stoichiometry verification by ICP
6. Particle size analysis
7. Microstructural studies

2) Preparation and characterization of the zeolite

Responsibilities:

CISM:

- Formulation of the compound
- Preparation of the powder
- Microstructural studies
- Characterization of the powder

ACTIVITIES

1. Preparation of ion-exchange solutions
2. Prepare HY and CUY, various loading levels
3. Phase analysis by XRD
4. Stoichiometry verification by ICP
5. Particle size analysis
6. Microstructural studies

3) Fabrication of the sensor

Responsibilities:

CISM:

- Fabrication of the sensor

SCI:

- Packaging of the sensor

-5-

ACTIVITIES

1. Design the prototype
2. Preparation of zeolite materials
3. Deposition of electrodes, zeolite, and metal oxide
4. Packaging of the sensor

-6-

ATTACHMENT B

COOPERATIVE AGREEMENT

SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM ALLOCATION OF RIGHTS IN INTELLECTUAL PROPERTY AND RIGHTS TO CARRY OUT FOLLOW-ON RESEARCH, DEVELOPMENT, OR COMMERCIALIZATION.

This Agreement between Superconductive Components, Inc., a small business concern organized as an Ohio Corporation under the laws of the State of Ohio and having a principal place of business at 1145 Chesapeake Ave., Columbus, OH 43212, ("SBC") and The Ohio State University Research Foundation, a research institution having a principal place of business at 1960 Kenny Road, Columbus, OH 43210, ("RI") is entered into for the purpose of allocating between the parties certain rights relating to an STTR project to be carried out by SBC and RI (hereinafter referred to as the "PARTIES") under an STTR funding agreement that may be awarded by the National Science Foundation (NSF) to SBC to fund a proposal entitled "NOx Sensor for Internal Combustion Engines," submitted, or to be submitted, to NSF by SBC on or about December 14, 1998.

1. Applicability of this Agreement.

(a) This Agreement shall be applicable only to matters relating to the STTR project referred to in the preamble above.

(b) If a funding, agreement for an STTR project is awarded to an SBC based upon the STIR proposal referred to in the preamble above, SBC will promptly provide a copy of such funding agreement to RI, and SBC will make a subaward to RI in accordance with the funding agreement, the proposal, and this Agreement. If the terms of such funding agreement appear to be inconsistent with the provisions of this Agreement, the Parties will attempt in good faith to resolve any such inconsistencies. However, if such resolution is not achieved within a reasonable period, SBC shall not be obligated to award nor RI to accept the subaward. If a subaward is made by SBC and accepted by RI, this Agreement shall not be applicable to contradict the terms of such subaward or of the funding agreement awarded by NSF to SBC except on the grounds of fraud, misrepresentation, or mistake, but shall be considered to resolve ambiguities in the terms of the subaward.

(c) The provisions of this Agreement shall apply to any and all consultants, subcontractors, independent contractors, or other individuals employed by SBC or RI for the purposes of this STTR project.

2. Background Intellectual Property.

(a) "Background Intellectual Property" means property and the legal right therein of either or both parties developed before or independent of this Agreement including inventions, patent applications) patents, copyrights, trademarks, mask works, trade secrets and any information embodying proprietary dam such as technical data and computer software.

(b) This Agreement shall not be construed as implying that either party hereto shall have the right to use Background Intellectual Property of the other in connection with this STTR project except as otherwise provided hereunder.

(1) The following Background Intellectual Property Of SBC may be used nonexclusively and, except as noted, without compensation by RI in connection with research or development activities for this STTR project (if "none" so state):

NONE:

-7-

(2) The following Background Intellectual Property of RI may be used nonexclusively and, except as noted, without compensation by SBC in connection with research or development activities for this STTR project (if "none" so state):

NONE:

(3) The following Background Intellectual Property of RI may be used by SBC nonexclusively in connection with commercialization of the results of this STTR project, to the extent that such use is reasonably necessary for practical, efficient and competitive commercialization of such results but not for commercialization independent of the commercialization of such results upon the condition that SBC pay to RI, in addition to any other royalty including any royalty specified in the following list, a royalty of 2% of net sales or leases made by or under the authority of SBC of any product or service that embodies, or the manufacture or normal use of which entails the use of, all or any part of such Background Intellectual Property (if "none" so state):

BACKGROUND INTELLECTUAL PROPERTY WILL CONSIST OF THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION INVENTION DISCLOSURE 97ID66F ENTITLED POTENTIOMETRIC TYPE NOx WITH ZEOLITE COATED ELECTRODES.

3. Project Intellectual Property.

(a) "Project Intellectual Property" means the legal rights relating to inventions (including Subject Inventions as defined in 37 CFR Section 401), patent applications, patents, copyrights, trademarks, mask works, trade secrets and any other legally protectable information, including computer software, first made or generated during the performance of this STTR Agreement.

(b) Except as otherwise provided herein, ownership of Project Intellectual Property shall vest in the party whose personnel conceived the subject matter or first actually reduced the subject matter to practice, and such party may perfect legal protection therein in its own name and at its own expense. Jointly made or generated Project Intellectual Property shall be jointly owned by the Parties unless otherwise agreed in writing. The SBC shall have the first option to perfect the rights in jointly made or generated Project Intellectual Property unless otherwise agreed in writing.

(1) Profits, resulting from any product, process, or other innovation or invention based on the cooperative agreement shall be negotiated in good faith at the conclusion of the project.

(2) Expenses and other liabilities associated with the development and marketing of any product, process, or other innovation or invention shall be allocated as follows: the SBC will be responsible for one hundred percent (100%) and the RI will be responsible for zero (0) percent.

(c) The Parties agree to disclose to each other, in writing, each and every Subject Invention which may be patentable or otherwise protectable under the United States patent laws in Title 35, United States Code. The Parties acknowledge that they will disclose Subject Inventions to each other and the awarding agency within one (1) month after their respective inventor(s) first disclose the invention in writing to the person(s) responsible for patent matters of the H disclosing Party. All written disclosures of such inventions shall contain sufficient detail of the invention, identification of any statutory bars, and shall be marked confidential, in accordance with 35 U.S.C. Section 205.

(d) Each party hereto may use Project Intellectual Property of the other nonexclusively and without compensation in connection with research or development activities for this STTR project, including inclusion in STTR project reports to the NSF and proposals to the NSF for continued funding of this STTR project through additional phases.

-8-

(e) In addition to the Government's rights under the Patent Rights clause of 37 CFR Section 401.14, the Parties agree that the Government shall have an irrevocable, royalty free, nonexclusive license for any governmental purpose in any Project Intellectual Property.

(f) SBC will have an option to commercialize the Project Intellectual Property of RI, subject to any rights of the Government therein, as follows --

1) Where Project Intellectual Property of RI is a potentially patentable invention, SBC will have an exclusive option for a license to such invention, for an initial option period of six (6) months after such invention has been reported to SBC. SBC may, at its election and subject to the patent expense reimbursement provisions of this section, extend such option for an additional three (3) months by giving written notice of such election to RI prior to the expiration of the initial option period. During the period of such option following notice by SBC of election to extend, RI will pursue and maintain any patent protection for the invention requested in writing by SBC and, except with the written consent of SBC or upon the failure of SBC to reimburse patenting expenses as required under this section, will not voluntarily discontinue the pursuit and maintenance of, any United States patent protection for the invention initiated by RI or of any patent protection requested by SBC. For any invention for which SBC gives notice of its election to extend the option, SBC will, within thirty (30) days after invoice, reimburse RI for the expenses incurred by RI prior to expiration or termination of the option period in pursuing and maintaining (i) any United States patent protection initiated by RI and (ii) any patent protection requested by SBC. SBC may terminate such option at will by giving written notice to RI in which case further accrual of reimbursable patenting expenses hereunder, other than prior commitments not practically revocable, will cease upon RI's receipt of such notice. At any time prior to the expiration or termination of an option, SBC may exercise such option by giving written notice to RI, whereupon the parties will promptly and in good faith enter into negotiations for a license under RI's patent rights in the invention for SBC to make, use and/or sell products and/or services that embody, or the development, manufacture and/or use of which involves employment of the invention. The terms of such license will include: (i) payment of reasonable royalties to RI on sales of products or services which embody, or the development, manufacture or use of which involves employment of the invention, (ii) reimbursement by SBC of expenses incurred by RI in seeking and maintaining patent protection for the invention in countries covered by the license (which reimbursement, as well as any such patent expenses incurred directly by SBC with RI's authorization, insofar as deriving from RI's interest in such invention, may be offset in full against up to fifty percent (50%) of accrued royalties in excess of any minimum royalties due RI); and, in the case of an exclusive license, (iii) reasonable commercialization milestones and/or minimum royalties.

(2) Where Project Intellectual Property of RI is other than a potentially patentable invention, SBC will have an exclusive option for a license, for an option period extending until L months following completion of RI's performance of that phase of this STTR project in which such Project Intellectual Property of R1 was developed by RI SBC may exercise such option by giving written notice to RI, whereupon the parties will promptly and in good faith enter into negotiations for a license under RI's interest in the subject matter for SBC to make, use and/or sell products or, services which embody, or the development, manufacture and/or use of which involve employment of, such Project Intellectual Property of RI. The terms of such license will include: (i) payment of reasonable royalties to RI on sales of products or services that embody, or the development, manufacture or use of which involves employment of, the Project Intellectual Property of RI and, in the case of an exclusive license, (ii) reasonable commercialization milestones and/or minimum royalties.

-9-

(3) Where more than one royalty might otherwise be due in respect of any unit of product or service under a license pursuant to this Agreement, the parties shall in good faith negotiate to ameliorate any effect thereof that would threaten the commercial viability of tile affected products or services by providing in such license(s) for a reasonable discount or cap on total royalties due in respect of any such unit.

4. Follow-on Research or Development.

All follow-on work, including any licenses, contracts, subcontracts, sublicenses or arrangements of any type, shall contain appropriate provisions to implement the Project Intellectual Property rights provisions of this agreement and insure that the Parties and the Government obtain and retain such rights granted herein in all future resulting research, development, or commercialization work.

5. Confidentiality/Publication.

(a) Background Intellectual Property and Project Intellectual Property of a party, as well as other property or confidential information of a party, disclosed by that party to the other in connection with this STTR project shall be received and held in confidence by the receiving party and, except with the consent of the disclosing party or as permitted under this Agreement, neither used by the receiving party nor disclosed by the receiving party to others, provided that the receiving party has notice that such information is regarded by the disclosing party as proprietary or confidential. However, these confidentiality obligations shall not apply to use or disclosure by the receiving party after such information is or becomes known to the public without breach of this provision or is or becomes known to the receiving party from a source reasonably believed to be independent of the disclosing party or is developed by or for the receiving party independently of its disclosure by the disclosing party.

(b) Subject to the terms of paragraph (a) above, either party may publish its results from this STTR project, However, the publishing party will negotiate the right of review with the other party with respect to a proposed publication, as well as a 30 day period in which to review proposed publications and submit comments, which will be given full consideration before publication. Furthermore, upon request of the reviewing parry, publication will be deferred for up to 150 additional days for preparation and filing of a patent application which the reviewing party has the right to file or to have filed at its request by the publishing party.

6. Liability.

(a) Each party disclaims all warranties running to the other or through the other to third parties, whether express or implied, including without limitation warranties of merchantability, fitness for a particular purpose, and freedom from infringement, as to any information, result, design, prototype, product or process deriving directly or indirectly and in whole or pan from such party in connection with this STTR project.

(b) SBC will indemnify and hold harmless RI with regard to any claims arising in connection with commercialization of the results of this STTR project by or under the authority of SBC. To extent permitted under Ohio law, the PARTIES will indemnify and hold harmless the Government with regard to any claims arising in connection with commercialization of the results of this STTR project.

7. Termination.

(a) This agreement ma be terminated by either Party upon thirty
(30) days written notice to the other Party. This agreement may also be terminated by either Party in the event of the failure of the other Party to comply with the terms of this agreement.

-10-

(b) In the event of termination by either Parry, each Party shall be responsible for its share of the costs incurred through the effective date of termination, as well as its share of the costs incurred after the effective date of termination, and which are related to the termination. The confidentiality, use, and/or non-disclosure obligations of this agreement shall survive any termination of this agreement.

8. Governing Law.

(a) This agreement shall be governed by the state of Ohio and shall also be subject to applicable U.S. federal laws and regulations which derive from the prime National Science Foundation grant to SBC.

AGREED TO AND ACCEPTED

Small Business Concern

By: Date:

Print Name:

Title:

Research Institution

By: Date:

Print Name:

Title:

-11-

EXHIBIT 10(b)

LEASE AGREEMENT
1145 CHESAPEAKE AVE
COLUMBUS, OHIO 43212

This lease made this 7th day of February, 1997 between the Landlord and the Tenant hereinafter named.

Article 1. Definition and Certain Basic Provisions:

1.1      a)       "Landlord":          Cavin Carmell DBA University Area Rentals

         b)       Landlord's Address:  1439 North High Street
                                       Columbus, Ohio  43201

         c)       "Tenants":           Superconductive Components

         d)       Tenant's Address:    1145 Chesapeake Avenue Suite D
                                       Columbus, Ohio 43212

e) Demised Premises: In the township of Clinton, County of Franklin Ohio, a unit of a building with approximately 17,845 gross feet in area and described in exhibit A and high lighted in yellow ink located in a building known as 1145 Chesapeake Ave Columbus, Ohio 43212, hereinafter referred to as the building. Plus a unit of a building with approximately 4,200 gross sq. ft in area described in exhibit A and high lighted in blue ink.

f) Lease Term: 24 month commencing on the 1st day of February, 1997 ("The commencement date") as hereinafter defined, and on

         the 31st of January, 1999.

g)       Base Rental:      Year 1 - $3.15 per sq. ft.   ($5786.50)
                           Year 2 - $3.15 per sq. ft.   ($5786.50)

h)       Permitted Use:  Office / Machineshop

i)       Prepaid Rent:  None

j)       Security Deposit:  None

k)       Reserved Parking:  North side of building

l) Utilities: Tenants to pay all Utilities to include, but not limited to: gas, electric, water, and all metered, sub-metered or fixed municipal charges.


LEASE AGREEMENT
1145 CHESAPEAKE AVE
COLUMBUS, OHIO 43212

Article 1. Definition and Certain Basic Provisions:

1.1      a)       "Landlord":          Cavin Carmell DBA University Area Rentals

         b)       Landlord's Address:  1439 North High Street
                                       Columbus, Ohio  43201

         c)       "Tenants":           Superconductive Components

         d)       Tenant's Address:    1145 Chesapeake Avenue Suite D
                                       Columbus, Ohio 43212

e) Demised Premises: In the township of Clinton, County of Franklin Ohio, a unit of a building with approximately 17,845 gross feet in area and described in exhibit A, located in a building known as 1145 Chesapeake Ave Columbus, Ohio 43212, hereinafter referred to as the building

f) Lease Term: 48 month commencing on the 1st day of January, 1997 ("The commencement date") as hereinafter defined, and on the 31st day of December, 2000.

g) Base Rental: Year 1 - $3.15 per sq. ft.($4684.00) Year 2 - $3.15 per sq. ft.($4684.00)

h) Permitted use: Manufacturing, and Office use

i) Parking reserved space: North and South side of building

-2-

1.2 Each of the foregoing definitions and basic provisions shall be construed in conjunction with and limited by references thereto in the other provisions of this lease.

ARTICLE II
GRANTING CLAUSE

2.1 In consideration of the obligation of Tenant to pay rent herein provided and in consideration of the other terms, covenants and Tenant hereby takes from Landlord, the Demised Premises as described in Section 1.1(e) TO HAVE AND TO HOLD the Demised Premises for the Lease Term specified in Section 1.1(f), all upon the terms and conditions set forth in this Lease.

ARTICLE III
RENT

3.1 The annual rental above provided for shall be paid in equal monthly installments of one-twelfth (1/12th) of said annual rent. Said monthly installments of rent shall be paid in advance on the first day of each month during the entire term of this Lease.

ARTICLE IV
UTILITIES

4.1 Landlord shall not be liable for any interruption whatsoever in utility service not furnished by him, nor for interruptions in utility furnished by him which are due to fire, accident, strike, acts of God, or other causes beyond the control of Landlord or in order to make alterations, repairs, or improvements to the Building and appurtenances.

ARTICLE V
MAINTENANCE

5.1 Tenant shall repair and maintain, at its expense, the following items:

(a) Any special treatment of interior walls, wall coverings, partitions, floors and ceilings;

(b) Fixtures or other improvements installed by or at the request of Tenant;

(c) Damages caused by misuse or neglect of Tenant, its agents, invites or employees;

(d) All glass, except plate glass windows and doors not damaged by misuse or neglect by Tenant, its agents, invites or employees;

(e) Exposed electrical systems in tenant area and exposed plumbing related to tenants office area. Exposed electrical and plumbing in common area to be shared with tenant to the east.

Tenant shall keep the Demised Premises in good order and report any damage or repair to Landlord. In the event Tenant fails to make such repairs and perform such maintenance, Landlord may make such repairs and perform such maintenance. The expense so incurred by Landlord in making repairs or performing maintenance, together with interest thereon at the rate of ten (10%) percent per annum from date of payment thereof by Landlord shall become due and payable at the next rent date after such payment is made and Landlord gives notice to Tenant that it has performed the repairs or maintenance and the cost thereof.

5.2 Tenant shall cooperate with Landlord in keeping the Building and sidewalks, service ways, landscaped areas and loading areas adjacent to the Demised Premises neat, clean and free from dirt or rubbish at all times.

-3-

ARTICLE VII
ALTERATIONS

6.1 Tenant shall make no alterations, changes, additions or improvements to the Demised Premises without prior written consent of Landlord or Agents.

6.2 Any and all alterations, changes, additions, or improvements made to or upon the Demised Premises by Tenant shall be and become a part of the real estate and the property of Landlord, except machinery or equipment, appurtenances and trade fixtures placed therein or thereon by Tenant, which are easily moveable or of a temporary nature, and upon the expiration of this Lease, under any of its terms, Tenant shall not be entitled to any repayment or compensation therefor.

6.3 Tenant may place or install trade fixtures or equipment as it deems desirable for the conduct of its business, and Tenant shall have the right to remove from the Demised Premises, at any time, all personal property, the Demised Premises, whether nailed, bolted, or otherwise temporarily fastened to said premises. Any damage caused to the Demised Premises by the placement or removal of such property shall be repaired by Landlord at Tenant's expense.

ARTICLE VII
INSURANCE

7.1 Tenant further agrees and covenants to keep in force, at its own expense, during the full term of this Lease, public liability insurance, as follows:

(a) Bodily injury in limits of not less than $100,000 for any one person, any $300,000 for one occurrence;

(b) Property damage in limits of not less than $100,000 for any one occurrence and not less than $100,000 in the aggregate;

covering the Tenant and Landlord against all claims, actions, damages, liabilities and expenses in connection with personal injuries or damage to property arising from or out of the occupancy or use of Landlord's property.

7.2 All policies of insurance required to be carried by Tenant hereunder shall be placed with solvent, incorporated insurance companies, approved by Landlord, each company being then licensed to do business in the State of Ohio. Tenant hereby agrees to furnish Landlord with proof of such insurance upon a request by Landlord and further agrees and covenants to furnish Landlord with receipted bills or other evidence showing the payment of premiums on all policies covering the Demised Premises at any time. All policies to be procured by Tenant shall be so written that the Landlord will be notified of cancellation or any restrictive amendment of the policy at least ten (10) days prior to the effective date of such cancellation or amendment. Notice shall be certified by mail, return receipt requested, addressed to Landlord at the address contained in ARTICLE 1, Section 1.1 of this Lease. If tenant shall neglect to procure and keep in force any policies of insurance as herein required, Landlord may, without notice to Tenant, renew or procure insurance, and the premiums paid thereof, together with interest thereon at the rate of twelve (12%) percent per annum from the date of payment thereof by Landlord, shall be and become due and payable to Landlord as so much additional rent at the next rent due date after such payment is made and Landlord gives notice to Tenant that it has renewed or procured such insurance and the amount of premiums paid therefor appurtenances, equipment, Tenant's improvement and stock located in the Building arising out of fire or theft perils which come within the purview of the insurance provided above covering the property listed above.

ARTICLE IX
TENANT INDEMNIFICATION

8.1 Tenant agrees that it will indemnify Landlord and save it harmless from and against any and all claims, actions, damages, liabilities, attorneys fees, cost and for all other expense in connection with personal injuries or damage to property arising from or out of the occupancy or use by Tenant of the Demised Premises, or any part of the Landlord's property, or occasioned in whole or in part by any act or omission of Tenant, its agent,

-4-

contractors or employees, and not solely caused by any negligence of Landlord, its agents or employees. Tenants shall keep in force, at its own expense, so long as this Lease remains in effect, the public liability insurance provided or in Article VIII hereof.

ARTICLE X
LANDLORD NOT RESPONSIBLE

9.1 Tenant waives all claims it may at any time have against Landlord, its agents or employees, for damage to persons or property resulting from the Demised Premises or any other part of the Building becoming out of repair or resulting from any accident within the Demised Premises or within the Building or resulting directly or indirectly from any act of Tenant or any other occupant of the Building or any other person while in the Building, except if caused by the negligence of the Landlord, its agents, or employees.

ARTICLE XI
DAMAGE AND/OR DESTRUCTION

10.1 If, during the term of this Lease, the Building or Demised Premises are destroyed by fire or other cause, or partially destroyed or damaged so that the Landlord shall decide not to restore or rebuild same, whether or not the Demised Premises are damaged, the Landlord may, within ninety (90) days after such fire or other cause, give notice in writing to the Tenant of such decision, whereupon this Lease shall expire forthwith and the Tenant shall within Thirty (30) days surrender the Demised Premises and all interest therein to the Landlord and shall pay rent only up to the time of such surrender. However, if the Landlord shall decide to restore or rebuild the Building and/or Demised Premises, this Lease shall remain in full force and effect and the Landlord agrees that the rent shall be diminished in proportion to the time and the part of the Demised Premises of which the Tenant has been deprived. In no case shall the Landlord be liable to the Tenant for any loss or damage occasioned by such fire or other cause.

ARTICLE XIII
LIENS

11.1 Tenant covenants that it will not voluntarily place any lien on the Demised Premises, or any part thereof, without the written consent of the Landlord, and Tenant further agrees and covenants that it shall pay all costs, expenses and liabilities arising out of or in or modifications and shall keep the Demised Premises free and clear from any and all liens of mechanics or materialmen, and all liens of a similar character arising out of or growing out of the construction, repair alteration or maintenance of the Building by Tenant or upon Tenant's behalf. In the event Tenant fails to keep the Demised Premises free and clear from such liens, Landlord shall, at its option, have the right, at all times during the terms of this Lease, to pay such costs, expenses, liabilities or charges on the Demised Premises and to pay, cancel and clear off all liens of any kind of nature, and claims on or against the Demised Premises, and to redeem the Demised Premises from same or any of them, from time to time, and the amount so paid, including reasonable expenses, shall be so much additional rent due from Tenant at the next rent date after such payment, with interest at the rate of twenty-four (24%) percent per annum from the date of payment until repayment thereof to Landlord by Tenant.

ARTICLE XIII
QUIET ENJOYMENT

12.1 Landlord covenants, warrants, and represents that it has the full right and power to execute and perform this Lease and to grant the estate demised herein and that Tenant, on payment of the rent herein reserved and performing the covenants and agreements herein contained, shall peaceably and quietly have, hold, and enjoy the Demised Premises during the full term of this Lease and any extension or renewal hereof; provided, however, that Tenant accepts this Lease subject and subordinate to any recorded mortgage, deed of trust, or other lien presently existing upon the Demised Premises, and Tenant agrees upon demand to execute such further instruments subordinating this Lease and Landlord may request, provided such further subordination shall be upon the express condition that this Lease shall be recognized by the Mortgage and that the rights of Tenant shall remain in full force and effect during the term of the Lease so long as Tenant shall continue to perform all of the covenants and conditions of this Lease.

-5-

ARTICLE XIV
EMINENT DOMAIN

13.1 If all the Demised Premises shall be taken for any public or quasi public use, under any statute, by right of eminent domain, or if any part of the Demised Premises is so taken and the part not so taken is insufficient for the reasonable operation of Tenant's business then, in either such event, this Lease and the term hereby granted shall cease and expire on the date when possession shall be taken thereunder of the Demised Premises or part thereof, and all rents, taxes and other charges shall be pro rated and paid to such date.

13.2 In the event that only a part of the Demised Premises is so taken and the part not so taken shall be sufficient for the reasonable operation of Tenant's business, this Lease shall remain unaffected, except that Tenant shall be entitled to a pro rata reduction in the rent paid hereunder, based on the proportion which the rental value of the space so taken bears to the rental value of the space originally demised.

13.3 In the case of any such taking, whether of all or any part of the Demised Premises, and regardless of whether this Lease survives, the Tenant shall only be entitled to receive the portion of the award equivalent in amount to the cost of any alterations, changes, additions, or improvements which were installed by Tenant at its cost and which are so taken, less depreciation thereof. In determining the rate of depreciation, such alterations, changes, additions or improvements shall be deemed to have a useful life commencing with the date of their installation and terminating on the date specified herein for the expiration of the term of the Lease. In no event, however, shall any alterations, additions, changes or improvements be deemed to have a useful life in excess of twenty (20) years. Tenant shall not be entitled to any payment based, interaiia, upon the value of the unexpired term of this tease, consequential damages to the leasehold interest not so taken or otherwise. The balance of the award shall be solely to Landlord and Tenant hereby assigns such balance of the award to Landlord.

ARTICLE XV
LANDLORD'S RIGHT TO ACCESS

14.1 Landlord's agents, employees, or representatives shall have the right to enter upon the Demised Premises any time for the purpose of inspecting the same, or of making repairs to the Demised Premises, or adjacent premises if necessary, or of showing the Demised Premises to prospective purchasers, lessees or lenders.

ARTICLE XVI
PERMITTED USE

15.1 Tenant agrees that the Demised Premises shall only be used for the permitted use defined in ARTICLE I, Section 1.1, and Tenant agrees that the Demised Premises, or any part thereof, shall not at any time during the term of the Lease, be used for any purpose or business which is considered dangerous or unsafe, or which contributes a nuisance, or is noxious or offensive by reason the emission of dust, gas, smoke, fumes, or noise.

15.2 Tenant agrees that the Demised Premises, or any part thereof, shall not be used or occupied, or that it will not use or suffer or permit the Demised Premises, or any part thereof, to be occupied for any vicious or immoral purpose, nor for any purpose in violation of the laws of the State of Ohio, or of the United States, or of municipal ordinances, or of the police, health, sanitary, building and fire rules, regulations and instructions relating to or affecting the use or occupancy or possession of the Demised Premises now or hereafter in force and applicable thereto.

ARTICLE XVLL
DEFAULT BY TENANT AND REMEDIES

16.1 The following events shall be deemed to be events of default by Tenant under this Lease:

(a) Tenant shall fail to pay any installment of rent hereby reserved and such failure shall continue for a period of five (5) days.

-6-

(b) Tenant shall fail to comply with any term, provision or covenant of this Lease, other than the payment of rent and shall not cure such failure within thirty
(30) days or such reasonable time as required to cure such failure after written notice thereof to Tenant.

(d) Tenant shall file a petition under any section or chapter of the National Bankruptcy Act, as amended or under any similar law or statute of the United States or any State thereof, or Tenant shall be adjudged bankrupt or insolvent in proceedings filed against Tenant thereunder.

(e) A receiver or trustee shall be appointed for all or substantially all of the assets of Tenant.

(f) Tenant shall desert or vacate any substantial portion of the Demised Premises.

16.2 Upon the occurrence of any such event of default, Landlord shall have the option to pursue any one or more of the following remedies without any notice of demand whatsoever:

(a) Terminate this Lease, in which event Tenant shall immediately surrender the Demised Premises to Landlord, and if Tenant fails to do so, Landlord may, without prejudice to any other remedy which it may have for possession or arrearages in rent, enter upon and take possession of the Demised Premises and expel or remove Tenant and any other person who may be occupying the Demised Premises or any part thereof, by force if necessary, without being liable for prosecution or any claim of damages therefor, and Tenant agrees to pay to Landlord, on demand, the amount of all loss and damage which Landlord may suffer by reason of such termination, whether through inability to relet the Demised Premises on satisfactory terms, or, otherwise.

(b) Entered upon and take possession of the Demised Premises and expel or remove Tenant and any other person who may be occupying the Demised Premises or any part thereof, by force if necessary, without damage therefor, and if Landlord so elects, relet the Demised Premises on such terms as Landlord may deem advisable and receive the rent therefor; and Tenant agrees to pay Landlord, on demand, any deficiency that may arise by reason of such reletting.

(c) Enter upon the Demised Premises by force, if necessary, without being liable for prosecution or any claims for damages therefor, and do whatever Tenant is obligated to do under the terms of this Lease, and Tenant agrees to reimburse Landlord on demand, for any expenses which Landlord may incur in thus effecting compliance with Tenant's obligations under this Lease, and Tenant further agrees that Landlord shall not be liable for any such damages resulting to the Tenant from such action.

16.3 Pursuit of any of the foregoing remedies shall not prelude pursuit of any other such remedies herein provide by law, nor shall pursuit of any other such remedy constitute a forfeiture or waiver of any rent due to Landlord by reason of violation of any of the terms, provisions and covenants herein contained. Forbearance by Landlord to enforce one or more of the remedies herein provided upon an event of default shall not be deemed or construed to constitute a waiver of such default. In determining the amount of loss or damage which Landlord may Suffer by reason of termination of this Lease or the deficiency arising by reason of any reletting by Landlord as above provided, allowance shall be made for the expense of repossession and any repairs or remodeling undertaken by Landlord following repossession.

16.4 If on, account of any breach or default by Tenant in its obligations hereunder, Landlord shall employ an attorney to enforce or defend any of Landlord's right or attorney's fees and costs incurred by Landlord in such connection.

16.5 Landlord hereby acknowledges receipt from Tenant of the sum stated in Section 1.1 (i) above, to be applied to the first accruing installments of rent.

-7-

16.6 Landlord further acknowledges receipt from Tenant of the sum stated in Section 1.1(j) above, to be held by Landlord, without covenants and obligations under this Lease, it being expressly understood that such deposit is not an advance payment of rental or a measure of Landlord's damages in case of default by Tenant. Upon the occurrence of any event of Tenant, Landlord may, from time to time, without prejudice to any other remedy provided herein or provided by law, use such fund to the extent necessary to make good any arrears of rent and other damage, injury, expense or liability caused to Landlord by such event or default, and Tenant shall pay to Landlord, on demand, the amount so applied in order to restore the security deposit to its original amount. If Tenant is not then in default hereunder, any remaining balance of such deposit shall be returned by Landlord to Tenant upon termination of this Lease.

ARTICLE XVIII
LANDLORD'S LIEN

17.1 Landlord shall, in the event of default, as provided for in
Section 17, have the right to place a lien for all rentals and other sums of money becoming due hereunder from Tenant, upon all goods, wares, equipment, fixtures, furniture, and all personal property situated on the Demised Premises, and such property shall not be removed there from without the consent of Landlord until all arrearages in rent and other sum of money then due to Landlord hereunder shall first have been paid. Upon the occurrence of an event of default by Tenant, Landlord may, in addition to any other remedies provided herein or by law, enter upon the Demised Premises and take possession of any and all goods, wares, equipment, fixtures, furniture, and all personal property situated on the Demised Premises without liability for trespass or conversions, and sell the same with or without having such property at the sale, at which Landlord or its assigns may purchase, and apply to proceeds thereof, less any and all expenses connected with the taking of possession and sale of the property, as a credit against any sums due by Tenant to Landlord. Any surplus shall be paid by Tenant, and Tenant agrees to pay any deficiency forthwith. Alternatively, the lien hereby granted may be foreclosed in the manner provided by law. The statutory lien herein granted being an addition and supplementary thereto.
ARTICLE XIX PERMITS

18.1. Tenant shall, at Tenant's own cost and expense, procure each and every permit, license, certificate or other authorization required in connection with the lawful and proper use of the Demised Premises or required in connection with any building or improvements now or hereafter erected on the Demised Premises.

ARTICLE XX
ASSIGNMENTS AND SUBLETTING

19.1 Tenant shall not assign this Lease or sublet the whole or any part of the Demised Premises, without the prior written consent of the terms and provisions of this Lease. Notwithstanding any such assignment or subletting, Tenant shall, at all times, remain fully responsible and liable for the payment of the rent herein specified and for compliance with all of its other obligations under the terms, provisions and covenants of this Lease. If an "event of default" as heretofore defined should occur while the Demised Premises or any part thereof are the assigned or sublet, Landlord, in addition to any other remedies herein, provided by law, may at its option, collect directly from such assignment or sublease and apply such rent against any sums due to it by Tenant hereunder.

19.2 Landlord shall have the right to transfer and assign, in whole or in part, all and every feature of its rights and obligations hereunder, and in the Building and property referred to herein. Such transfers or assignments may be made either to a corporation, trust company, individual, or group of individuals, and howsoever made are to be in all things respected and recognized by Tenant.

ARTICLE XXI
HOLDING OVER

20.1 In the event that Tenant remains in possession of the Demised Premises after the expiration of this Lease and without the execution of a new Lease, it shall be deemed to be occupying the Demised Premises as a

-8-

tenant from month-to-month at a rental equal to the rental herein provided, (one hundred (100%) percent) of such amounts and otherwise subject to all the conditions, provisions and obligations of this Lease.

ARTICLE XXII
TERMINATION

21.1 By the last day of the term hereof or on the earlier termination thereof, Tenant shall peaceably and quietly leave, surrender and deliver up to Landlord the Demised Premises, broom clean, together with any and all alterations, changes, additions and improvements which may have been made upon the Demised Premises, in thorough repair and good order and safe condition. Tenant, on or before said date, shall remove all of the Tenant's personal property for the Demised Premises and all property not so removed shall be deemed to have been abandoned any may be appropriated, sold, or destroyed or otherwise disposed of by Landlord without obligation to account therefor. Tenant shall reimburse Landlord for any cost incurred by Landlord to remedy any default of Tenant's responsibilities of this section 23.1.

21.2. If the Demised Premises be not surrendered, Tenant, in addition to the rental provided for by Article XXII hereof, shall indemnify Landlord from and against all claims made by a succeeding tenant.

ARTICLE XXIII
NOTICE

22.1 All notices, demands, and communications hereunder shall be served or given by registered mail, and if intended for Landlord, shall be addressed to Landlord as provided in Article 1, Section 1.1, if intended for Tenant, shall be addressed to Tenant, in writing. Any notices given hereunder by mail shall be deemed to be delivered when deposited in a United States or general or branch post office, enclosed in a registered, prepaid wrapper, addressed as above provided.

ARTICLE XXIV
LATE PAYMENT

23.1 Any rent or any portion thereof remaining unpaid for five (5) days after it is due and without demand, Tenant agrees to pay Landlord (ten (10%) percent) of the monthly rental rate to defray the expense incurred by Landlord as a result of late rental payment and also as penalty for late payment. After ten (10) days an additional five dollars ($5.00) per day and shall extend for the term of the Lease. This provision shall not be construed as a waiver of any of Landlord's rights relating to Tenant's default.

ARTICLE XXV
PLACE OF PAYMENT

24.1 All payments of rent or other sums to be paid Landlord hereunder shall be sent to: University Area Rentals, 1439 North High Street, Columbus, Ohio 43201.

ARTICLE XXVI

25.1 This Lease contains the entire agreement between the parties and shall not be modified or amended in any manner, except by an instrument in writing executed by the parties or their respective successors in interest.

25.2 This Lease shall be governed by and construed in accordance with the laws of, or applicable to, the State of Ohio.

25.3 The article titles are inserted only as a matter of convenience and for the reference and in no way define, limit or describe the scope of intent of this Lease, nor in any way affect this Lease.

25.4 This Lease may be executed in any number of counterparts, each of which, when so executed, shall be deemed to be an original.

-9-

25.5 If any clause or provision of this Lease is illegal, invalid or unenforceable under a present or future law effective during the term of this Lease, then and in that event, it is the intention of the parties hereto that the remainder of this Lease shall not be affected thereby, and it is also the intention of the parties to this Lease that in lieu of each clause or provision of this Lease that is illegal, invalid or unenforceable, there be added as a part of this Lease a clause or provision as similar in terms to such illegal, invalid, or unenforceable clause or provision as may be possible and be legal, valid and enforceable.

ARTICLE XXVII
ADDITIONAL TERMS

IN WITNESS WHEREOF, The parties have executed this lease as of the day and year here in below written. The later of the dates appearing below shall be the effective date of this lease.

Signed and acknowledged                 Signed and acknowledged
in the presence of:                            Landlord:




-------------------------------                ---------------------------------
                                               Cavin C. Carmell DBA
                                               University Area Rentals


Signed and acknowledged                        Signed and acknowledged
in the presence of:                            Tenants:



-------------------------------                ---------------------------------
                                               Ed Funk, President


Date

-10-

EXHIBIT 10(c)

SUPERCONDUCTIVE COMPONENTS, INC.

1987 INCENTIVE STOCK OPTION PLAN

1. PURPOSE. The purpose of this plan is to advance the interests of Superconductive Components, Inc. (the "Company") by providing an opportunity to selected key employees of the Company and its subsidiaries (hereinafter, the "employees") to purchase stock of the Company through the exercise of options granted under this Plan. By encouraging such stock ownership, the Company seeks to attract, retain and motivate employees of training, experience and ability. It is intended that this purpose will be effected by the granting of stock options as provided herein which will qualify as "incentive stock options" under the provisions of Section 422A of the Internal Revenue Code of 1986, as amended (the "Code").

2. EFFECTIVE DATE. This Plan shall become effective on November 16, 1987 provided that the Plan is approved by the shareholders of the Company within one (1) year from that date. Although options may be granted before such approval, no option may be exercised until such approval is obtained and such options will be null and void if such approval is not obtained.

3. STOCK SUBJECT TO THE PLAN. The shares that may be granted under this Plan shall not exceed in the aggregate 400,000 shares of no par value Common Stock of the Company. Any shares subject to an option which for any reason expires or is terminated unexercised as to such shares may again be the subject of an option under the Plan. The shares delivered upon exercise of options under this Plan may, in whole or in part, be either authorized but unissued shares or issued shares reacquired by the Company.

4. ADMINISTRATION. The Plan shall be administered by a committee (the "Stock Option Committee") consisting of two (2) or more members, who shall be eligible to participate in the Plan. The Stock Option Committee shall be appointed by and shall serve at the pleasure of the Board of Directors of the Company. Subject to the provisions of this Plan, said Committee shall have full power to construe and interpret the Plan and to establish, amend and rescind rules and regulations for its administration. Actions by a majority of the Stock Option Committee at a meeting, or actions approved in writing by all of the members of such Committee, shall be the valid acts of the Stock Option Committee. No member of the Board or the Stock Option Committee shall be liable for any action or determination made in good faith, with respect to the Plan or any option granted under it.

5. ELIGIBLE EMPLOYEES. Options may be granted by the Board of Directors to such key employees of the Company or any of its subsidiaries, including members of the Board of Directors who are also employees of the Company or any of its subsidiaries, as are selected by the Stock Option Committee.

6. DURATION OF THE PLAN. The Plan shall terminate ten (10) years from the effective date unless terminated earlier pursuant to Paragraph 11 hereafter, and no options may be granted thereafter.

7. LIMITATIONS ON NUMBER OF SHARES. The aggregate fair market value, determined as of the date the option is granted, of the shares for which options are exercisable for the first time by an employee during any calendar year shall not exceed $100,000. In the event that such employee is eligible to participate in any other stock incentive plans of the Company or a subsidiary which are also intended to comply with the provisions of Section 422A of the Code, such annual limitation shall apply to the aggregate number of shares for which options may be granted for such plans.

8. TERMS AND CONDITIONS OF OPTIONS. Options granted under this Plan shall be evidenced by stock option agreements in such form and not inconsistent with the Plan as the Stock Option Committee shall approve from time to time, which agreements shall include, but not be limited to, the following terms and conditions:

(a) PRICE. The purchase price per share of stock payable upon the exercise of each option granted hereunder shall be not less than 100 percent of the fair market value of the stock on the day the option is


granted; provided, however, that if at the time of the grant the optionee owns stock possessing more than 10 percent of the combined voting power of all classes of stock of the Company or its parent or a subsidiary, such purchase price per share shall be not less than 110 percent of the fair market value of the stock on the day the option is granted. Such fair market value shall be determined in accordance with procedures to be established in good faith by the Stock Option Committee conforming to regulations issued by the Internal Revenue Service with regard to incentive stock options.

(b) NUMBER OF SHARES. Each option agreement shall specify the number of shares to which it pertains.

(c) EXERCISE OF OPTIONS. Each option shall be exercisable for the full amount or for any part thereof and at such intervals or in such installments as the Board of Directors may determine at the time it grants such option; provided, however, that no option shall be exercisable with respect to any shares later than ten (10) years after the date of the grant of such option; and provided, further, that if at the time of the grant of such option, the optionee owns stock possessing more than 10 percent of the combined voting power of all classes of stock of the Company or a subsidiary, such option shall be exercisable no later than five (5) years after the date of its grant.

(d) NOTICE OF EXERCISE AND PAYMENT. An option shall be exercisable only by delivery of a written notice to the Stock Option Committee, any member of the Committee, the Company's Treasurer, or any other officer of the Company designated by the Committee to accept such notices on its behalf, specifying the number of shares for which it is exercised. If said shares are not at the time effectively registered under the Securities Act of 1933, as amended, the optionee shall include with such notice a letter, in form and substance satisfactory to the Company, confirming that the shares are being purchased for the optionee's own account for investment and not with a view to distribution. Payment shall be made in full at the time of delivery to the optionee of a certificate or certificates covering the number of shares for which the option was exercised. Payment shall be made either by (i) cashier's or certified check, (ii) if permitted by a vote of the Board of Directors by delivery and assignment to the Company of shares of Company stock, or (iii) by a combination of (i) and (ii). The value of the Company stock for such purpose shall be its fair market value as of the date the option is exercised, as determined in accordance with the procedures to be established by the Stock Option Committee.

(e) NON-TRANSFERABILITY. No option shall be transferable by the optionee otherwise than by will or the laws of descent or distribution, and each option shall be exercisable during his lifetime only by him.

(f) TERMINATION OF OPTIONS. Each option shall terminate and may no longer be exercised if the optionee ceases for any reason to be an employee of the Company, or its parent or a subsidiary, except that:

(i) if the optionee's employment shall have terminated for any reason other than cause, disability (as defined below) or death, he may at any time within a period of thirty (30) days after such termination of employment exercise his option to the extent that the option was exercisable by him on the date of termination of his employment;

(ii) if the optionee's employment shall have been terminated because of disability within the meaning of Section 105(d)(4) of the Code, he may at any time within a period of one (1) year after such termination of employment exercise his option to the extent that the option was exercisable by him on the date of termination of his employment; and

(iii) if the optionee dies at a time when the option was exercisable by him, then his estate, personal representative or beneficiary to whom it has been transferred pursuant to paragraph 8(e) hereof may, within six (6) months following the death, exercise the option to the extent the option might have been exercised at the time of his death; provided, however, that no option may be exercised to any extent by anyone after the date of expiration of the option.

(g) RIGHTS AS SHAREHOLDER. The optionee shall have no rights as a shareholder with respect to any shares covered by his option until the date of issuance of a stock certificate to him for such shares.

-2-

9. STOCK DIVIDENDS; SPLITS, STOCK COMBINATION; RECAPITALIZATION. Appropriate adjustment shall be made in the maximum number of shares of Common Stock subject to the Plan and in the number, kind, and option price of shares covered by outstanding options granted hereunder to give effect to any stock dividends or other distribution, stock splits, stock combinations, recapitalizations and other similar changes in the capital structure of the Company after the effective date of the Plan.

10. MERGER; SALE OF ASSETS, DISSOLUTION. In the event of a change of the Common Stock resulting from a merger or similar reorganization as to which the Company is the surviving corporation, the number and kind of shares which thereafter may be optioned and sold under the Plan and the number and kind of shares then subject to options granted hereunder and the price per share thereof shall be appropriately adjusted in such a manner as the Stock Option Committee may deem equitable to prevent substantial dilution or enlargement of the rights available or granted hereunder. If the Company at any time should elect to dissolve, sell all or substantially all of its assets, undergo a reorganization, or merge or consolidate with any corporation and the Company is not the surviving corporation, then (unless in the case of a reorganization, merger, or consolidation the surviving corporation assumes the optionees' rights under the Plan or issues substantially equivalent substitute rights in place thereof) each optionee shall be notified by the Company of his right to exercise all outstanding options prior to any such dissolution, sale, reorganization, merger or consolidation. The failure to exercise such outstanding options within twenty
(20) days of such notification shall cause the options to be terminated.

11. TERMINATION OR AMENDMENT OF PLAN. The Board of Directors may at any time terminate the Plan or make such changes in or additions to the Plan as it deems advisable without further action on the part of the shareholders of the Company; provided:

(a) that no such termination or amendment shall adversely affect or impair any then outstanding option without the consent of the optionee holding such option;

(b) that any such amendment which increases the number of shares subject to this Plan shall be subject to approval by shareholders of the Company within one (1) year from the effective date of such amendment and shall be null and void if such approval is not obtained; and

(c) that in no event shall any amendment be made to the Plan which would cause the options granted hereunder to fail to qualify as incentive stock options under the Code.

12. EFFECT OF THE PLAN ON EMPLOYMENT RELATIONSHIP. The establishment of the Plan shall in no way, now or hereafter, reduce, enlarge or modify the employment relationship between the Company and the optionee. Nothing contained in the Plan shall be construed as conferring upon any optionee any right to continue in the employ of the Company.

13. DEFINITIONS.

(a) The term "key employees" means those executive, administrative, operational or managerial employees of the Company who are determined by the Stock Option Committee to be eligible for options under this Plan.

(b) The term "associate" means any employee of the Company or any of its subsidiaries.

(c) The term "optionee" means a key employee to whom an option is granted under this Plan.

(d) The term "parent" shall, for purposes of this Plan, have the meaning ascribed to it under Section 425(e) of the Code.

(e) The term "subsidiary" shall, for purposes of this Plan, have the meaning ascribed to it under Section 425(f) of the Code.

-3-

EXHIBIT 10(d)

SUPERCONDUCTIVE COMPONENTS, INC.

1991 NON-STATUTORY STOCK OPTION PLAN

1. PURPOSE. The purpose of this 1991 Non-Statutory Stock Option Plan (the "Plan") is to advance the interests of Superconductive Components, Inc. (the "Company") by providing an opportunity to selected key employees and directors of the Company and its subsidiaries and to consultants, sales representatives, technical advisory committee members, and others who may associate with the Company or its subsidiaries to purchase stock of the Company through the exercise of options granted under the Plan. By encouraging such stock ownership, the Company seeks to attract, retain, and motivate employees, directors, consultants, advisers, sales , representatives and other employees of training, experience, and ability.

2. EFFECTIVE DATE. The Plan shall become effective on February 21, 1991.

3. STOCK SUBJECT TO THE PLAN. The shares that may be granted under the Plan shall not exceed in the aggregate 200,000 shares of no par value Common Stock of the Company. Any shares subject to an option which for any reason expires or is terminated unexercised as to such shares may again be the subject of an option under the Plan. The shares delivered upon exercise of options under the Plan, in whole or in part, may be either authorized but unissued shares or issued shares reacquired by the Company. Options granted hereunder shall not be treated as incentive stock options.

4. ADMINISTRATION. The Plan shall be administered by the Board of Directors of the Company, unless the Board of Directors shall designate such administration to a committee (the "Stock Option Committee") consisting of not less than three directors, who shall continue to be eligible to participate in the Plan. If the Board does not appoint a Stock Option Committee, any reference in the Plan to the Stock Option Committee shall mean the Board of Directors. Subject to the provisions of the Plan, the Stock Option Committee shall have full power to construe and interpret the Plan and to establish, amend, and rescind rules and regulations for its administration.

5. ELIGIBLE EMPLOYEES AND DIRECTORS.

(a) Persons shall be selected by the Stock Option Committee from among the key employees, directors, consultants; advisers and sales representatives of the Company, or any of its subsidiaries, to be recommended to the Board of Directors to receive options under the Plan.

(b) NUMBER OF SHARES. Each option agreement shall specify the number of shares to which it pertains.

(c) EXERCISE OF OPTIONS. Each option shall be exercisable for the full amount or for any part thereof and at such intervals or in such installments as the Board of Directors may determine at the time it grants such option; provided, however, that no option shall be exercisable with respect to any shares later' than ten (10) years after the date of the grant of such option.

(d) NOTICE OF EXERCISE AND PAYMENT. An option shall be exercisable only by delivery of a written notice to the Stock Option Committee, any member of the Stock Option Committee, the Company's Treasurer, or any other officer of the Company designated by the Stock Option Committee to accept such notices on its behalf, specifying the number of shares for which it is exercised. If said shares are not at the time effectively registered under the Securities Act of 1933, as amended, the optionee shall include with such notice a letter containing representations and warranties, in form and substance satisfactory to the Company, that the shares are being purchased for the optionee's own account for investment and not with a view to distribution. Payment shall be made in full at the time of delivery to the optionee of a certificate or certificates covering the number of shares for which the option was exercised. Payment shall be made either by (i) cashier's or certified check,
(ii) if permitted by a vote of the Board of Directors, by delivery and assignment to the Company of shares of Company stock, or (iii) by a combination of (i) and (ii). The value of the Company's common stock for such purpose shall be its fair market


value as of the date the option is exercised, as determined in accordance with the procedures to be established by the Stock Option Committee.

(e) NON-TRANSFERABILITY. No option shall be transferable by the optionee otherwise than by will or the laws of descent or distribution, and each option shall be exercisable, during the optionee's lifetime, only by the optionee.

(f) TERMINATION OF OPTIONS. Unless otherwise provided for in the stock option agreements or by the Board of Directors, each option shall terminate and may no longer be exercised if the optionee ceases for any reason to be an employee, director, advisor or sales representative of the Company or a subsidiary, except that:

(i) if the optionee's employment or directorship shall have terminated for any reason other than cause, disability (as defined below), or death, the optionee at any time within a period of thirty (30) days after such termination of employment or directorship, but not later than the expiration date of the option, may exercise the option to the extent that the option was exercisable by the optionee on the date of such termination;

(ii) if the optionee's employment or directorship shall have been terminated because of disability within the meaning of Section 105(d)(4) of the Internal Revenue. Code of 1986, as amended (the "Code"), the optionee at any time within a period of one (1) year after such termination of employment or directorship, but not later than the expiration date of the option, may exercise the option to the extent that the option was exercisable by the optionee on the date of such termination; and

(iii) if the optionee dies at a time when the option was exercisable by the optionee, then the optionee's estate, personal representative, or beneficiary to whom it has been transferred pursuant to paragraph 7(f), at any time within a period of six (6) months following the death, but not later than the expiration date of the option, may exercise the option to the extent the option might have been exercised at the time of the optionee's death.

(g) RIGHTS AS SHAREHOLDER. The optionee shall have no rights as a shareholder with respect to any shares covered by an option until the date of issuance of a stock certificate to the optionee for such shares.

8. STOCK DIVIDENDS; STOCK SPLITS; STOCK COMBINATIONS; RECAPITALIZATIONS. Appropriate adjustment shall be made in the maximum number of shares of Common Stock subject to the Plan and in the number, kind, and option price of shares covered by outstanding options granted hereunder to give effect to any stock dividends or other distribution, stock splits, stock combinations, recapitalizations, and other similar changes in the capital structure of the Company after the effective date of the Plan.

(b) No optionee may receive options under the Plan in any one fiscal year of the Company exceeding that number of shares representing 15% of the total number of shares which options may be granted under the Plan and no optionee shall be entitled to receive options under the Plan exceeding in the aggregate that number of shares representing 33-1/3% of the total number of shares for which options may be granted under the Plan, in each case as such total number of shares may be increased from time to time with shareholder approval.

(c) Options may be granted by the Board of Directors to its members on the recommendation of the Stock Option Committee only at meetings of the Board of Directors held in the months of February, May, August, and November of each year.

(d) Options granted under the Plan to key employees and directors of the Company shall not be exercisable until a period of one year from the date of grant, except in the event of the optionee's termination of employment as a result of disability or death as specified in paragraph 7(f), in which event the option shall be immediately exercisable for the corresponding period specified in paragraph 7(f).

(e) Notwithstanding any other provision of the Plan, no option shall be exercisable unless the sale of the underlying shares is registered or qualified under applicable federal and state securities laws or, in the opinion of counsel for the Company, there is an available exemption for the underlying shares from such registration or qualification.

-2-

6. DURATION OF THE PLAN. The Plan shall terminate ten (10) years from the effective date of February 21, 1991, unless terminated earlier pursuant to paragraph 10, and no options may be granted thereafter.

7. TERMS AND CONDITIONS OF OPTIONS. Options granted under the Plan shall be evidenced by stock option agreements in such form and not inconsistent with the Plan as the Stock Option Committee shall approve from time to time, which agreements shall include, but are-not limited to, the following terms and conditions:

(a) PRICE. Each option agreement shall specify the purchase price per share of stock payable upon the exercise of each option granted hereunder, as determined by the Board of Directors.

9. MERGER; SALE OF ASSETS; DISSOLUTION. In the event of a change of the Common Stock resulting from a merger or similar reorganization as to which the Company is the surviving corporation, the number and kind of shares which thereafter may be optioned and sold under the Plan and the number and kind of shares then subject to options granted hereunder and the price per share thereof shall be appropriately adjusted in such a manner as the Stock Option Committee may deem equitable to prevent substantial dilution or enlargement of the rights available or granted hereunder. If the Company at any time should elect to dissolve, sell all or substantially all of its assets, undergo a reorganization, or merge or consolidate with any corporation and the Company is not the surviving corporation, then (unless in the case of a reorganization, merger, or consolidation where the surviving corporation assumes the optionees' rights under the Plan or issues substantially equivalent substitute rights in place thereof) each optionee shall be notified of his or her right to exercise all outstanding options prior to any such dissolution, sale, reorganization, merger, or consolidation. The failure to exercise such outstanding options within twenty
(20) days of such notification shall cause the options to be terminated.

10. TERMINATION OR AMENDMENT OF THE PLAN. The Board of Directors may at any time terminate the Plan or make such changes in or additions to the Plan as it deems advisable, provided that no such termination or amendment shall adversely affect or impair any then outstanding option without the consent of the optionee holding such option.

11. EFFECT OF THE PLAN ON EMPLOYMENT RELATIONSHIP. The establishment of the Plan shall in no way, now or hereafter, reduce, enlarge, or modify the employment relationship between the Company and the optionee. Nothing contained in the Plan shall be construed as conferring upon any optionee any right to continue in the employ of the Company.

12. DEFINITION.

(a) The term "key employees" means those executive, administrative, operational, or managerial employees who are determined by the Stock Option Committee to be eligible for options under the Plan.

(b) The term "optionee" means a key associate or a director to whom an option is granted under the Plan.

(c) The term "Parent", for purposes of the Plan, shall have the meaning ascribed to it under Section 425(e) of the Code.

(d) The term "subsidiary", for purposes of the Plan, shall have the meaning ascribed to it under Section 425(f) of the Code.

The undersigned, pursuant to approval of the Board of Directors on February 21, 1991, does herewith execute this Superconductive Components, Inc. 1991 Non-Statutory Stock Option Plan effective February 21, 1991.


Chairman of the Board of Directors

-3-

EXHIBIT 10(e)
SUPERCONDUCTIVE COMPONENTS, INC.

1995 STOCK OPTION PLAN
AMENDED SEPTEMBER 8, 1997, AUGUST 9, 1999 AND AUGUST 22, 2000

1. PURPOSE. This plan (the "Plan") is intended as an incentive and to encourage stock ownership by certain key associates, officers, directors, consultants and advisers who render services to Superconductive Components, Inc., an Ohio corporation (the "Company"), and any current or future subsidiaries or parent of the Company (the "Company Group"), by the granting of stock options (the "Options") as provided herein. By encouraging such stock ownership, the Company seeks to attract, retain and motivate employees, officers, directors, consultants and advisers of training, experience and ability. The Options granted under the Plan may be either incentive stock options ("ISOs") which meet the requirements of Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"), or options which do not meet such requirements ("Non-statutory Options").

2. EFFECTIVE DATE. The Plan shall become effective on September 29, 1995 (the "Effective Date").

3. ADMINISTRATION.

(a) The Plan shall be administered by the Board of Directors of the Company (the "Board"), which may, to the full extent permitted by law, delegate all or any of its powers under the Plan to a committee (the "Committee") which consists of not fewer than three members of the Board. If the Committee is so appointed and to the extent such powers are delegated, all references to the Board in the Plan shall mean and relate to the Committee.

(b) Subject to the provisions of the Plan, the Board is authorized to establish, amend and rescind such rules and regulations as it may deem appropriate for its conduct and for the proper administration of the Plan, to make all determinations under and interpretations of, and to take such actions in connection with, the Plan or the Options granted thereunder as it may deem necessary or advisable. All actions taken by the Board under the Plan shall be final and binding on all persons. No member of the Board shall be liable for any action taken or determination made relating to the Plan, except for gross negligence or willful misconduct.

(c) Each member of the Board shall be indemnified by the Company against costs, expenses and liabilities (other than amounts paid in settlements to which the Company does not consent, which consent shall not be unreasonably withheld) reasonably incurred by such member in connection with any action taken in relation to the Plan to which he or she may be a party by reason of service as a member of the Board, except in relation to matters as to which he or she shall be adjudged in such action to be personally guilty of gross negligence or willful misconduct in the performance of his or her duties. The foregoing right to indemnification shall be in addition to such other rights as the Board member may enjoy as a matter of law, by reason of insurance coverage of any kind, or otherwise.

4. ELIGIBILITY.

(a) ISOs and Non-statutory Options may be granted to such key associates of the Company Group, and Non-statutory Options only may be granted to directors who are not employees of and to consultants and advisers who render services to the Company Group, as the Board shall select from time to time (the "Optionees"). More than one Option may be granted to an individual under the Plan.

(b) No ISO may be granted to an individual who, at the time an ISO is granted, is considered under Section 422(b)(6) of the Code to own stock possessing more than 10 percent of the total combined voting power of all classes of stock of the Company or of its parent or any subsidiary corporation; PROVIDED, HOWEVER, this restriction shall not apply if at the time such ISO is granted the option price per Share of such ISO shall be at least 110% of the fair market value of such Share, and such ISO by its terms is not exercisable after the expiration of five years from the date it is granted. This subparagraph 4(b) has no application to Options granted under the Plan as Non-statutory Options.

(c) The aggregate fair market value (determined as of the date the ISO is granted) of Shares with respect to which ISOs are exercisable for the first time by any Optionee during any calendar year under the Plan or any other ISO plan of the Company or the Company Group may not exceed $100,000. If an ISO which exceeds the $100,000 limitation of this subparagraph 4(c) is granted, the portion of such Option which is exercisable for Shares in excess of the $100,000 limitation shall be treated as a Non-statutory Option pursuant to


Section 422(d) of the Code. Except as otherwise expressly provided in the immediately preceding sentence, this subparagraph 4(c) has no application to Options granted under the Plan as Non-statutory Options.

5. STOCK SUBJECT TO PLAN. The stock subject to Options under the Plan shall be shares of the common stock, no par value, of the Company ("Shares"). The Shares issued pursuant to Options granted under the Plan may be authorized and unissued Shares, Shares purchased on the open market or in a private transaction, or Shares held as treasury stock. The aggregate number of Shares reserved for options under the Plan shall be 600,000 subject to adjustment in accordance with the terms of paragraph 12 hereof. Any Shares subject to an option which for any reason expires or is terminated unexercised as to such Shares and any Shares reacquired by the Company pursuant to any forfeiture or any repurchase right hereunder may again be the subject of an Option under the Plan. The Board, in its sole discretion, may permit the exercise of any Option as to full Shares or fractional Shares. Proceeds from the sale of Shares under Options shall constitute general funds of the Company.

6. TERMS AND CONDITIONS OF OPTIONS.

(a) At the time of grant, the Board shall determine whether the Options granted are to be ISOs or Non-statutory Options and shall enter into stock option agreements with the recipients accordingly. All Options granted shall be authorized by the Board and, within a reasonable time after the date of grant, shall be evidenced by stock option agreements in writing ("Stock Option Agreements"), in such form and containing such terms and conditions not inconsistent with the provisions of this Plan as the Board shall from time to time determine. Any action under paragraph 12 may be reflected in an amendment to or restatement of such Stock Option Agreements.

(b) The Board may grant Options having terms and provisions which vary from those specified in the Plan if such Options are granted in substitution for, or in connection with the assumption of, existing options granted by another corporation and assumed or otherwise agreed to be provided for by the Company pursuant to or by reason of a transaction involving a corporate merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation to which the Company is a party.

7. PRICE. The option price per Share (the "Option Price") of each Option granted under the Plan shall be determined by the Board; PROVIDED, HOWEVER, the Option Price of each ISO granted under the Plan shall not be less than the fair market value (determined without regard to any restrictions other than a restriction which, by its terms, will never lapse) of a Share on the date of grant of such Option. An Option shall be considered granted on the date the Board acts to grant the Option or such later date as the Board shall specify.

8. OPTION PERIOD. The period during which the Option may be exercised (the "Option Period") shall be determined by the Board; PROVIDED, HOWEVER, any ISO granted under the Plan shall have an Option Period which does not exceed 10 years from the date the ISO is granted.

9. NON-TRANSFERABILITY OF OPTIONS. An Option shall not be transferable by the Optionee otherwise than by will or the laws of descent and distribution and may be exercised, during the lifetime of the Optionee, only by him or by his guardian or legal representative.

10. EXERCISE OF OPTIONS.

(a) Options granted hereunder will be exercisable upon the terms and conditions and in accordance with the vesting percentages determined by the Board in its sole discretion. Notwithstanding the foregoing or the terms and conditions of any Stock Option Agreement to the contrary, (i) in the event of the Optionee's termination of employment as specified in subparagraph 11(a), the Options shall be exercisable to the extent and for the period specified in subparagraph 11(a); (ii) in the event of the Optionee's termination of employment as a result of disability or death as specified in subparagraph
11(b), the Options shall be exercisable to the extent and for the period specified in subparagraph 11(b); (iii) in the event of a merger, reorganization or sale of all or substantially all of the assets of the Company as specified in subparagraph 12(c), the Options shall be exercisable to the extent and for the period specified in subparagraph 12(c); and (iv) in the event of a change in control, as defined herein, all Options held by Optionee shall become exercisable for the period specified in subparagraph 12(d).

-2-

(b) An Option shall be exercisable only upon delivery of a written notice to the Board, any member of the Board, the Company's Treasurer, or any other officer of the Company designated by the Board to accept such notices on its behalf, specifying the number of Shares for which it is exercised.

(c) Within five business days following the date of exercise of an Option, the Optionee or other person exercising the Option shall make full payment of the Option Price (i) in cash; (ii) with the consent of the Board, by tendering previously acquired Shares (valued at their fair market value as of the date of tender); (iii) with the consent of the Board, and to the extent permitted by applicable law, with a full recourse promissory note of the Optionee for the portion of the Option Price in excess of the par value of Shares subject to the Option, under terms and conditions determined by the Board and in cash for the par value of the Shares; or (iv) with the consent of the Board, any combination of (i), (ii), or (iii).

(d) The Optionee or other person exercising such Option shall pay to the Company an amount equal to the withholding amount required to be made less any amount withheld by the Company under paragraph 16.

If previously acquired Shares are to be used to pay the exercise price of an ISO, the Company prior to such payment must be furnished with evidence satisfactory to it that the acquisition of such Shares and their transfer in payment of the exercise price satisfy the requirements of Section 422 of the Code and other applicable laws.

11. TERMINATION OF EMPLOYMENT.

(a) Upon termination of an Optionee's employment with all of the members of the Company Group, other than termination of employment by reason of disability or death or for cause, the Optionee shall have 30 days after the date of termination of employment (but not later than the expiration date of the Stock Option Agreement) to exercise all Options held by him or her to the extent the same were exercisable on the date of termination; PROVIDED, HOWEVER, if such termination is due to the Optionee's retirement with the consent of the Company, such Option shall then be exercisable to the extent of 100% of the Shares subject thereto. The Board shall determine in each case whether a termination of employment shall be considered a retirement with the consent of the Company and, subject to applicable law, whether a leave of absence shall be considered a termination of employment. The Board may cancel an Option during the 30-day period after termination of employment referred to in this paragraph if the Optionee engages in employment or activities contrary, in the sole opinion of the Board, to the best interests of the Company or any parent or subsidiary of the Company.

(b) Upon termination of an Optionee's employment by reason of disability, as defined in subparagraph 25(a) of this Plan, or death, the Optionee or the Optionee's personal representative, or the person or persons to whom his or her rights under the Options pass by will or the laws of descent or distribution, shall have one year after the date of termination of employment by reason of disability or death (but not later than the expiration date of the Stock Option Agreement) to exercise all Options held by Optionee to the extent the same were exercisable on the date of the Optionee's termination of employment; PROVIDED, HOWEVER, the Board may, but shall not be required to, permit, in its discretion, the exercise of all or any portion of any Option granted to such Optionee not otherwise exercisable.

(c) Upon termination of an Optionee's employment for cause, as defined herein, all Options held by such Optionee shall terminate effective on the date of termination of employment.

12. STOCK SPLITS; MERGERS; REORGANIZATIONS; SALE OF ASSETS.

(a) In the event of a stock split, stock dividend, combination or exchange of shares, exchange for other securities, reclassification, reorganization, redesignation or other change in the Company's capitalization, the aggregate number of Shares for which Options may be granted under this Plan, the number of Shares subject to outstanding Options and the Option Price of the Shares subject to outstanding Options shall be proportionately adjusted or substituted to reflect the same. The Board shall make such other adjustments to the Options, the provisions of the Plan and the Stock Option Agreements as may be appropriate and equitable, which adjustments may provide for the elimination of fractional Shares.

(b) In the event of a change of the Common Stock resulting from a merger or similar reorganization as to which the Company is the surviving corporation, the number and kind of Shares which

-3-

thereafter may be purchased pursuant to an Option under the Plan and the number and kind of Shares then subject to Options granted hereunder and the price per Share thereof shall be appropriately adjusted in such manner as the Board may deem equitable to prevent dilution or enlargement of the rights available or granted hereunder.

(c) Except as otherwise determined by the Board, in the event of a merger or a similar reorganization which the Company does not survive (other than a merger or similar reorganization involving only a change in the state of incorporation or an internal reorganization not involving a change in control as defined herein), or a sale of all or substantially all of the assets of the Company, shall cause every Option hereunder to terminate, to the extent not then exercised, unless any surviving entity agrees to assume the obligations hereunder; provided, however, that, in the case of such a merger or similar reorganization, or such a sale of all or substantially all of the assets of the Company, if there is no such assumption, the Board may provide that some or all of the unexercised portion of any one or more of the outstanding Options shall be immediately exercisable and vested as of such date prior to such merger, similar reorganization or sale of assets as the Board determines.

(d) If a change in control, as defined herein, occurs, all outstanding options granted under this Plan shall then be immediately exercisable to the extent of 100% of the Shares subject thereto notwithstanding any contrary waiting or vesting periods specified in this Plan or in any applicable Stock Option Agreement.

13. RIGHTS AS SHAREHOLDER. The Optionee shall have no rights as a shareholder with respect to any Shares covered by an Option until the date of issuance of a stock certificate to the Optionee for such Shares.

14. NO CONTRACT OF EMPLOYMENT. Nothing in the Plan or in any Option or Stock Option Agreement shall confer on any Optionee any right to continue in the employ or service of the Company Group or interfere with the right of the Company Group to terminate such Optionee's employment or other services at any time. The establishment of the Plan shall in no way, now or hereafter, reduce, enlarge or modify the employment relationship between the Company Group and the Optionee. Options granted under the Plan shall not be affected by any change of duties or position of the Optionee with the Company Group.

15. AGREEMENTS AND REPRESENTATIONS OF OPTIONEES. As a condition to the exercise of an Option, the Board may, in its sole determination, require the Optionee to represent in writing that the Shares being purchased are being purchased only for investment and without any present intent at the time of the acquisition of such Shares to sell or otherwise dispose of the same.

16. WITHHOLDING TAXES. The Company's obligation to deliver Shares upon exercise of an Option shall be subject to the Optionee's satisfaction of all applicable federal, state or local tax withholding obligations. The Company shall have the right to withhold from any salary, wages, or other compensation for services payable by the Company to or with respect to an Optionee, amounts sufficient to satisfy any federal, state or local withholding tax liability attributable to such Optionee's (or any beneficiary's or personal representative's) receipt or disposition of Shares purchased under any Option or to take any such other action as it deems necessary to enable it to satisfy any such tax withholding obligations. The Board, in its sole discretion, may permit Optionees to elect to have Shares that would be acquired upon exercise of Options (valued at their fair market value as of the date of exercise) withheld by the Company in satisfaction of such Optionees' withholding tax liabilities.

17. EXCHANGES. The Board may permit the voluntary surrender of all or a portion of any Option granted under the Plan to be conditioned upon the granting to the Optionee of a new Option for the same or a different number of Shares as the Option surrendered, or may require such voluntary surrender as a condition precedent to a grant of a new Option to such Optionee. Subject to the provisions of the Plan, such new Option shall be exercisable at the same price, during such period and on such other terms and conditions as are specified by the Board at the time the new Option is granted. Upon surrender, the Options surrendered shall be cancelled and the Shares previously subject to them shall be available for the grant of other Options.

18. REPURCHASE OF SHARES BY THE COMPANY. Any Shares purchased or acquired upon exercise of an Option may, in the sole discretion of the Board, be subject to repurchase by or forfeiture to the Company if and to the extent and at the repurchase price, if any, specifically set forth in the Stock Option Agreement pursuant to which the Shares were purchased or acquired. Certificates representing Shares subject to such repurchase or forfeiture may be subject to such escrow and stock legending provisions as may be set forth in the Stock Option Agreement pursuant to which the Shares were purchased or acquired.

-4-

19. CONFIDENTIALITY AGREEMENTS. Upon the Company's request, each Optionee shall execute, prior to or contemporaneously with the grant of any Option hereunder, the Company's then standard form of agreement relating to nondisclosure of confidential information, noncompetition and/or assignment of inventions and related matters.

20. COMPLIANCE WITH LAWS AND REGULATIONS. The Plan, the grant and exercise of Options thereunder, and the obligation of the Company to sell and deliver the Shares under such Options, shall be subject to all applicable federal and state laws, rules and regulations and to such approvals by any government or regulatory agency as may be required. Options issued under the Plan shall not be exercisable prior to (i) the date upon which the Company shall have registered the Shares for which Options may be issued hereunder under the l933 Act, and (ii) the completion of any registration or qualification of such Shares under state law, or any ruling or regulation of any governmental body which the Company shall, in its sole discretion, determine to be necessary or advisable in connection therewith, or alternatively, unless the Company shall have received an opinion from counsel to the Company stating that the exercise of such Options may be effected without registering the Shares subject to such Options under the l933 Act, or under state or other law.

21. ASSUMPTION. The Plan may be assumed by the successors and assigns of the Company.

22. EXPENSES. All expenses and costs in connection with administration of the Plan shall be borne by the Company.

23. AMENDMENT, MODIFICATION AND TERMINATION OF THE PLAN. The Board may terminate, amend or modify the Plan at any time without further action on the part of the shareholders of the Company; PROVIDED, HOWEVER, that (a) in no event shall any amendment be made to the Plan which would cause the ISOs granted hereunder to fail to qualify as incentive stock options under the Code; and (b) any amendment to the Plan which requires the approval of the shareholders of the Company under the Code or the regulations promulgated thereunder shall be subject to approval by the shareholders of the Company in accordance with the Code or such regulations.

With the consent of the Optionee affected, the Board may amend outstanding Options or related agreements in a manner not inconsistent with the Plan. The Board shall have the right to amend or modify the terms and provisions of the Plan and of any outstanding ISO's granted under the Plan to the extent necessary to qualify any or all such Options for such favorable federal income tax treatment (including deferral of taxation upon exercise) as may be afforded incentive stock options under Section 422 of the Code.

24. LIMITATION OF LIABILITY. The liability of the Company under this Plan or in connection with any exercise of an Option is limited to the obligations expressly set forth in the Plan and in any Stock Option Agreements, and no term or provision of this Plan or of any Stock Option Agreements shall be construed to impose any further or additional duties, obligations or costs on the Company not expressly set forth in the Plan or the Stock Option Agreements.

25. DEFINITIONS.

(a) DISABILITY. "Disability," as used herein, shall mean a physical or mental condition resulting from bodily injury, disease, or mental disorder which renders the Optionee incapable of continuing the Optionee's usual and customary employment or service with the Company Group.

(b) FAIR MARKET VALUE. If the Shares are publicly traded, the term "fair market value" as used in this Plan shall mean (a) the closing price quoted in the NASDAQ National Market System, if the shares are so quoted, (b) the last quote reported by NASDAQ for small-cap issues, if the shares are so quoted, (c) the mean between the bid and asked prices as reported by NASDAQ, if the Shares are so quoted, or (d) if the Shares are listed on a securities exchange, the closing price at which the Shares are quoted on such exchange, in each case at the close of the date immediately before the Option is granted or, if there be no quotation or sale on that date, the next previous date on which the Shares were quoted or traded. In all other cases, the fair market value shall be determined by and in accordance with procedures established in good faith by the Board and with respect to ISOs, conforming to regulations issued by the Internal Revenue Service regarding incentive stock options.

-5-

(c) KEY ASSOCIATES. The term "key associates" shall include those executive, administrative, operational and managerial employees who are determined by the Board to be eligible for Options under the Plan.

(d) PARENT AND SUBSIDIARY. The terms "subsidiary" and "parent" as used in the Plan shall have the respective meanings set forth in sections 424(f) and (e) of the Code.

(e) TERMINATION FOR CAUSE. The term "termination of employment for cause" shall mean termination of employment for (a) the commission of an act of dishonesty, including but not limited to misappropriation of funds or property of the Company; (b) the engagement in activities or conduct injurious to the reputation of the Company; (c) the conviction or entry of a guilty or no contest plea to a misdemeanor involving an act of moral turpitude or a felony;
(d) the violation of any of the terms and conditions of any written agreement the Optionee may have from time to time with the Company Group (following 30 days' written notice from the Company specifying the violation and the employee's failure to cure such violation within such 30-day period); or (e) any refusal to comply with the written directives, policies or regulations established from time to time by the Board or the person to whom the Optionee reports.

(f) CHANGE IN CONTROL. A "change in control" shall be deemed to have taken place if, as a result of a tender offer, merger, consolidation, sale of assets or contested election, or any combination of the foregoing transactions (a "Transaction"), the persons who were directors of the Company immediately before the Transaction shall cease to constitute a majority of the Board of Directors of the Company or of any successor to the Company; provided, however, that any Transaction shall not be deemed to be a change in control if the Transaction causing such change shall have been approved by the affirmative vote of at least a majority of the members of the Board of Directors of the Company in office immediately prior to the change in control.

-6-

EXHIBIT 23

INDEPENDENT AUDITORS' CONSENT

We consent to the use of our report dated July 26, 2000, in the Registration Statement on Form 10-SB dated September 28, 2000 of Superconductive Components, Inc.

                                      /s/HAUSSER + TAYLOR LLP


Columbus, Ohio


September 26, 2000


EXHIBIT 24

POWER OF ATTORNEY

Each of the undersigned officers and directors of Superconductive Components, Inc., an Ohio corporation (the "Company"), hereby appoints Edward R. Funk and Curtis A. Loveland as his true and lawful attorneys-in-fact, or either of them, with power to act without the other, as his true and lawful attorney-in-fact, in his name and on his behalf, and in any and all capacities stated below, to sign and to cause to be filed with the Securities and Exchange Commission the Company's registration statement on Form 10-SB, and any and all amendments thereto, hereby granting unto said attorneys, and to each of them, full power and authority to do and perform in the name and on behalf of the undersigned, in any and all such capacities, every act and thing whatsoever necessary to be done in and about the premises as fully as each of the undersigned could or might do in person, hereby granting to each such attorney full power of substitution and revocation, and hereby ratifying all that either such attorney or his substitute may do by virtue hereof.

IN WITNESS WHEREOF, the undersigned have executed this Power of Attorney in counterparts if necessary, effective as of August 18, 2000.

DIRECTORS/OFFICERS:

       SIGNATURE                                     TITLE


/s/ EDWARD R. FUNK             President, Chief Executive Officer and a Director
--------------------------
     Edward R. Funk

/s/ ROBERT J. BAKER            Director
--------------------------
     Robert J. Baker, Jr.

/s/ J.R. GAINES, JR.           Director
--------------------------
     J. R. Gaines, Jr.

/s/ ROBERT H. PEITZ            Director
--------------------------
     Robert H. Peitz

/s/ CHARLES E. WASHBUSH        Director
--------------------------
     Charles E. Washbush

/s/ CURTIS A. LOVELAND         Director
--------------------------
     Curtis A. Loveland

/s/ LLOYD E. HACKMAN           Director
--------------------------
     Lloyd E. Hackman

/s/ EDWARD W. UNGAR            Director
--------------------------
     Edward W. Ungar


ARTICLE 5


PERIOD TYPE YEAR 12 MOS 6 MOS 6 MOS
FISCAL YEAR END DEC 31 1999 DEC 31 1998 DEC 31 2000 DEC 31 1999
PERIOD START JAN 01 1999 JAN 01 1998 JAN 01 2000 JAN 01 1999
PERIOD END DEC 31 1999 DEC 31 1998 JUN 30 2000 JUN 30 1999
CASH (30,735) 4,580 (61,765) (21,077)
SECURITIES 0 0 0 0
RECEIVABLES 326,084 277,389 436,411 408,058
ALLOWANCES 23,688 19,715 47,000 24,000
INVENTORY 531,682 479,228 584,421 552,217
CURRENT ASSETS 878,570 771,147 1,040,832 958,146
PP&E 2,172,849 2,043,182 2,210,963 2,064,284
DEPRECIATION 1,440,331 1,185,150 1,589,133 1,311,968
TOTAL ASSETS 1,666,983 1,696,496 1,723,272 1,772,622
CURRENT LIABILITIES 820,579 758,092 867,433 838,500
BONDS 0 0 0 0
PREFERRED MANDATORY 4,854,248 4,674,238 5,336,038 4,676,638
PREFERRED 180,841 236,250 107,037 174,187
COMMON 691,672 876,183 360,032 912,283
OTHER SE (5,377,168) (5,139,881) (5,522,987) (5,197,235)
TOTAL LIABILITY AND EQUITY 1,666,983 1,696,496 1,723,272 1,772,622
SALES 2,253,209 2,067,610 1,151,507 1,062,989
TOTAL REVENUES 2,678,362 2,498,162 1,499,715 1,194,654
CGS 1,835,027 1,721,986 938,818 827,989
TOTAL COSTS 2,201,183 2,059,939 1,198,033 108,603
OTHER EXPENSES 598,340 359,751 367,900 253,017
LOSS PROVISION 0 301,618 0 0
INTEREST EXPENSE 44,473 28,847 33,633 20,616
INCOME PRETAX (145,934) (241,803) (94,147) (13,192)
INCOME TAX 0 0 0 0
INCOME CONTINUING (145,934) (241,803) (94,147) (13,192)
DISCONTINUED 0 0 0 0
EXTRAORDINARY 0 0 0 0
CHANGES 0 0 0 0
NET INCOME (145,934) (241,803) (94,147) (13,192)
EPS BASIC (0.12) (0.20) (0.07) (0.01)
EPS DILUTED (0.12) (0.20) (0.07) (0.01)